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Cassava is a well-known cyanogenic plant, which contains the cyanogenic 
glycosides linamarin and lotaustralin, the former being the principal cyanogenic 
glycoside. The ability to detect and quantify cyanogenic glycosides, capable of 
generating cyanide, could contribute to prevention of acute and subacute 
cyanide poisoning from the consumption of improperly processed plants. 
Enzyme-linked immunosorbent assay (ELISA) can be used to detect and 
measure the amount of linamarin directly within the fresh cassava or cassava-
related products with minimal sample preparation using antibodies as the key 
detector. However, there has been no antibody and ELISA developed for 
linamarin detection in foods, hence the need. The aim of the project was to 
generate polyclonal antibodies (pAbs)  obtained by immunizing two New Zealand 
white rabbits with linamarin (hapten) conjugated to a carrier protein, bovine 
serum albumin (BSA) using cyanuric chloride as chemical linker to be used with 
the ELISA. Monoclonal antibodies (mAbs) development was attempted by 
immunizing four BALB/c mice with linamarin-CC-KLH and 3 BALB/c mice with 
linamarin-CC-BSA but failed to produce the desired antibodies. PAbs generated 
by both immunised rabbits were highly immunoreactive with antiserum titre of 
1:100,000. The pAbs were able to establish positive inhibition assay towards free 
linamarin with high specificity and sensitivity (limit of detection of 0.0015 µg/ml 
and IC50 of 2.1 µg/ml). The optimised ELISA was able to determine the amount 
of linamarin in fresh cassava and processed products available in the UK market, 
ranging from 0.003 mg/kg to 43.08 mg/kg fresh and dry weight depending on the 
products. Levels of linamarin of some fresh cassava products are way beyond 





consumers. In contrast, highly processed cassava products contained less than 
1.0 mg/kg of linamarin, indicating the effectiveness of proper food processing 
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TNBS Trinitrobenzene sulfonic acid 
UV Ultraviolet 
v/v Volume to volume ratio 




Chapter 1 : Introduction 
 
1.1 Cassava (Manihot esculenta Crantz) 
1.1.1 Importance of cassava 
 
Cassava (Manihot esculenta Crantz), also commonly known as tapioca, manioc 
or yuca, is an important economical and nutritional perennial woody tall shrub 
(Figure 1-1) cultivated and domesticated from one or more species of genus 
Manihot, belonging to the Euphorbiaceae family (Allem, 2002; McKey et al. 
2010), native to South America. The genus Manihot comprises 98 species of 
which M. esculenta is the most widely cultivated member (Rogers and Appan, 
1973; Nassar et al., 2008). It ranks fourth as a major food crop after rice, wheat 
and maize and the productivity of cassava in terms of calories per unit land area 
per unit of time is significantly higher than other staple food crops (Nambisan, 
2011; Latif and Müller, 2014).  
 
  
Figure 1-1: Cassava tree and roots. a) Cassava tree, b) cassava root (whole), 





The drought tolerance of cassava, combined with high yield on poor soils and 
the possibility to leave the starch-rich tubers in the soil for extended time periods 
thus enabling harvest on demand, renders the increasing use of cassava as a 
food source where in the past thirty years, the area under cultivation has doubled 
and is expected to increase further (Nweke et al., 2002; Chauynarong et al. 2009; 
Burns et al., 2012). Besides high yields, the plant has enormous potential for 
accumulation of starch, ability to produce moderate yields in marginal lands 
(semi-arid tropic: < 600 mm, sub-humid and humid-tropics: > 10,000 mm of rain 
per year) and is tolerant to diseases and pests (De Tafur et al., 1997; Pellet and 
El-Sharkawy, 1997). In terms of yield it is the most productive crop per unit land 
area especially when cultivated under tropical conditions (warm climate, mean 
day temperature of > 20°C, optimum leaf temperature between 25-35°C) (El-
Sharkawy et al., 1992a), with a yield of between 25 and 60 tonnes/ha (L/ha = 
10,000 m2) (Garcia and Dale, 1999).  
 
These attributes make cassava a favoured crop for both, small scale farmers and 
large scale plantation as it requires low input of time, labour and money hence 
often regarded as a valuable food security crop and an insurance against famine 
(Nambisan, 2011, Latif and Müller, 2014). The estimated total of world cassava 
production was 228 million tonnes in 2007 (FAO, 2008) and in 2012 it reached 
276.7 million tonnes, an approximate of 10 million tonnes (1 tonne = 1000 kg) 
annual production, contributing to almost 40% production increase since 2000 
according to the FAO (2013) and FAO (2014). By 2020 the production of cassava 
is predicted to reach an estimate of 291 million tonnes (Scott et al., 2000, FAO, 





been sluggish due to changes in policies and incentives favouring cultivation of 
other crops in Africa and uncertainty of cassava sectors in Asia as they are 
strongly susceptible to developments in China,  the principal destination for 
internationally traded cassava products. In 2008/2009 about 51% of cassava in 
the world was produced in Africa, 35% in Asia and only 14% in South America 
and the Caribbean (Howeler, 2017) and from that almost 70% of world’s cassava 
production alone comes from five countries, namely Nigeria, Democratic 
Republic of Congo (Africa), Brazil (South America), Thailand and Indonesia 
(South East Asia) (Chauynarong et al., 2009, Burns et al., 2010). ). It provides 
an important source of carbohydrates for more than 800 million people worldwide 
being extensively cultivated in nearly 105 countries mostly in tropical and 
subtropical regions of sub-Saharan Africa,  South East Asia and South America, 
with an estimated total cultivated area greater than 13 million hectares and partly 
due to the amount of energy it yields per hectare is evidently more than other 
staple food crops. (El-Sharkawy, 2003; Montagnac et al., 2009a).  
 
1.1.2 Nutritional value of cassava roots and leaves 
About 70% of cassava tubers/roots and leaves (to a lesser extent) are edible, 
mainly used for human consumption either directly after cooking or in processed 
forms/products (Westby, 2002); the remaining 30% is used for animal feed and 
other industrial products such as starch, glucose and alcohol (El-Sharkawy, 
2004). Tapioca, a commercially important starch product common in the United 
States and in South East Asia, mainly used in drinks and desserts is one of the 
products of cassava roots whereby the leaves are usually cooked as green 





sauce, eaten with starchy dishes like chikwange, cassava fufu, boiled cassava 
roots, rice and pounded yam (Latif and Muller, 2015).  The nutritional values of 
cassava root and leaves have been extensively studied by several authors and 
recently reviewed by Montagnac et al. (2009a), Morgan and Choct (2016) on 
cassava as a whole and Latif and Muller (2015) mainly on cassava leaves. 
 
Table 1-1: Proximate, vitamin and mineral composition of cassava roots 
and leaves. 








Proximate composition  
(g per 100g) 
   
Food energy (kcal) 160 110 to 149 91 
Food energy (KJ) 667 526 to 611 209 to 251 
Moisture (g) 59.68 45.9 to 85.3 64.8 to 88.6 
Dry weight (g) 40.32 29.8 to 39.3 19 to 28.3 
Protein (g) 1.36 0.3 to 3.5 1.0 to 10.0 
Lipid (g) 0.28 0.03 to 0.5 0.2 to 2.9 
Carbohydrate, total (g) 38.06 25.3 to 35.7 7 to 18.3 
Dietary fiber (g) 1.8 0.1 to 3.7 0.5 to 10.0 
Ash 0.62 0.4 to 1.7 0.7 to 4.5 
    
Vitamins    
Thiamin (mg) 0.087 0.03 to 0.28 0.06 to 0.31 
Riboflavin (mg) 0.048 0.03 to 0.06 0.21 to 0.74 
Niacin (mg) 0.854 0.6 to 1.09 1.3 to 2.8 
Ascorbic acid (mg) 20.6 14.9 to 50 60 to 370 
Vitamin (mg) - 5.0 to 35.0 8300 to 11800 
    
Minerals    
Calcium (mg) 16 19 to 176 34 to 708 
Phosphorus, total (mg) 27 6 to 152 27 to 211 
Ca/P 0.6 1.6 to 5.48 2.5 
Iron (mg) 0.27 0.3 to 14.0 0.4 to 8.3 
Potassium (%) - 0.25 (0.72) 0.35 (1.23) 
Magnesium (%) - 0.03 (0.08) 0.12 (o.42) 
Cooper (ppm) - 2.00 (6.00) 3.00 (12.0) 
Zinc (ppm) - 14.00 (41.00) 71.0 (249.0) 
Sodium (ppm) - 76.00 (213.00) 51.0 (177.0) 
Manganese (ppm) - 3.00 (10.00) 72.0 (252.0) 






The roots are twice as rich as the leaves in carbohydrates, but the leaves contain 
more protein, lipid, minerals, vitamins and fibre. The total protein content in 
cassava leaves is 5 to 10 times higher than in roots and is comparable with the 
protein content of an egg based on grams of nitrogen (Latif and Muller, 2015). 
The lipid content is 10 times higher in leaves than in roots. Although the lipids 
and lipid-soluble components such as photosynthetic pigments are much more 
concentrated in leaves, some of them, such as volatile fatty acids, do not bring 
significant energy to the diet. Therefore, the energy density of the lipid is lower 
in leaves than in roots. The mineral content of cassava leaves is 2 to 5 times 
higher than of the roots. The roots typically have more phosphorus, but the 
leaves have a greater concentration of calcium (Gil and Buitrago, 2002). The 
calcium content in the leaves is 100 times higher than in roots and the 
phosphorus content is 2 to 3 times higher in roots than in the leaves. Cassava 
leaves are more concentrated than the roots in vitamins, and the minerals iron, 
potassium, magnesium, copper, zinc and manganese. Overall, their nutritional 
value is, consequently, lower than those of cereals, legumes and some other 
root and tuber crops in terms of mineral,  vitamin, lipid and protein contents but 
the leaves are well provided in these, and should be added to diet consisting 
mainly of roots (Latif and Muller, 2015) or perhaps from other food plants or 
sources (El-Sharkawy, 2004), which sometimes hard to come by in certain areas 








1.1.3 Antinutritional aspects of cassava roots and leaves 
Given the comprehensive reports on the nutritional value of cassava, it appears 
that cassava roots are a good energy dense source of carbohydrate meanwhile 
cassava leaves provide good sources of minerals, vitamins and fibre for human 
and animal consumption. Despite the positive attributes, it has a number of 
serious limitations as reported by Burns et al. (2009). Firstly, cassava roots are 
not tubers and therefore cannot be used for reproductive purpose (Ceballos et 
al., 2004). As a major consequences of this, Beeching et al. (1998) reported the 
problem of rapid post-harvest physiological deterioration (PPD) of the roots 
within one or two days following removal from the soil, which limits its 
marketability unless they are immediately processed or consumed (van Oirschot 
et al., 2000; El-Sharkawy, 2004; Lebot, 2009). Secondly, the roots are low in 
protein and some essential micro-nutrients which would results in unbalanced 
diet, thus, additional requirements for protein and other essential nutrients are 
commonly fulfilled by other food sources (El-Sharkawy, 2004), for instance, the 
cassava leaves (Latif and Muller, 2015). Thirdly, cassava contains a number of 
bioactive products that are harmful to human health. Antinutritional factors such 
as tannins, polyphenols, phytic acid and high fibre content could reduce nutrient 
bioavailability, nutrient uptake and digestibility and the presence of cyanogenic 
glycosides (CGs), may eventually lead to toxic exposure depending on the 
processing method and amount consumed (Montagnac et al., 2009b; Wobeto et 
al., 2007). The level of antinutrients also varies depending on the maturity status, 






In contrast, depending on the ingested amount, some of these compounds can 
either act as antioxidants and to some extent, anticarcinogens (Wobeto et al., 
2007). For example, polyphenols found in the leaves are usually considered as 
antioxidants but they also bind with essential minerals and make them 
unavailable for absorption (Latif and Muller, 2015). In term of protein digestibility 
in young and old leaves, it was found to be 80% and 67% respectively (Bokanga, 
1994). This reduction may be attributed to the condensed tannin in cassava 
leaves due to the indigestible tannin-protein complexes or negative effect on the 
enzyme activity (Lancaster and Brooks, 1983). Massey (2007) reported 
antinutritional property of oxalate, a simple dicarboxylic acid [(COO)22-] found in 
cassava leaves, which negatively affects the bioavailability of magnesium and 
calcium as the oxalates bind to the calcium and excreted through urine or formed 
crystals which might cause kidney stones. However, the negative effect of 
oxalates on human health depends on the oxalate and calcium levels as Wobeto 
et al. (2007) reported the calcium-to-oxalate ratio in five cassava cultivars was 
lower than the critical limit of calcium uptake. Therefore, the oxalate levels in 
cassava leaf may not negatively affect the calcium uptake present in cassava 
leaves.  
 
Above all, the major concern among these antinutrients are the presence of CG, 
one of the plant secondary metabolites, which could release toxic hydrogen 
cyanide (HCN) in a process known as cyanogenesis. The levels of CGs content 
in cassava have been long associated with the bitter taste by several studies 
(Sundaresan et al., 1987; King and Bradbury, 1985; Bokanga, 1994). The bitter 
taste is often used by cassava farmers to predict toxicity of single raw roots by 





them to classify cultivars that are toxic and require extensive processing and the 
less toxic cultivars, mostly referred to as ‘cool’, ‘sweet’ or ‘non-bitter’ cassava. 
However, this relationship was still debatable as some studies failed to prove the 
association (Sinha and Nair, 1968; Pereira et al., 1981) but a recent 
comprehensive study by Chiwona-Karltun et al. (2004) found a strong correlation 
between bitterness and glycoside level which is consistent with the majority of 
the earlier studies. Studies indicated that roots from bitter cassava cultivars are 
preferred for making flour (Nweke, 1994) and it produces products that have 
superior taste and texture qualities (Dufour, 1993; 1994). In many parts of Africa, 
farmers who are prone to food insecurity preferentially grow ‘bitter’ cassava 
cultivars that yield toxic roots as it improves food security by conferring protection 
from theft and animal destruction (Kapinga, 1997). The methods for processing 
cassava that have evolved in Africa have been adapted to remove the toxicity 
and suit the local preferences of the desired food products (Lancaster et al., 
1982). However, in other parts of the world where consumption of cassava occur 
occasionally, lack of knowledge in cassava toxicity and preparation could 
become a serious food safety issue. Cassava consumption can lead, therefore, 
to chronic health problems and acute cyanide poisoning unless the food products 






1.2 Plant secondary metabolites  
A characteristic feature of vascular plants is their capacity to synthesize an 
enormous variety of low molecular weight chemical compounds, the so-called 
secondary metabolites. Secondary metabolites are plant-produced organic 
compounds that play an important role in the defence of plants against 
herbivorous animals including insects and vertebrates, invading pathogens 
(bacteria or viruses), fungi growth as well as in their adaptation to the 
environment as such competing for better light source, water uptake and 
nutrients, although they are not directly involved in the growth and development 
of organisms (Bennett and Wallsgrove, 1994; Fürstenberg-Hägg et al., 2013; 
Sakamoto et al., 2017). More often, they serve as key components of active and 
potent chemical compounds and depending on plant species, they may be 
present in the whole plant or compartmentalized in seeds, fruits, leaves or stalks. 
According to a review by Wittstock and Gershenzon (2002), parts of the plant 
that are highly exposed and within reach of insects, herbivores or other predators 
have the tendency to synthesise and accumulate high levels of toxic compounds 
(mostly attributed to plant secondary metabolites) compared to parts that are well 
or partly hidden and out of reach. Tens of thousands of these secondary 
metabolites have already been isolated and their structures determined (Table 
1-2) by various analytical methods such as mass spectrophotometry (electron 
impact, EIMS, chemical ionization/gas CI/GCMS, fast atom bombardment/liquid 
secondary ion, FAB/LSIMS), nuclear magnetic resonance (H-NMR, 13C-NMR), 
X-ray diffraction (Harbone, 1993), and high performance liquid chromatography 






Table 1-2: Number of known secondary metabolites of higher plants 
Compounds No. of structures 
Cyanogenic glycosides  50 
Sesquiterpenes 1,500 
Tetraterpenes  350 
Triterpenes/steroids 800 
Diterpenes 1,000 




Flavonoids  1,200 
Alkaloids 7,000 
Nonprotein amino acids 400 
Monoterpenes 1,000 
Polyketides 700 
(Adapted from Wink, 1988) 
 
The specific odours, tastes and colours of plants are mostly contributed by these 
secondary metabolites which are distinct from the intermediate and products of 
primary metabolism that could be distinguished according to their family and 
species. Such restricted distribution of compounds enable them to be used as 
taxonomic markers (Bennett and Wallsgrove, 1994). They usually behave by 
altering specific mechanisms involving enzymes, receptors and genetic targets 
in particular cells and tissues and their formation is usually organ-, tissue-, cell- 
and often development-specific regulated by their respective genes (Wink, 1988, 
1999). These secondary metabolites are therefore ultimately important for the 
fitness and survival of the plant producing them (Wink, 1999). Although not all 





metabolites that are, particularly CGs present in cassava. The toxins proved to 
be toxic to humans, animals and insects when they come into contact with them 
either internally or externally.  
 
1.2.1 Plant toxins in plants  
Most plants possess multiple lines of defence to avoid being eaten; these include 
physical methods such as hairs and spines to impale potential herbivores and 
chemical methods targeting the nervous, reproductive or digestive systems of 
potential herbivores as reviewed by Petersen (2011). Plant toxins are naturally-
occurring chemical of secondary metabolites that may be poisonous to 
pathogens, herbivores and humans. They provide protection for plants from 
predators by acting as deterrent against herbivores, insects and pathogens as 
represented in Table 1-3.  
 
Table 1-3: Chemical defence strategies of plant secondary metabolites 






Toxic for vertebrates, arthropods, 
bacteria 
Cyanogenic glycosides  Toxic for animals   
Flavonoids/anthocyanins  Antimicrobial, insectistatic  
Glucosinolates  Repellent for animals, antimicrobial 
Non-protein amino acids  Toxic for animals, antimicrobial 
Phenylpropanoids  Antimicrobial   
Terpenes   Repellent for animals, antimicrobial 






They may be present in the whole plant or concentrated in vital regions that are 
usually prone to animal disturbance such as seeds, fruits, leaves and stalks. 
According to Chandra (2012), the poisonous constituent may be concentrated in 
one or more parts of the plant depending on plant species. These toxins, if 
consumed or touched, are toxic to humans, animals and insects. Plant toxins are 
classified based on their structural and chemical constituents; alkaloids, 
glycosides, proteins, oxalates, anti-vitamins, tannins, volatile ethers, 
phytoestrogens, terpenes, glucosinolates and phenylpropanoids (Wink, 1988; 













Examples of specific natural plant toxins from each class of plant toxin are listed 
in Table 1-4: 






Toxin name References 
Nitrile Alkanenitriles Cyanogenic 
glycosides 
Flemming, 1999  a, b-unsaturated 
nitriles 
Samentosin 
 Aromatic nitriles Cytotoxin 






Schep et al., 2009 
Glucosides Methylazoxymethanol Cycasin Wogan & Busby, 
1980) 




Wogan & Busby, 
1980) 
Toxic effects    














 Saponin Osbourn, 1996 
Stimulatory effect 




Schep et al., 20009 
Growth inhibitor  Glucosinolate Ulmer et al., 2001 






Several plant species are cultivated from food and many plants or plant parts 
(seeds, leaves, fruits) are consumed as food. Seeds are important sources for 
animals including humans because of their high nutrient contents (starch, 
protein, lipids, fibre, vitamins and minerals). Leaves and fruits are good sources 
of vitamins and minerals for humans. Although animals including humans 
depend on plants for sustenance, plant foods contain quite a large numbers of 
naturally-occurring toxins that are harmful to both animals and humans.  
 
1.2.2 Cyanogenic glycosides 
Cyanogenic glycosides (CGs), classified as phytoanticipins, are the most 
important defence-related secondary metabolites and a class of natural plant 
toxin mainly found in plant foods. Phytoanticipins are of low molecular weight, 
antimicrobial compounds that are present in plants before challenge by 
microorganisms or are produced after infection solely from pre-existing 
constituents (VanEtten et al., 1994). There are approximately 25 known CGs and 
these are generally found in edible parts of the plants, particularly in the seed of 
such fruits (Bolarinwa et al., 2016; Cressey and Reeve, 2019) and they are 
widely distributed in the plant kingdom, being present in more than 2,650 species 
(Conn, 1980; Poulton., 1990; Møller, 1999; Bak et al., 2006, Ganjewala et al., 
2010; Zagrobelny et al., 2018), commonly found in certain families belong to the 
Angyospermatophyta and remaining to the Dicotyledonopsida and 
Monocotyledonopsida. This includes economically important crop and edible 







Table 1-5: Cyanogenic glycosides and its occurence in major food plants 
Cyanoglucosides Sugar moiety Food plants 
 
Linamarin D-glucose Cassava (Manihot esculenta) 
Lima beans (Phaseolus lunatus) 
Flaxseed (Linum usitatissimum) 
Kidney beans (Phaseolus vulgaris) 
Oats (Avena sativa) 
 
Dhurrin D-glucose Wheat (Triticum aestivum) 
Rye (Secale cereale) 
Sorghum (Sorghum bicolor) 
Macademia nut (Macademia 
ternifolia) 
 
Prunasin D-glucose Apple (Malus pumila) 
Quince (Cydonia oblonga) 
Passion fruit (Passiflora edulis) 
 
Taxiphyllin D-glucose Bamboo shoots (Bambusa vulgaris) 
 
Amygdalin Gentiobiose Almond (Prunus dulcis) 
Apricot (Prunus armeniace) 
Peaches (Prunus persica) 
Plums (Prunus domestica) 
Sweet cherry (Prunus avium) 
Sour cherry (Prunus cerasus) 
 
Triglochinin D-glucose Millets (Eluesine coracana) 
Taro (Colocasia esculenta) 
Giant taro (Alocasia macrorrhizos) 
 
Lucumin Primeverose Sapote (Pouteria sapota) 
   
(Adapted from Jones, 1999; Vetter , 2000; Haque and Bradbury, 2002); Codex Committee 






CGs are b-glucosides of α-hydroxynitrile (the aglycones) (Bjarnholt and Møller, 
2008) biosynthesised from mainly five amino acids; the aliphatic protein amino 
acids L-valine, L-isoleucine and L-leucine and the aromatic amino acids L-
phenylalanine and L-tyrosine, and from the cyclopentanoid non-proteinogenic 
amino acid, 2-(2’-cyclopentenyl)-glycine (Zagrobelny et al., 2004; Zagrobelny et 
al., 2018), and consist of a sugar moiety, mostly D-glucose, stored in the 
vacuoles (Flemming, 1999; Vetter, 2000). The structure arrangement includes a 
core carbon attached to a -CN moiety and two substitute groups (R1 and R2) 
and attached to a sugar, either a monosaccharide (glucose) or a disaccharide 
(gentiobiose) by a glycosidic bond. R1 may be a methyl group of a phenyl or p-
hydroxyphenyl group. R2 is most commonly hydrogen but may also be a methyl 
or ethyl group (Cressey and Reeve, 2019). Accordingly, CGs  are defined as 
aliphatic, aromatic or cyclopentenoid, based on their parent amino acids (Vetter, 
2000; Zagrobelny et al., 2018). For instance, the two aliphatic CGs, linamarin 
and lotaustralin are derived from valine and isoleucine; the three aromatic CGs, 
dhurrin is derived from tyrosine, amygdalin and prunasin are derived from 
phenylalanine (Seigler, 1975; Conn, 1979), while cyclopentenoid CGs are 
derived from cylopentenyl glycine (Bjarnholt and Møller, 2008). Therefore, it is 
immediately apparent that there is a high degree of structural relatedness within 
this group of compounds. The structure of some CGs and their sugar moiety is 






Table 1-6: The chemical structure of cyanogenic glycosides in major edible 
plants and their sugar moiety 
 
 
1.2.2.1 Functions of cyanogenic glycosides in plants 
Significant numbers of CGs are produced in plants to mediate both general and 
specialised functions. Their primary function in plants is dependent on activation 
by b-glucosidase enzyme to break down and release toxic volatile HCN as well 
as a ketones or aldehydes to fend off herbivore and pathogen attack (Møller, 
2010), hence dictating the plant-insect interactions and co-evolution as 
comprehensively reviewed by Zagrobelny et al., (2004). CGs have also been 





and Møller, 2002), nitrogen metabolism and transport (Lieberei et al., 1985; 
Selmar, 1993; Gleadow et al., 1998) and the control of germination (Esashi et 
al., 1996). They also serve as phagostimulants towards herbivores that 
specializes on them (Gleadow and Woodrow, 2002). Ressler et al. (1969) 
reported the degradation products of CGs such as b-cyanoalanine, possess 
potent neurotoxin property that serve to deter predators and is a catabolic 
product in some plants.  
 
Furthermore, identification of these constituents in plants may serve as a useful 
tool for informative taxonomic markers (Vetter, 2000). In general, the functions 
and level of CGs in plants depends on the age and variety of the plant as well as 
the ecosystem, biotic and abiotic challenges in their surroundings. For instance, 
Oluwole et al. (2007) reported that cassava crops grown in low altitude areas 
contain high levels of CGs while those grown in high altitude area contain low 
levels of CGs. Levels of CGs in different parts of the plants vary and also vary 
between the same parts of different individual plants of the same species 
(Oluwole et al, 2007). While high concentrations of CGs are usually found in plant 
leaves, CGs may also be concentrated in plant roots, seeds or other plant tissues 
(Seigler, 1975).  
 
Table 1-7 lists the major CGs of food plants and their cyanogenic potential where 














































Leaves Dhurrin 750-790 








Kernels Amygdalin 400-4000 
Bitter 
almond 












(Adapted from Haque & Bradbury, 2002; Simeonova & Fishbein, 2004; Zhang 
et al., 2014) 
 
However, the effectiveness of CGs as herbivore deterrent is not universal as 
described by Gleadow and Woodrow (2002). From the findings, Møller (2010) 
has outlined five important reasons that need to be considered whenever 
effectiveness of CGs as plant’s defence mechanism is concerned: 
i. The importance of CG concentration and its large variability between 
individual plants in a population. 
ii. The importance of avoidance of CG containing plants when alternative 





iii. Importance of feeding style to avoid release of toxic HCN. 
iv. Plant material containing CGs may not be cyanogenic due to lack of b-
glucosidase activity required for HCN release. 
v. Specialized herbivores and pathogens have coevolved to circumvent 






1.3 Linamarin – a cyanogenic glycoside in cassava 
Cassava, is a well-known staple plant which provides major source of calories in 
the tropics where its roots could be processed into varieties of other delicacies 
(Agbor-Egbe and Mbome, 2006; Aloys, 2006). It contains both linamarin (2-b-D-
glucopyranosyloxy-2-2methylpropiononitrile) and lotausralin ([(2R)-2-b-D-
glucopyranosyloxy-2-methylbutyronitrile]) at a ratio of 93:7, the former being the 
principal cyanogenic glycoside (CG) (Nartey, 1968; Cock, 1984). The linamarin 
and lotaustralin, its methyl variant, have a relatively broad distribution in the plant 
kingdom, having been demonstrated in the following plant families: Compositae, 
Euphorbiaceae, Linaceae, Papaveraceae and Fabaceae (Leguminosae) (Vetter, 
2000). Linamarin (95~97% of total cyanogen content) contributes to the bitter 
taste of fresh cassava roots (Sundaresan et al., 1987), which may function as a 
feeding deterrent (Poulton, 1990) and is found in all parts of cassava except the 
seeds (McMahon et al., 1995). Both linamarin and lotaustralin are synthesised 
in the leaves of cassava plants and transported to the tuberous roots, probably 
in the phloem and some additional synthesis in the periderm of the tubers (Koch 
et al., 1992; Jørgensen et al., 2005, Burns et al., 2010). Their levels vary 
considerably between tissues within individual plants, among cultivars and with 
environmental conditions (Bruijin, 1971; Ramanujam et al., 1984; Nambisan and 
Sundaresan, 1994). The highest concentrations are in the young leaves, newly 
germinated seedlings and the outer layer of the tuber (Jørgensen et al., 2005), 
consistent with its primary function in herbivore defence (Belloti and Riis, 1994, 






Figure 1-3: Linamarin (and lotaustralin) synthesis, distribution and 
degradation in cassava plant. 
(Adapted from Burns et al. 2010) 
 
Cyanide in cassava is not detected under normal physiological conditions but 
Haque & Bradbury (2004) reported that the linamarin (and lotaustralin), 
separately contained in the vacuoles within the cellular structure of the plant and 
the b-glucosidase enzyme, also known as linamarase, from either the latex or 
the region outside of the cell known as the apoplast, can be released and mixed 
due to mechanical damage caused by chewing, processing or preparation prior 
to consumption. Upon contact with the linamarase enzyme, linamarin will be 
hydrolysed to glucose and acetone cyanohydrins. The acetone cyanohydrin then 
breaks down spontaneously under certain conditions to form acetone and HCN 





cassava plant is represented diagrammatically in Figure 1-3. This is the likely 
route of cyanide exposure in humans and animals and may present significant 
safety and health issues. 
 
1.3.1 Biosynthesis of cyanogenic glycosides in cassava 
CGs biosynthesis have been broadly studied and described extensively in many 
important plants, for instance the tyrosine-derived CGs dhurrin in sorghum 
(Sorghum bicolor), cassava (Manihot esculenta), seaside arrow grass (Triglochin 
maritimum) barley (Hordeum vulgare) as reviewed by Ganjewala et al. (2010). In 
plants, CGs biosynthetic pathway could be generally described in three steps as 
described below and depicted in Figure 1-4.  
 
Step 1: Conversion of a precursor amino acid into aldoxime through two 
successive N-hydroxylation of amino group of parent amino acid by an enzyme 
of cytochrome-P450 family. 
Step 2: Conversion of aldoxime into cyanohydrin catalysed by another 
cytochrome P-450 enzyme. 
Step 3: Glycosylation of the cyanohydrins by a soluble enzyme uridine 5’-






Figure 1-4: General scheme of the biosynthesis of cyanogenic glycosides 
in plants 
(Adapted from Ganjewala et al. 2010) 
 
The primary precursors for the biosynthesis of linamarin and lotaustralin in 
cassava are derived from L-valine and L-isoleucine respectively (Du et al. 1995).  
The general pathway involves the sequential conversion of the amino acids to 
the N-hydroxyaminoacid, an N, N-dihydroxyamino acid, an E- and Z-oxime, and 
an a-hydroxynitrile (cyanohydrin) by a multi-microsomal enzyme complex of 
cytochrome-P450-I (CYP79D1, CYP79D2) and cytochrome-P450-II (CYP71E7) 
(Nartey, 1969; Du et al. 1995; Andersen et al. 2000; Zhang et al. 2003). The first 
and the second steps of CG biosynthesis are catalysed by cytochrome CYP79D1 
and CYP79D2 through two successive N-hydroxylations of the amino group of 
the parent amino acid, followed by decarboxylation and dehydration to produce 





(Zagrobelny et al. 2018). The cyanohydrin is produced from the action of a 
CYP71E7 on the Z-aldoxime via a dehydration reaction and C-hydroxylation 
(Kahn et al., 1997; Bak et al., 1998 and Jørgensen et al., 2011). Finally, the 
glycosylation of the cyanohydrin moiety (the final step in CG synthesis) by the 
UGT85B (a soluble enzyme) will form the CGs, linamarin and lotaustralin 
respectively (Jensen et al., 2011). The involvement of the microsomal systems 
catalysing the synthesis of the aglycone of linamarin and lotaustralin have been 
described by Koch et al. (1992) through the isolation from young etiolated 
cassava seedlings and root tissue, suggesting that both leaves and roots, to a 
certain extent or partly, are capable of linamarin synthesis (White et al., 1994; 
McMahon et al., 1995; Du et al., 1995). The biosynthetic pathway of linamarin 






Figure 1-5: The biosynthetic pathway for cyanogenic glycosides in 
cassava.  







1.3.2 Cyanogenesis, catabolism and detoxification of cyanogenic 
glycosides in cassava 
 
CGs are not toxic when intact but have to be activated to release HCN for 
defence, as well as to recycle nitrogen and glucose into other metabolic 
processes (Zagrobelny et al., 2018). Cyanogenesis is the ability of plants and 
other living organisms to release HCN upon breakdown of CGs (Poulton, 1990; 
White et al., 1999; Zagrobelny et al., 2008; Balhorn et al., 2009) causing potential 
toxicity issues for animals including humans. In cassava, autotoxicity is 
prevented by spatial separation of the CGs (linamarin and lotaustralin), located 
in the plant vacuoles, meanwhile the enzymes are located in the chloroplast or 
apoplastic spaces in plants (Conn, 1980; Poulton, 1990; Gruhnert et al., 1994). 
Cyanogenesis in cassava starts from the disintegration of the tissues during 
chewing action of the herbivores, processing or meal preparation that releases 
both CGs and the endogenous enzymes (linamarase and a-hydroxynitrile lyase). 
The linamarase enzyme cleaves the glucose residue stabilising the linamarin 
structure, converting it into the corresponding a-hydroxynitrile, which at pH 
condition of more than 6 will spontaneously dissociates into a sugar, a keto 
compound (acetone), and liberates HCN, which is toxic (Zagrobelny et al., 2004). 
At pH lower than 6, a-hydroxynitrile does not dissociate spontaneously but an 
enzyme a-hydroxynitrile lyase may catalyse its dissociation (Hughes et al., 1994; 
Ganjewala et al., 2010). During processing, reduced moisture and/or increased 
temperature facilitate the spontaneous breakdown of a-hydroxynitrile to toxic 
HCN (McMahon, 1995). A simplified cyanogenesis reaction of linamarin in 






Figure 1-6: Structure and cyanogenesis pathway of linamarin in cassava.  
(Adapted from Bjarnholt and Møller, 2008) 
 
HCN, the toxic, final product of dissociation of a-hydroxynitrile then detoxified via 
two pathways (Møller and Poulton, 1993). The endogenous detoxification of 
cyanide in plants and animals uses sulphur. The first detoxification pathway 
involves the binding of HCN to cysteine forming b-cyanoalanine and this reaction 
is catalysed by an enzyme of mitochondrial origin, b-cyanoalanine synthase 
(Zagrobelny et al, 2004). b-cyanoalanine synthase detoxifies HCN in pyridoxal 
phosphate (PLP) dependent reaction and produce b-cyanoalanine. The process 
is beneficial both ways as the detoxification of HCN prevents the mitochondrial 
degradation from the vulnerable attack of HCN and the resulted detoxification 
product b-cyanoalanine (a neurotoxin) serve to deter predators (Ressler et al, 
1997). b-cyanoalanine is subsequently converted into asparagine by the enzyme 
b-cyanoalanine hydrolase (Miller and Conn, 1980). This route seems to be most 
common in plants and possibly in insects too (Ganjewala et al., 2010). The 
second pathway proceeds with binding of HCN into thiosulfate (an oxyanion of 
sulfur) forming thiocyanate catalysed by sulphurtransferase enzyme also of 
mitochondrial origin known as rhodanese (Bordo and Bork, 2002). Vertebrates 





also reported to follow the same path. The whole metabolism, catabolism and 
detoxification processes of CGs is summarized diagrammatically in Figure 1-7. 
 
 
Figure 1-7: Metabolism, catabolism and detoxification of cyanogenic 
glycosides in plants, insects and higher animals. Enzymes involved are 
highlighted in red, HCN in purple. 
(Adapted from Zagrobelny et al, 2004, Ganjewala et al, 2010 and Burns et al 
2010) 
 
1.3.3 Mechanism of cyanide poisoning 
Cyanide released from the degradation of CGs is extremely toxic to all aerobic 
organisms (including human), could be fatal depending upon dose and is a 
rapidly acting poison (Piantadosi and Sylvia, 1984). Cyanide poisoning can occur 





parenteral administration by one of its salts or derivatives (Leybell et al., 2018). 
The toxicity of cyanide is largely attributed to the impairment of mitochondrial 
oxygen utilization due to cessation of aerobic cell metabolism (Hamel, 2011; 
Reade et al., 2012). This was achieved by reversibly binding to the cytochrome 
c oxidase (also known as cytochrome a,a3) which is the terminal oxidase complex 
(Complex IV) necessary for the reduction of oxygen to water in the oxidative 
phosphorylation chain within the mitochondria (Hamel, 2011). Cyanide has high 
affinity towards metalloenzymes such as ferric iron (Fe3+) and cobalt, 
consequently, able to bind to numerous critical enzyme systems in the body (Hall 
et al., 2007). Binding of cyanide to ferric ion (Fe3+) in cytochrome c oxidase 
inactivates the terminal enzyme complex and halts the electron transfer through 
the oxidative phosphorylation preventing synthesis of adenosine triphosphate 
(ATP) causing reduction in oxygen utilization by the body tissues (Beasley and 
Glass, 1998; Hamel, 2011). This may result in cytotoxic hypoxia, a shift from 
aerobic metabolism to anaerobic metabolism (due to reduction in the ATP/ADP) 
and an increase in the levels of glucose and lactic acid in the blood which leads 
to high-anion-gap metabolic acidosis and central nervous system injury (Hall et 
al., 2007; Hammer et el., 2013). Cyanide also inhibits the tricarboxylic acid cycle 
by decreasing the rate of glycolysis and activating glycogenolysis, thus causing 
a reduction in energy available to the respiratory system, the heart and other 
cells (Speijers, 1993). Although toxicity of cyanide can develop over minutes or 
hours depending upon route of exposure, exposure to high doses of cyanide 






1.3.4 Clinical manifestation of cyanide poisoning from food plants 
The clinical manifestation of cyanide poisoning are largely a reflection of 
cascading effects of intracellular hypoxia (Hamel, 2011). Consumption of 
cassava products with high concentrations of cyanogens can lead to illness or 
even death. Cases of cyanide poisoning from cassava consumption are most 
common among people who subsist on a monotonous cassava-based diet 
(Tylleskar et al., 1992; Cliff and Nicala, 1997; Banea-Mayambu et al., 2000). 
Cases of cyanide poisoning can also occur from the consumption of other food 
plants such as Rosacceae (peach, apricot, plum, apple seed), Leguminosae 
(lima beans, broad beans), or members of the genus Sorghum (Jones, 1998; 
Francisco and Pinotti, 2000; Vetter, 2000). The onset of signs and symptoms of 
cyanide poisoning usually could be seen in less than 1 minute after inhalation 
and within a few minutes after ingestion (Hall et al, 2007). Acute intoxication 
symptoms, which occur within hours of consumption of insufficiently processed 
cassava reflect reflexive attempts of the respiratory, neurologic and 
cardiovascular system to overcome tissue hypoxia. Early signs and symptoms 
include dizziness, fatigue, headache, palpitations, shortness of breath, 
hyperventilation and nausea. Stupor, coma, seizures, haemodynamic shock and 
cardiorespiratory arrest are common signs of late or severe poisoning 
(DesLauriers et al, 2006; Nelson, 2006). The clinical features of acute cyanide 
poisoning are listed in Table 1-8. The major determinants of severity and 
mortality are the source of exposure, the route and the magnitude of exposure 
and the effects and the time taken for any treatments that may have been 






Table 1-8: Clinical manifestation of the toxic effects of cyanide 
Human body systems Manifestations 
Central nervous system Early symptoms 
  Anxiety 
   Headache 
   Giddiness 
   Dizziness 
   Confusion 
     Mydriasis 
   Bright retinal veins 
 Late symptoms 
  Decreased consciousness 
   Seizures 
   Paralysis 
   Coma 
Respiratory system Early symptoms 
  Hyperventilation and tachypnea (due to    
  hypoxic stimulation of peripheral and central  
  chemoreceptor) 
   Absence of cyanosis (caused by an increased    
  in oxygen content in venous blood) 
   Hypoventialtion 
   Apnea (cells cannot take up oxygen) 
Cardiovascular system Early symptoms 
  Tachycardia 
 Late symptoms 
  Hypotension 
   Supraventricular tachycardia 
   Atrioventricular blocks 
   Ventricular fibrillation 
   Asystole 







1.3.5 Cyanogenic glycosides in cassava: Impacts on human health 
The occurrence of CGs in food and fodder can be a significant social and 
economic problem in many parts of the world. Consumption of inadequately 
processed cassava can lead to dietary cyanide exposure. The toxicity produced 
by cassava consumption would depend on the cyanogen level in the consumed 
product, the type of cyanogen present, quantity of cassava consumed, nutritional 
status of the subject, quantity of protein consumed and the amount of detoxified 
product formed in the body (Nambisan, 2011). While many food crops are 
cyanogenic, unlike cassava, the CGs are generally either in parts of the plant 
that are not consumed (e.g. apple seeds, wheat leaves) or are eaten in small 
amounts (e.g., almonds). The risk of cyanide toxicity from cassava is high 
because not only is the part that is consumed highly cyanogenic but it also 
frequently forms a large proportion of the overall diet (Burns et al, 2010). The 
acute onset and chronic conditions of prolong exposure to cyanide include: 
 
i. Acute cyanide poisoning: occurs as a result if consumption of bitter 
cassava and their products without proper processing. The clinical 
symptoms are vomiting, nausea, dizziness, abdominal pains, weakness, 
headache, diarrhea and occasionally death (Lasch and Shawa, 1981; 
Mlingi et al., 1992; Kwok, 2008; Akylidiz et al., 2010; Sanchez-Verlaan et 
al., 2011). 
 
ii. Tropical ataxic neuropathy (TAN): occurs in older people due to a 
monotonous consumption of CGs from a bitter cassava diet for many 





thiamine by the CGs (Osuntokun 1994, Adamolekun, 2010a). The disease 
is characterized by unsteady walking, loss of sensation in the hands and 
feet, blindness, deafness, reduced visual perception, ataxic gait and 
weakness (Onabolua et al., 2001; CCDN, 2008). The mechanism of 
thiamine deficiency however vary in the different communities from where 
TAN has been reported. In the African communities where cassava is the 
staple diet, chronic thiamine deficiency resulted from poor concomitant 
thiamine intake and the inactivation of thiamine by CGs in cassava. The 
major pathway of the detoxification of cyanide is its reaction with cysteine 
to form iminothiozidine compound that is excreted in the saliva and urine. 
Hence, effectively, detoxification is dependent on the nutritional status, 
protein malnutrition and levels of sulfur containing amino acids. This is 
based largely on studies which showed high intakes of cassava foods and 
high levels of thiocyanate in saliva and urine of subjects in the endemic 
area of Nigeria. It is difficult to estimate the exposure to cyanide from the 
frequency of intake of cassava foods because of the wide variation in 
levels of CGs in foods that have been processed using different methods. 
 
iii. Konzo: an upper motor neurone disease of acute onset due to continuous 
large intake of CGs from insufficiently processed bitter cassava, also 
resulting in thiamine deficiency from inactivation of thiamine when the 
sulfur in thiamine is utilized for detoxification of cyanide in the human 
body, thereby causing an irreversible paralysis (spastic paraperisis) of the 
lower limbs mainly in children (greater than 2 years of age) and women 
(less than 45 years of age) (Rosling, 1988; Tylleskar et al., 1992; Ernesto 





2011). This is due to the high nutritional demands of pregnant and 
lactating women, and children, who have been weaned but have only 
limited access to alternative foods (Burns et al., 2010). Symptoms at onset 
often occur after a long walk and include sudden trembling in the legs 
(paresthesia), sensations of electrical charges in the spine and legs and 
loss of visual acuity (Tshala-Katumbay et al., 2016) 
 
iv. Goitre: exacerbation of goitre and cretinism results from interference by 
thiocyanate (the end product of cyanide detoxification in the human body) 
in iodine metabolism leading to dietary iodine deficiency and associated 
disorders (Delange et al., 1994, Gbadebo and Oyesanya, 2005, Nhassico 
et al., 2008). 
 
In Africa, although cassava is a major staple, toxic effects due to its consumption 
are restricted to only few regions, and accounts for <1% of the cassava eating 
population (Tylleskar, 1994). TAN and konzo are prevalent only in cassava 
consuming populations and associated with high cyanogen intake due to the 
consumption of improperly processed bitter cassava, deficiency of sulphur and 
low protein intake (Cliff et al., 1985; Tylleskar et al., 1992; Osuntokun, 1981). 
Most poisoning cases reported have been from the Democratic Republic of 
Congo, Nigeria, Tanzania and Mozambique (Nhassico et al., 2008, Mlingi et al., 
2011, Ciglenecki et al., 2011).  
 
1.3.6 Toxicity of cyanogenic glycosides in cassava 
Since toxicity of linamarin is associated with free cyanide, toxic levels of CGs are 





and incubation period (Bradbury et al., 2010). The acute lethal dose of cyanide 
for human is 0.5-3.5 mg/kg body weight (Jones, 1998). The lethal dose of orally 
ingested HCN for a 60kg adult man ranges from 30 – 210 mg equivalent HCN 
(Nhassico et al., 2008) and a list of minimum lethal dose of HCN per body weight 
is shown in Table 1-9. World Health Organization (WHO) has set the safe level 
of total cyanogens in cassava flour at 10 mg/kg dry weight (10 ppm). Food 
Standards Australia New Zealand (FSANZ) amended Standard 1.4.1 of the 
Australia New Zealand Food Standards Code by including a maximum limit of 10 
mg/kg for cassava chips (FSANZ, 2009, Cressey et al. 2013). In Indonesia, the 
acceptable limit of total cyanide in cassava products is set at 40 mg/kg fresh 
weight (40 ppm) (Hidayat et al., 2000, Cardoso et al., 2005). Since the toxic effect 
of cyanide depends on body weight, a child of approximately 20 kg could safely 
eat up to 1 kg of flour with a concentration of 10 mg/kg total cyanide, in a meal; 
and adult of 60 kg, up to 3 kg of flour with 10 mg/kg total cyanide. Considering 
that the daily per capita consumption of cassava products is up to 700-800 g in 
parts of Africa (Nhassico et al., 2008), a child and an average adult (60-80 kg) 
would start to reach their minimum lethal dose of cyanide if the cassava products 
contained 40 mg/kg or more of total cyanide. Moreover, on top of the body 
weight, the lethal dose that might affect each individuals would have to rely on 
other factors such as the other nutrients availability in diet (sulphur-containing 
amino acids, vitamin B12) and the ability to detoxify the cyanide (conversion to 
thiocyanate, methemoglobin) in which these two factors often interrelates. The 
rate of absorption also plays an important role in cyanide toxicity, and even an 
acute lethal dose is tolerated without symptoms if it is split into even parts 
ingested, for example, hourly over the day. As the delay in absorption would 





levels. These mechanisms influencing the peak levels of cyanide in body tissues 
can be expected to be different for different foods, depending on the degree of 
plant tissue destruction, the type of the cyanogenic glycosides, the effectiveness 
of the accompanying b-glucosidase, the pH value of the stomach, the bacterial 
flora of the gut, an/or possible influences related to the plant matrix. 
 
Table 1-9: Minimum lethal dose ranges of HCN in human per body weight, 
and the amount of cassava product, containing 10 mg/kg and 40 mg/kg 
HCN, required to reach these lethal doses (based on lethal dose of 0.5-3.5 
mg/kg body weight). 
Body weight 
(kg) 
Lethal dose range 
of HCN (mg/kg) 
Lethal amount of cassava 
product (kg) 
10 mg/kg HCN 40 mg/kg HCN 
10 5-35 0.5-3.5 0.13-0.88 
20 10-70 1-7 0.25 – 1.75 
40 20-140 2-14 0.50 – 3.50 
60 30-210 3-21 0.75 – 5.25 
80 40-280 4-28 1.00 – 7.00 
100 50-350 5-35 1.25 - 8.75 
 (Adapted from Jones 1998, Burns et al., 2010) 
 
With regard to the complex issue described, several incidents of acute cyanide 
poisoning from cassava meal or products have been reported from several case 
reports and literatures, mainly affecting those in tropical countries, although not 
their staple food but consume cassava occasionally as desserts and snacks. 
Cheok (1978), reported the first case of acute cyanide poisoning involving 2 
siblings in East Malaysia (Sarawak) after eating a plate of ‘tapioca’ cake, made 





called ‘gari’ was responsible for the death of three people in Nigeria (Akintowa 
and Tunwashe, 1992) and eight children were in bad condition after eating bitter 
cassava in Venezuela (Espinoza et al., 1992). In the same year, three sisters 
were admitted with cyanide poisoning in West Malaysia after eating 3-5 chunks 
of boiled cassava (Ariffin et al., 1992). In March 2005, more than 100 children 
were admitted to the hospital and  left 27 children at San Jose Elementary School 
in Magini, Bohol, Philippines dead after eating caramelized cassava roots sold 
by a street vendor outside of the school as reported by The Seattle Times and 
China Daily. Five Nigerians apparently died of cyanide poisoning after eating a 
meal prepared with cassava flour (Makinde, 2010). In September 2017, an 
outbreak of 98 cases of suspected cyanide poisoning from consumption of a 
cassava dish made by combining hot water with cassava flour left two people 
dead in Kasese District, Uganda (Alitubeera et al., 2019).  
 
Cases of cyanide poisoning from other cyanogenic food plants have also been 
highlighted in the literatures. For instance, a woman was affected with cyanide 
poisoning after ingesting apricot kernels (Suchard et al., 1998). A similar case of 
self-medication using apricot kernel extract of a 67-year- old man with cyanide 
level 25 times above acceptable limit was reported by Konstantatos et al. (2017). 
Thirteen people were also reported to be intoxicated with cyanide after eating 
apricot seeds (Akyildiz, 2010). A case of a girl who became unconscious after 
eaten apricot kernels was reported by Sahin (2011). In another report, an elderly 
woman was affected with cyanide poisoning after ingesting bitter almonds 
(Sanchez-Verlaan et al., 2011), and a man from Lancashire suffered cyanide 
poisoning after eating cherry seeds in July 2017 as reported by BBC News. 





CGs, the awareness of consumers on this safety issue is still poor especially in 
regions where cassava is not the staple crop. People living in regions with higher 
cassava consumption are mostly aware of this issue although not necessarily 
understand the science behind it, but more often continuing the rituals that have 
been performed years ago and there is always a case of ignorance where 
farmers continue to cultivate crops with high levels of CGs due to taste 
preference, reduction in herbivory and protection against infections and theft 
(Cock, 1985, Nweke et al., 2002, Siritunga and Sayre, 2004). 
 
1.3.7 Mechanism of cyanide detoxification in human 
In human, intravenous and inhaled exposures to cyanide produce rapid onset of 
signs and symptoms than does oral ingestion due to the two former routes 
provide faster diffusion and direct distribution to target organs via the 
bloodstream (Hamel, 2011). Following an acute exposure, cyanide is detoxified 
by the enzyme rhodanese (a sulphur transferase enzyme present in the liver) 
with the help of rate limiting cofactor known as sulphane sulphur (Tor-Agbidye et 
al., 1999), forming a goiterogenic compound thiocyanate (SCN-) which is rapidly 
excreted via the kidney through the urine with very little in the faeces (Oke, 1973, 
Dhas et al., 2011). The concentration of sulphane sulphur is dependent on the 
availability of sulphur-containing amino acids (SAA) such as cysteine and 
methionine from dietary diets (Cliff et al., 1985). However, this mechanism will 
only cope with minute amount of cyanide generated from the consumption of 
small amounts of cyanogenic plants. Exposure above the threshold will 
overwhelm the mechanism as seen in patients with acute poisoning or in patients 





remains the most useful biomarker for dietary cyanide exposure (Rosling, 1994) 
and according to Foss & Lund-Larsen, (1986), thiocyanate levels in urine have 
been used in several studies to measure exposure to cyanide quantitively.  
However, in much more recent report by EFSA, (2018), serial measurements of 
cyanide in whole-blood after ingestion was reported to be a far more reliable 
biomarker to assess acute cyanide exposure. Although the determination of 
linamarin or other partially absorbed CGs as well as their metabolite thiocyanate 
in urine is useful for comparing different chronic exposure levels, it cannot 
provide information on the absolute exposure, because the degree if absorption 
and the proportion of the CGs degraded to cyanide in the intestine or colon are 
not known and because urinary thiocyanate might be strongly confounded by 
other factors including smoking. Apart from that Onabolu et al. (2000) suggested 
both frequency of intake of cassava foods and the cyanogen content of the 
cassava foods contributed to dietary cyanide load.  
 
Cyanide can also be temporarily trapped (reversible reaction) by the 
methemoglobin fraction in red blood cell corpuscle in the form of 
cyanomethemoglobin (Schutlz, 1984, Lunquist et al., 1985). This is a rapid buffer 
system that comes into play only after the CN-/SCN- conversion pathway has 
been saturated (Lunquist et al., 1985). Cyanide detoxification also occurs to a 
lesser extent by mercaptopyruvate sulphurtransferase (MST) (Oke, 1973, 
Moeller et al., 2017). MST catalyses the transfer of sulphur from 3-
mercaptopyruvate to the active enzyme site, which then reacts with cyanide, 
forming the much less toxic thiocyanate (Moeller et al., 2017). 3-





this compound can provide sulphur rapidly for cyanide detoxification (Figure 1-
8). 
 
Figure 1-8: The reaction of cyanide with 3-mercaptopyruvate to form 
sulphur and thiosulfate. 
 
Although the human body is protected to some extent against cyanide toxicity 
via the pathways describe previously, the amount of cysteine and methionine in 
the diet is a contributing factor to cyanide induced disease as SAA are required 
for the detoxification process. Diet consisting of food plants and products with 
high cyanogenic content without complementing it with adequate source of SAA 
will result in the depletion of SAA in the body and could consequently leads to 






1.3.8 Prevention of cyanide induced disease and intoxication 
Cassava roots and leaves are consumed both, fresh and cooked in different parts 
of the world according to the taste preferences, economic status and availability 
of other food plants (Latif and Muller, 2015). Cyanide induced disease can be 
prevented by effective removal of cyanogenic compounds in food plants prior to 
consumption which could be achieved via proper and efficient processing 
technique. A wide diversity of processing methods are used in cassava 
consuming communities, and cassava processing have been extensively studied 
and documented where they were subjected to various processing methods such 
as peeling, slicing, soaking, grating and grinding followed by cooking, steaming, 
boiling, roasting, baking, deep frying, fermenting and sun drying to reduce their 
cyanide content to safe levels (Westby, 1991, Nambisan, 1994; Oke, 1994, 
Essers, 1994; Kemdirim et al., 1995; Dufour, 1988; Obilie et al., 2004; Cardoso 
et al., 2005; Bradbury, 2006; Montagnac et al., 2009a, Perera, 2010, Bradbury 
and Denton, 2014). Most of the methods reviewed in all of the literatures were 
able to reduce up to 99% of total cyanide content (with significant loses of 
vitamins and minerals) and usually involved combinations of processing 
techniques. Depending on the nature of the process, they either lead to 
hydrolysis of CGs to liberate HCN, which are volatilized and subsequently lost or 
the highly soluble CGs and its hydrolytic products are leached out in water 
(Nambisan, 2011). A simple slicing and baking, steaming and frying of the roots 
or leaves of high-cyanogenic cultivar results in very little loss of linamarin. This 
is due to inactivation of linamarase preventing further decomposition of the 
cyanogenic glycoside and stability of linamarin at high temperature (Burns et al., 
2010). Cyanide is later released, during digestion, due to hydrolysis of the intact 





In eastern and southern Africa, cassava is preferably processed into flour, which 
is produced by sun drying of the peeled root followed by pounding and sieving 
or heap fermentation, however, because this process does not allow enough 
contact between linamarase and linamarin, the product may contain up to 59 
ppm of HCN equivalents, as compared to the WHO safe level of 10 ppm 
(Montagnac et al., 2009a). In western Africa and southern America, cassava 
parenchyma is ground, grated or crushed into small pieces to disrupt many plant 
cells and allow good contact between linamarin and linamarase. The moist mash 
is then soaked and left to ferment for several days, the water-soluble cyanogens 
squeezed out by dewatering and the residual HCN gas is removed by roasting. 
The percentage of cyanogens retained in these fermented foods can vary from 
0% to 20%, higher retention can occur with inadequate processing (Westby and 
Choo, 1994; Essers and Nout, 1989). Recently, new processing method that 
reduced the total cyanide content of cassava by three to six-fold of its former 
value (i.e from 43 ppm to 7 ppm, over 80% reduction) was developed by 
Bradbury & Denton (2010). The ‘wetting’ method involved mixing dry cassava 
flour with water and spreading it on a thin layer in the shade for five hours or in 
the sun for two hours (prior to cooking) which allows the enzymatic breakdown 
of linamarin to HCN and volatilised into the warm environment. 
 
Both the initial content of CGs and the method of processing influence the level 
and nature of cyanogens in the final processed products. Hence, adequately 
processed cyanogenic plants, effective detection methods for residual cyanogen 
in processed products and use of plant cultivars with low level of cyanogen 
content will reduce and help to maintain safe level of cyanogenic glycoside 





safe level of cyanide recommended by World Health Organization (McMahon et 
al., 1995; Ademolekun, 2010b, Nambisan et al., 2011). 
 
1.3.9 Analysis of cyanogenic glycosides in cassava 
Conventionally, the cyanogenic glucosides in food plants are quantified indirectly 
in terms of total cyanide released after acid or enzymatic hydrolysis of 
cyanogenic glycoside rather than the glycoside itself. Efficient extraction and 
complete hydrolysis is the key for accurate determination of plant cyanogens 
using these indirect methods. This quantification however does not give reliable 
and reproducible data because of the difficulty involved in the isolation and 
recovery of cyanide from digested samples (which arises as a result of the 
volatility of HCN boiling point of 26oC). Various methods were used to determine 
linamarin in cassava which have been extensively studied and modified for 
improved precision, sensitivity and ease of use. Probably the most common 
analysis involves three main steps: (i) extraction of linamarin from cassava, (ii) 
hydrolysis of linamarin by linamarase to liberate HCN and (iii) analysis of the 
latter (Cooke, 1978; Borges et al., 1993; Bradbury et al., 1994). Extraction of 
linamarin from plant material is normally carried out using dilute acid such as 
0.1M phosphoric acid in order to stop endogenous linamarase activity and to 
stabilise the cyanohydrins (Cooke, 1978; Essers et al., 1993). Few strategies 
have been adapted to hydrolyse cyanogens to cyanide which Bradbury et al. 
(1991) reported by acid hydrolysis, by autolysis (AOAC, 1990), or by enzymatic 
hydrolysis (Cooke, 1978; O’Brien et al., 1991; Essers et al., 1993). The acid 





addition, discrepancies might occur in acid hydrolysis due to formation of amides 
and ammonia. 
 
Meanwhile, in spontaneous autolysis by enzymes, the activity of enzymes is 
influenced by the conditions prevailing in the heterogenous plant substrate, the 
accompany secondary reactions and the accumulation of products of hydrolysis 
(Zitnak, 1973). The hydrolysis of linamarin by the endogenous enzyme 
linamarase reaction time could take up to 24 hours for certain sample (Bradbury 
and Bradbury, 1994). This autolysis method however, is more suitable for fresh 
cassava material and it cannot be applied to cooked or roasted products since 
the endogenous enzyme is permanently inactivated. In enzymatic hydrolysis, 
exogenous linamarase is added to the acid-extracted sample after pH 
adjustments (pH 5-6). Enzymatic breakdown of linamarin is rapid at around 30oC 
and takes less than 15 minutes depending on enzymatic activity (Cooke, 1978; 
Essers et al., 1993; Haque and Bradbury, 1999; Nambisan, 1999). Linamarase 
can be easily isolated from cassava latex (Haque and Bradbury, 1999; 
Nambisan, 1999). Both acid and enzymatic hydrolysis methods convert linamarin 
to cyanohydrins, which further decompose to HCN and acetone at alkaline pH 
levels (Bradbury and Bradbury, 1994). 
 
Various techniques have been developed to determine endogenous HCN 
liberated from CGs by all the hydrolysis methods described previously. AOAC 
(1990) described a titration method whereby the endogenous cyanide is 
precipitated with AgNO3 after steam distillation of HCN from autolysed cassava 





process (Borges et al., 1993). Perhaps, the most notably used method since the 
early 1990s with various modifications and improvements throughout the years 
would be the use of alkaline picrate in which, cyanide reacts with alkaline picrate 
paper, and the change of colour is matched against a colour chart. The resulting 
chromophore can also be dissolved from the picrate paper for more accurate 
quantitative determination using a spectrophotometer (Bradbury et al., 1999; 
Bradbury, 2009). The picrate method was used in a micro diffusion method, 
where the change in colour of picrate pre-coated in an ion-exchange sheet is 
read in reflectometer (Saka et al., 1998). Although the picrate method is easy to 
use, it has certain disadvantages. The reaction can be really slow (~16-24 
hours), the chemical needs special handling and storage and the response 
sometimes is imprecise due to the limitations mentioned previously. 
Nevertheless, the method has been used and later on extensively modified for 
the determination of the cyanogen potential of cassava roots and cassava 
products; picrate paper assay (Bradbury et al., 1991; Egan et al., 1998; Haque 
and Bradbury, 1999; Djazuli and Bradbury,1999, Bradbury and Denton, 2011, 
Burns et al., 2012); picrate based solid state detection (Brimer et al., 1998; 
Haque and Bradbury, 2002; Abban et al., 2011); Feigl-Anger paper based 
semiquantitative detection (Olsen et al., 2007; Takos et al., 2008). The picrate 
method was also implemented and incorporated into a paper strip indicator 
(Yeoh, 1993; Yeoh and Truong, 1993) and later on into an enzyme-based 
dipstick for semi-quantitative estimation of cyanogenic potential in cassava 
(Yeoh and Tan, 1994; Yeoh et al., 1996; Yeoh and Egan, 1997; Yeoh and Sun, 
2001). This semi-quantitative method could be made quantitative by eluting the 
colour formed on the picrate paper in water and measuring its absorbance at 





Other indirect quantitative methods have also been employed for determination 
of CGs in plants. These methods include amperometric measurement with a 
cyanide-sensitive electrode (Dalgaard and Brimer, 1984; Tatsuma et al., 1996); 
use of methemoglobin complex (Ajaelu et al., 2008); colorimetric methods 
(Tatsuma et al., 2000); chemiluminescence assay (Ruengprapavut and 
Chulavatnatol, 1999); chloramine T/barbituric acid/isonicotinic acid method 
(Saka and Nyirenda, 2012); barbituric acid/pyridine method (Spectroquant® 
cyanide test from Merck) (Ballhorn et al., 2005; Takos et al., 2010); ninhydrin 
method (Drochioiu, 2002; Nagaraja et al., 2002; Drochioiu et al., 2004). A 
resorcinol method which is based on enzymatic hydrolysis of cyanogenic plants 
and trapping of HCN in alkaline solution of resorcinol reagent followed by 
measuring the absorbance at 488nm has also been developed (Drochioiu et al., 
2008) and it was claimed that this method has been reported to be more sensitive 
than the picrate methods. Reaction of ninhydrin and cyanide was proposed for 
the spectrophotometric determination of free cyanide in environmental samples 
(Drochioiu et al., 2007); under flow injection conditions (Santelli et al., 2006; 
Themelis et al., 2009), in cuvetteless microspectrophotometry (Jain et al., 2010) 
and ninhydrin-based micromethod (Surleva and Drochioiu, 2013). 
 
Direct quantification of CGs are at the moment based on various instrumental 
chromatographic methods which include cyanogens content in passion fruit 
using Gas Chromatography-Mass Spectrometry (GC-MS) (Chassagne, 1996; 
Bacala and Barthet, 2007); CGs in gooseberry using LC-MS (Bjarnholt et al., 
2008); detection of CGs in grapevine using LC-MS/MS (Franks et al.,  2005); 
methanol extraction and HPLC analysis of CGs in sorghum (De Nicola et al., 





phase chromatography with UV and pulsed amperometric detection developed 
by Wasserkrug and Rassi (1997) for the detection of linamarin, amygdalin and 
prunasin and their degradation products (mandelonitrile and benzaldehyde). 
Sornyotha et al. (2007) developed an HPLC method with a refractive index 
detector to quantify  linamarin in cassava root cortex. Recently, Tivana et al. 
(2014) developed a direct quantification of total cyanide in various cassava 
products using a aquacyanocobyrinic (ACCA) chemosensor where it was firstly 
described by Zelder (2008) and Männel-Croise et al. (2009). An advantage of 
the chromatographic method is the quantification of cyanogens in their native 
form. These methods are summarized in Table 1-10. Although these methods 
are reliably accurate and sensitive in determining CGs, its wide application is 
limited as they often require expensive solvents and separation columns, 
complicated, time consuming sample pre-treatment, lack of CGs standards and 
are not easily adapted to rapid quality control monitoring purpose. There is 














Table 1-10: Various indirect and direct methods of detecting and 
quantifying cyanogenic glycosides in plants. 








- AgNO3 precipitation after steam 
distillation of HCN 
AOAC, 1990 
Alkaline picrate method 
- Microdiffusion and ion-exchange 
sheet 
Saka et al., 1998 
Picrate paper assay Bradbury et al., 1991; Egan 
et al., 1998; Haque and 
Bradbury, 1999; Djazuli 
and Bradbury, 1999; 
Bradbury and Denton, 
2011; Burns et al., 2012. 
Picrate based solid state detection Brimer et al., 1998; Haque 
and Bradbury, 2002; 
Abban et al., 2011 
Feigl-Anger paper based semiquantitative 
detection 
Olsen et al., 2007; Takos et 
al., 2008 
Picrate paper strip indicator Yeoh, 1993; Yeoh and 
Truong, 1993 
Enzyme-based dipstick for semi-
quantitative estimation 
Yeoh and Tan, 1994; Yeoh 
et al., 1996; Yeoh and 
Egan, 1997; Yeoh and 
Sun, 2001 
Amperometric measurement with cyanide-
sensitive electrode 
Dalgaard and Brime, 1984; 
Tatsuma et al., 1996 
Methemoglobin complex Ajaelu et al., 2008 
Colorimetric methods Tatsuma et al., 2000 
Chemiluminescence assay Ruengprapavut and 
Chulvatnatol, 1999 
Chloramine T/barbituric acid/isonicotinic 
acid 
Saka and Nyirenda, 2012 
Barbituric acid/pyridine method 
(Spectroquant® cyanide test from Merck) 
Ballhorn et al., 2005; Takos 
et al., 2010 
Resorcinol method Drochioiu et al., 2008 
Ninhydrin method – spectrophotometric 
determination 
Drochioiu et al., 2007 
Ninhydrin method – under flow injection 
conditions 
Santelli et al., 2006; 
Themelis et al., 2009;  
Ninhydrin method – cuvetteless 
microspectrophotometry 
Jain et al., 2010 










Gas chromatography mass spectrometry 
(GC-MS) (passion fruit) 
Chassagne, 1996; Bacala 
and Barthet, 2007 
Liquid chromatography mass spectrometry 
(LC-MS) (gooseberry) 
Bjarnholt et al., 2008 
High performance liquid chromatrography 
(HPLC) (sorghum) 




Franks et al., 2005 
Gas Chromatography and Near Infrared 
Spectroscopy (NIRS) 
Golf et al., 2011 
Reversed phase chromatography with UV 
and pulsed amperometric detection 
(linamarin, amygdalin and prunasin) 
Wasserkrug and Rassi 
High performance liquid chromatography 
with refractive index detector (linamarin in 
cassava) 
Sornyotha et al., 2007 
Aquacyanocobyrinic (ACCA) 
chemosensor 











Antibodies (Abs), a category of macromolecules which are known as 
immunoglobulins (Ig). Ig are glycoproteins, which are present at 12-15 mg/ml in 
the blood serum (carbohydrate 2%-14%), synthesised by the white blood cells 
(lymphocytes) in response to invading foreign substances (Wild, 2013). The 
function of these highly specialised macromolecules is for immune recognition of 
foreign proteins (antigens) that will activate specific response reactions aimed at 
protecting the host (Kemeny, 1991, Liddell, 2013). Abs are the most crucial 
component in all types of immunological methods, as it will pretty much 
determine the assay simplicity, specificity and sensitivity of the assay (Hage, 
1999). The five Ig classes in mammals are IgG, IgM, IgA, IgD and IgE, that differ 
on the basis of size, charge, amino acid composition and carbohydrate content, 
with IgG being the most abundant (molecular mass of 150 kDa) (Liddell, 2013). 
IgG represents 70 – 75% of total serum Ig and constitutes the majority of the 
secondary immune response to most Ags (Turner, 1981).  
 
The basic structure of IgG antibody resembles the letter Y made up of two 
identical heavy polypeptide chains (H) and two identical light chains (L), which 
are stabilized and linked by intrachain and interchain disulphide bonds (Hsieh, 
2010). The heavy chains are each made up of three constant domains (HC1, 
HC2, HC3) and one variable domain (HV), whereas the light chains are each 
made up of one constant domain and one variable domain (LC and LV) as 
depicted in Figure 1-9. IgG can be fractioned into two important fragments. The 





region or the ‘tail’ of the Y shaped molecule that is a dimer of the two last heavy 
chain domains (HC2 + HC3) while the Fab (fragment antigen binding) is the 
remaining upper part, combination of light and heavy chains (LC + LV and HC1 
+ HV). This fractionation method can be useful in assays where the Fc region is 
causing interference in assays.  
 
Figure 1-9: Basic antibody structure of human IgG illustrating a pair of 
identical heavy chain and light chains. 
(Adapted and modified from Paraf and Peltre, 2012; Liddell, 2013) 
 
Constant domains (HC and LC) as the name suggest are relatively constant in 
sequence with varying degree of glycosylation and are responsible mostly for the 
binding properties and interactions towards other effector cells involved in the 
immune response such as mast cells and phagocytes. The variable domains (HV 





fit a specific portion of an antigen called ‘epitope’, that leads to tremendous 
diversity of binding sites for different Abs. This can be achieved by the presence 
of three areas of hypervariable sequence each known as the complementarity-
determining regions (CDRs) (Paraf and Peltre, 2012; Liddell, 2013). HV and LV 
(total of six CDRs) together form the antigen-binding site (Fv). Structural 
information about these sequences has been an important basis on emergence 
of variable immunoassays techniques, development and advancement 
throughout the years. 
 
IgG antibodies are secreted by plasma cells produced by the B-lymphocytes of 
the adaptive immune system. Ab genes are assembled from pieces of DNA 
scattered widely throughout the genetic material (Deshpande, 1996). As the B-
cell that produces Ab matures, it rearranges these gene components such that 
the new gene and the antibody it encodes become unique. Once the B-cell 
containing this gene arrangement proliferates, all its descendants will make this 
unique antibody (Paraf and Peltre, 1991). IgG is used almost exclusively in 
immunoassays. It is produced in the highest yield in response to immunization, 
binds with higher affinity to its epitope and is stable during isolation and 
purification process and has several functional sites that can be used for 
chemical coupling with minimal loss of antibody binding (Liddell, 2013). 
Furthermore, since immunoglobulins are proteins, therefore they can undergo in-
vitro reactions developed specifically for proteins, e.g. iodination, conjugation, 
separation and all possible techniques which are routinely available for 
biochemist to make use of its advantageous features. The specificity of antigen-
antibody reaction makes Abs very useful and highly selective reagents in 





1.4.2 Antigen-antibody interaction 
The fundamental feature of all immunological methods is the recognition of an 
analyte, the antigen (Ag), by a reagent, the antibody (Ab) which has specificity 
directed against the antigen. This interaction will form an antibody-antigen (Ag-
Ab) complex that will lead to its elimination from circulation through the 
mononuclear phagocytic system. The attractive forces that stabilise this Ag-Ab 
interaction complex include a combination of hydrogen bonds, hydrophobic 
bonds, coulombic interactions and van der Waals forces (Steward ,1984). In 
general, these forces are weak individually in comparison to covalent bonds. 
However, combination of these forces altogether are able to form a strong bond 
(termed the affinity of the Ab) (Harlow and Lane, 1999) which leads to 
stabilization and they are of fundamental importance to the specificity of the Ag-
Ab complex (Deshpande, 1996).  
 
1.4.3 Immune response and antibody production 
The immune system of animals are capable of recognising and responding in a 
protective manner towards invasion of foreign materials when they break through 
the physical barriers such as the skin or mucous membrane which form the 
animal’s 1st line of defence. The immune response can be divided into two 
general systems, cell-mediated immunity and humoral immunity, where the 
former is dependent upon direct interaction of T-type lymphocytes and 
phagocytic cells with the foreign material, whereby the latter refers to the 
protection provided by a group of inducible globular proteins (immunoglobulins) 
produced by B-type lymphocytes (Rittenburg, 1990). In other words, the 





cells of the immune system, that lead to the release of Ab molecules in blood 
and other body secretions (Burns, 2005). Two important properties are 
necessary for a complete Ag immunogenicity, i.e. the capacity to stimulate 
formation of Abs; and the ability to react specifically with these Abs. Ag and 
immunogen are terms often used interchangeably where Ag refers to any 
substance with which an Ab will bind, and the term immunogen refers to those 
substances capable of inducing an immune response, but both able to stimulate 
the immune system and are able to induce humoral response when introduced 
into an animal. Macromolecules such as proteins (glycoprotein, lipoprotein or 
nucleoprotein) and polysaccharides are mostly good immunogens (Catty, 1988). 
However, Abs able to bind to a small molecules can also be produced under 
specific conditions. 
 
Although the natural purpose of Abs production is to protect against invading 
pathogens, Abs can be produced experimentally in vitro by the injection of an 
animal with an analyte (antigen) alone or bound to a protein carrier to induce the 
formation of specific Abs in the body of the animal. Generally, animals are 
capable of producing different types of Abs which can bind at specific sites 
(epitopes) of the Ag. The ideal Ab can be defined as possessing a high titre and 
high specificity as well as high affinity towards the Ag of interest. The affinity 
between an Ab and Ag represents the main factor for achieving a low detection 
limit in an immunoassay (Deshpande, 1996). There are three types of Abs 
usually used in immunoassays; polyclonal antibodies (pAbs), monoclonal 
antibodies (mAbs) and recombinant antibodies (rAbs), but in this study, only 





1.4.3.1 Polyclonal antibodies 
PAbs, are normally produced by immunizing animals with the Ag of interest. The 
B-lymphocytes have specific antigen binding receptors on the outer surface of 
the cell membrane that reflect the specificity of the Ab that it will produce. Many 
immunogens contain a variety of different antigenic determinants and thus bind 
to and induce different B-lymphocytes to proliferate, producing variety of Abs 
which bind specifically to different epitopes on a given substance respectively. 
Thus, pAbs are a heterogenous mixture of Abs of varying binding affinities, 
different specificities and isotype able to recognize epitopes both on the 
immunogen and any impurities injected with it (Liddell, 2013). PAbs have been 
raised in numerous species including mice, hen, rabbits, goats and sheep 
(Kascsak et al., 1987; Clarke et al., 1993; Beans, 2001; Matsumoto et al., 2005). 
The choice of host depends on the intended use of the resulting antibody. 
Although goats and sheep are the species of choice for large-scale antiserum 
production, rabbits are the most common species of choice for pAb intended for 
routine work, which balances the low maintenance costs with decent volumes of 
serum (Beans, 2001, Liddell, 2013). In addition, pAb raised in rabbits offers the 
advantage of ready availability and general high quality of a wide variety of anti-
rabbit Ab secondary detection reagents (Burns, 2005). PAbs are reagents of 
choice for general purpose analytical applications in immunoassay systems and 
have been used extensively in food immunoassay (Ramesh et al., 2007; Burkin 







1.4.3.2 Monoclonal antibodies 
These are Abs produced by the clone of a single B-lymphocyte, often identified 
and isolated from pool of B-lymphocytes that synthesize pAbs, and therefore 
have identical specificities. As normal lymphocytes cannot normally survive in 
vitro, monoclonal technology involves fusing of an antibody-producing B–
lymphocytes with immortal myeloma cell line (lacking the DNA salvage pathway) 
to produce hybrid cells that can be grown indefinitely in tissue culture, producing 
single Ab specificity, a Nobel pioneering work done by Köhler and Milstein in 
1975. These hybridomas inherit both the ability to survive in vitro from the 
myeloma cell and the capacity to produce Ab from the lymphocyte (Rittenburg, 
1990). Through a series of selection procedures, single-antibody secreting 
hybridoma cells can be isolated in individual tissue culture wells from which large 
colonies (monoclones) can develop through mitotic division, each secreting 
identical Abs, given rise to reagents of superb specificity able to distinguish very 
slight differences between epitopes of different immunogens (Liddell, 2013). 
These Abs can be made in limitless quantities since the hybridoma cells can be 
grown in tissue culture almost indefinitely at industrial scale, can be frozen for 
storage and recovered when required without the need for recharacterization as 
would be necessary for a new batch of pAbs (Liddell, 2013). The initial Abs or B-
lymphocytes are mostly derived from a successful immunisation of target Ags in 
mice before the fusion with immortal myeloma cells from murine cell line. Other 
cell lines are currently emerging such as rats and more rarely human-derived 
Abs. Rabbit mAbs can also now be made which have certain advantages over 
mice. Ten of thousands of mAbs are now available commercially, in purified form 
or as native culture supernatant or ascitic fluid, and can be supplied with a variety 





diagnostic tests, analytic and chemical use, therapeutic and clinical treatments 
(Drewe and Powell, 2002; Liddell, 2013).  
 
Monoclonal antibodies (mAbs) are important reagents used extensively in 
biomedical research, diagnostic tools in food safety and toxicity, diagnosis of 
diseases and treatment of illnesses such as infections and cancer (CMPMA, 
1999). It represents a novel way in which to target specific mutations and defects 
in protein structure and expression in a wide range of diseases and conditions 
(Liu, 2014). MAbs, as briefly described previously, are monovalent Abs which 
bind to the same epitope and are produced from a single B-lymphocyte clone. 
These Abs are produced by cell lines or clones obtained from animals that have 
been immunized with the substance (immunogen) that is the subject of study. 
Köhler and Milstein (1975) developed a technique that allows the growth of clonal 
populations of cell secreting homogenous Abs with a defined specificity. The 
generation of hybridomas involves immunising certain species against a specific 
epitope on an antigen and obtaining the B-lymphocytes from the spleen of the 
animal. The B-lymphocytes are then fused (by chemical or virus induced 
methods) with an immortal myeloma cell line (a type of B-cell tumour preferably 
from the same species that can divide indefinitely) lacking the hypoxantine-
guanine-phosphoribosyltransferase (HGPRT) gene and not containing any other 
immunoglobulin-producing cells. This conferring of immortality to that single 
plasma cell by fusion to myeloma cell results in a hybrid B-cell line (hybridomas). 
The fusion is then cultured in vitro in selective medium (hypoxanthine-
aminopterin-thymidine, HAT) where only hybridoma cells survive as they have 
inherited immortality from the myeloma cells and selective resistance (HGPRT 





die due to their short lifespan and for the myeloma cells, as they lack HGPRT 
enzyme, they cannot synthesise nucleotides (purine and pyrimidine) using the 
salvage pathway as the de novo pathway is already inhibited by aminopterin (an 
antibiotic) in the selective medium, hence they will not survive (Little, 2000).  
 
The initial culture of hybridomas contains mixture of Abs derived from many 
different primary B-lymphocyte clones, each secreting its own individual specific 
Ab into the culture medium (the Abs are still polyclonal at this stage). The cell 
culture medium can then be screened (ideally using ELISA) from many hundreds 
of different wells for the specific Ab activity required. Each individual clone can 
be separated by limiting dilution into different culture wells. The desired B-
lymphocytes (positive and monoclonal) are grown larger culture wells and then 
recloned and retested for activity until one can be reasonably sure that the cell 
line is monoclonal (Li et al., 2010). The positive hybridomas and monoclonal Abs 
generated should be stored in several vials of approximately 107 cells in several 
different -70°C or liquid nitrogen freezers and the freezing medium should 
contain 10% dimethyl sulfoxide (DMSO) to prevent crystallization of water within 
the cells (Liddell, 2013). The cells can be propagated by tissue culture 
conventionally in large flasks, roller bottles, stirred flasks or bioreactors such as 
the hollow fiber reactor and air lift fermenter depending on the amount of mAbs 
needed. Ascitic mice is the easiest way to obtain a very concentrated Ab (5-10 
mg/mL) from the ascitic fluid but this has been prohibited in certain countries due 







1.4.3.3 Antibody production against haptens 
Small molecules (hapten) of less than 5,000 – 10,000 Da which, if present by 
itself, is unable to stimulate the immune system for antibody production. To 
generate an antibody against haptenic molecules requires the covalent linkage 
of the hapten to a larger, immunogenic, protein carrier, usually 20,000 to 40,000 
Da or even higher molecular mass. Immunodominant structures usually project 
distally from the surface of the immunogen and are well exposed for inducing 
highly specific Abs. These sites are also less likely to be sterically hindered from 
closely approaching the antibody binding site. It is for these reasons that when 
preparing hapten-protein conjugates for immunisation, the coupling is usually 
done by the intermediary of a spacer arm (Catty, 1988; Rittenburg, 1990; 
Roucairol et al., 2007). A schematic representation of hapten on a carrier 
molecule is illustrated in Figure 1-10. The carrier protein, usually bovine serum 
albumin (BSA), keyhole limpet haemocyanin (KLH), or ovalbumin (OVA) 
contains many epitopes to which T-cells can respond in order to assist antibody-
producing B-lymphocytes after immunization with a hapten-carrier conjugate. 
The B-lymphocyte receptor binds to the hapten and incorporates the hapten-
carrier complex, thus the protein component yields primarily carrier related 
peptides that bind to MHC (major-histocompatability complex) class II molecules 
which are presented on the surface of the B-cells. T-cells with specificity for the 
MHC-presented carrier-derived peptides then activate the B-cells for the 






Figure 1-10: A schematic representation of hapten on a carrier molecule, 
showing the number of hapten bound to one molecule of carrier (adapted with 
modification from Paraf and Peltre, 1991) 
 
There are four important criteria that have been well defined by Goodrow et al. 
(1998), about the design of an ideal hapten derivative: i) the stereo structure, 
electronic distribution and hydrophobicity on the hapten derivative should be 
similar to those on the original hapten; ii) a spacer arm with several-carbon-chain 
length to couple with carrier is preferred, but the spacer arm should not induce 
the immunized animal to produce ‘arm antibodies’ or neodeterminants; iii) the 
presence of active group at the end of the spacer should not affect the electronic 
distribution of hapten molecule; and iv) after coupling with carrier, the basic 
molecular structure of the hapten should be retained. Hence, the most basic 
requirement of hapten design is to maintain the original molecular structure of 
the hapten and to exposed it on the surface of the carrier as much as possible, 
which in turn, will maximise the recognition of the hapten by the immune cells of 





response and generate high affinity and high specificity Abs against the hapten 
(Juan et al., 2010). In general, antigenic structures or epitopes are mostly located 
on the hydrophilic parts of the immunogen, each of them being recognized by a 
specific antibody. The procedure for the production of antibody against hapten is 
illustrated in Figure 1-11. 
 






Linamarin is a very small molecule (hapten) of less than 1,000 daltons, 247 
daltons to be exact (PubChem, 2005) in which, if present by itself, is unable to 
stimulate the immune system for antibody production. To generate an antibody 
against haptenic molecules requires the covalent linkage of the hapten to a 
larger, immunogenic, protein carrier, usually at least 20,000-40,000Da or even 
higher molecular mass. Immunodominant structures usually project distally from 
the surface of the immunogen and are well exposed for inducing highly specific 
Abs. These sites are also less likely to be sterically hindered from closely 
approaching the antibody binding site. It is for these reasons that when preparing 
hapten-protein conjugates for immunisation, the coupling is usually done by the 
intermediary of a spacer arm (Catty, 1988; Rittenburg, 1990; Roucairol et al., 
2007). Typically, haptens are conjugated to carrier proteins such as bovine 
serum albumin (BSA), keyhole limpet haemocyanin (KLH), ovalbumin (OVA), 
ovomucoid (OVO), thyroglobumin or fibrinogen. These proteins contain many 
epitopes to which T-cells can respond in order to assist antibody-producing B-
lymphocytes after immunization with a hapten-carrier conjugate (Hancock and 
O’Reilly, 2005). 
 
The B-lymphocyte receptor binds to the hapten and incorporates the hapten-
carrier complex; thus, the protein component yields primarily carrier-related 
peptides that bind to MHC (major-histocompatability complex) class II molecules 
which are presented on the surface of the B-cells. T-cells with specificity for the 
MHC-presented carrier-derived peptides then activate the B-cells for the 
production of hapten-carrier specific Abs (Pedersen et al., 2006). Among the 





used protein because of its stability in some organic solvents allowing a wide 
range of chemical reactions to be attempted, the abundance of Ɛ-amino groups 
of the lysine residues available for conjugation (Figure 1-12), in addition to its 
wide availability with low cost and ability to yield soluble conjugates (Erlanger, 
1980). KLH is also used by many but it is relatively expensive, and its high 
molecular weight might be limiting (Hsieh, 2010, Juan et al., 2010). 
 
Figure 1-12: Functional groups (with number of availability) in bovine serum 






The preparation of immunogenic hapten-protein conjugates is governed by the 
nature of the reactive functional groups of hapten. That is, functional groups of 
the hapten govern the selection method to be used to conjugate the hapten to 
the functional groups of the carrier. Haptens are covalently conjugated to carrier 
proteins using various coupling methods. According to Juan et al. (2010) hapten-
protein conjugates can be prepared by i) modifying the existing hapten, ii) using 
relevant intermediate or metabolite of the hapten and iii) resynthesizing the 
hapten-protein conjugate from raw materials.  
 
A review conducted by Erlanger (1980) on the preparation of antigenic hapten-
protein conjugates reports that conjugation methods such as carbodiimide and 
mixed anhydride procedures can be used for haptens with amino groups, 
succinic anhydride procedures can be used for haptens with carboxyl groups, 
while haptens such as alcohols, phenols, sugars, polysaccharides and 
nucleotides with available hydroxyl groups can be conjugated to protein with 
procedures using hemisuccinates (used for coupling alcohols to protein), 
aminophenyl derivatives (used for coupling of phenols and sugars to proteins) 
and oxidation to dialdehydes, a procedure which makes use of the reaction of 
vicinal hydroxyl groups with periodate to yield dialdehydes. The latter procedure 
is used for coupling of compounds such as glycols, glycerol derivatives and 
glycosides to protein. In another study, cyanuric chloride (2,4,6-trichloro-1,3,5-
triazine) has been reported to be an efficient coupling reagent for labelling Abs 







1.4.3.4 Primary antibody 
Primary antibody refers to the Ab obtained from active immunization of laboratory 
animals with an immunogen of interest that will form antibody-antigen complex 
to the same antigen adsorbed onto a solid phase. The Abs are made in response 
to any immunogenic epitope in the injected material, includes any impurities in 
the preparation and any carrier protein or linker attaching them which have been 
described in section 1.4.3.1.  
 
1.4.3.5 Secondary antibody 
Secondary Abs are anti-immunoglobulin Abs. Because Abs are proteins and 
exhibit distinct structural difference when obtained from different species, they 
themselves can be used as immunogens. Thus, anti-antibodies can be raised for 
example, when rabbit immunoglobulin is injected into a goat. The secondary 
antibody is usually directed against species-characteristic determinants on the 
constant regions of the primary of the immunizing Ab to which it binds 
irrespective of the binding or antigenic specificity of the primary Ab (Deshpande, 
1996). The secondary Ab used in immunoassay does not have the specificity to 
bind the Ag but only recognizes the primary Ab; thus it makes a link of the 
enzyme label to the bound immunomolecules without interfering with the primary 









1.4.3.6 Antibody titre 
In immunoassay, titre is the measurement of the amount and affinity of Ab 
generated from an immunised animal that recognises the Ag epitope. Ab titre 
can also be defined as the dilution factor which gives 2- times higher optical 
density values than the pre-immune control serum or the dilution that binds 50% 
of a certain amount of labelled antigen (Price & Newman, 1991). In hapten 
conjugation, different coupling methods may result in different Ab titres. 
 
1.4.3.7 Antibody specificity 
Specificity is described as the ability of one Ab to bind to one and not to another 
member of a family of chemically-related substances (Langman, 2000). 
Specificity is an important characteristics that determines Ab quality. The 
specificity of an immunoassay method is determined by the ability of the Ab to 
form a complex with only one kind of molecule (analyte) in the presence of 
different molecules (Catty, 1988). The structure of the Ag and the homogeneity 
of the Abs are important factors in determining specificity (Zhang et al., 2007). 
Specificity may be established by assaying a number of structurally related 
analytes and determining their cross-reactivity. Cross-reactivity can be defined 
as a situation in which at least two different Ags compete for the same antibody 
binding site (Benjamini, 2000). Abs with cross-reactivity ≤ 10% are very specific, 
and can be used for quantitative determinations, while Abs with cross-reactivity 
ranging from >10 to 100% can be used for qualitative tests, though Abs with 
cross-reactivity ranging from ≥ 50 to 150% can be used for semi-quantitative, 








Immunoassays are analytical techniques based on the specific and high affinity 
binding characteristics of a group of inducible, often, animal-derived proteins 
called Abs with particular target molecule known as Ag (Hsieh, 2010). Higher 
vertebrates are remarkably proficient in synthesizing Ab with precise specificity 
to its target Ag that could come in variety of organic molecules and 
macromolecules provided, they are able to induce the humoral immune 
response. Both Ags and Abs are interchangeably used either as target molecules 
or capture molecules making immunoassay a versatile technique that has been 
one of the fastest growing and most widely used analytical techniques (Edwards, 
1996; Price and Newman, 1997). The primary binding between the Ab and the 
target Ag forms the basis of the immunoassay, generating a signal that could be 
measured allowing quantification of the target and a wide variety of 
immunoassay formats have been developed to allow either visual or instrumental 
measurement of this primary binding reaction. The potential of rapidly measuring 
minute quantities of a specific analyte from within a complex sample matrix, often 
with little or no sample clean-up, is one of the attractive features that has led to 
the widespread application of immunoassay. In comparison to other analytical 
methods such as gas chromatography (GC), thin-layer chromatography (TLC), 
HPLC, and electrophoresis, immunoassay provides a rapid, cost effective, highly 







Several variations exist in the design of particular immunoassays. Generally, all 
assay names contain the word “immune” combined with another word indicating 
the type of label used, along with the word “assay”, generally means test. Signal 
generation mentioned previously usually involves conjugation of either the 
antibody or the target to ta detectable label such as a radioisotope or an enzyme. 
Therefore, in isotopic immunoassays, a radioimmunoassay (RIAs) described an 
assay system in which the detection label is radioisotope and in non-isotopic 
immunoassays, enzyme immunoassays (EIAs), fluorescent immunoassay 
(FIAs), and chemiluminescent immunoassay (CIAs) described a variety of 
markers or labels, individually or in combination, used to in the respective assay 
system (Voller et al., 1978; Quan et al., 2006). RIA was first described in 1959 
by Yalow and Berson for the analysis of the endogenous plasma insulin in human 
with a high degree of sensitivity and specificity. On the other hand, 
“immunometric assay” is used when the assay involves the use of reagents in 
stoichiometric excess (Deshpande, 1996). Such an assay may also be denoted 
as an immunoradiometric assay (IRMA), immunoenzymometric assay (IEMA) or 
immunofluorometric assay (IFMA), depending on the label used (Edwards, 1985; 
Hemmila, 1985). Immunoassays are popular techniques of choice because of 
their simplicities as well as the possibilities they offer in terms of automation to 
meet the numerous challenges faced in the analytical laboratories. 
 
1.5.2 Enzyme-linked immunosorbent assay (ELISA) 
Enzyme immunoassay (EIA) was developed as an alternative to some of the 
disadvantages of using the isotopic assay because radioisotope-labeled 





radioactive wastes is problematic. In addition, EIA can be as sensitive as 
radioimmunoassay, if not more so (Engvall & Perlmann, 1972). The work of 
Engvall and Perlmann  (1971) together with Van Weemen and Schuurs (1971),  
have changed the world of immunoassay immensely. They invented and 
developed the “enzyme-linked immunosorbent assay” (ELISA), a term generally 
used for reagent excess enzyme immunoassays for specific Abs or antigens. In 
their work, they were able to prove the achievability of an enzyme immunoassay 
technique, showing that a sensitive signal could be generated by an enzyme-
catalysed reaction, an idea that was opposed by others at that time who 
questioned how such large molecule like an enzyme could be linked to either the 
antigen or the antibody without affecting the reaction. Since then, the enzyme 
immunoassay has been the foundation of development of all immunoassays. 
Enzyme-linked immunosorbent assays (ELISAs) have been successfully 
developed not only for detection of macromolecular compounds (proteins, 
nucleic acids and bacteria, etc.) but also for analysis of low molecular weight 
compounds (hormones, toxins and drugs, etc.). The key ingredient in an 
immunoassay development is the antibody and the key process is its production, 
allowing a very specific detection associated with high sensitivity and high 
affinity. Attaining appropriate Abs is always a challenge even if the immune 
system can be exquisitely selective in producing Abs, particularly if the protein-
hapten conjugate has been carefully designed. Therefore, one of the most vital 
procedures for generating Abs with highly sensitive and specific determination of 
small, low molecular weight molecules is the design of the hapten and the way 
the hapten is being linked to the protein carrier. The orientation of attachment 
should be such that the relevant structural determinants of the analyte are free 





bind selectively to the desired analyte without cross-reaction with analogues or 
metabolites possibly present in the same samples (Roucairol et al., 2007). All 
ELISA protocols include the following five steps: i) coating of antibody or antigen 
on a solid phase (usually a microtitration plate); ii) blocking the remaining 
uncoated surface on the solid phase with blocking buffer containing non-specific 
protein such as bovine serum albumin or gelatine (this is to minimise the 
nonspecific reactions and also protect the adsorbed antigen or antibody from 
surface denaturation); iii) incubating with different immunoassay reagents at 
specified temperature and time; iv) washing the coated surface to separate free 
unbound molecules from bound molecules; and v) detecting the colour 
developed from the assay visually or spectrophotometrically (Hsieh, 2010). 
Specific procedures may vary with different variations of ELISA depending on 
the target analytes. There are several types of ELISA format that took advantage 
of the use of either immobilized antigen or Abs. Indirect non-competitive ELISA 
(incELISA) and indirect competitive ELISA (icELISA) will be discussed in section 
1.5.2.1 since these were the ELISA formats used throughout the study. 
 
1.5.2.1 Indirect and direct ELISA 
All immunoassay signals can be detected directly or indirectly. In the direct 
detection method, the detecting molecules are purified and linked to the label to 
directly measure the amount of the Ag-Ab complex. In contrast, the indirect 
detection method uses a commercially available intermediate reagent to link the 
capture molecule. Most often a labelled anti species Ab is used for an antibody-
captured assay to indirectly measure the amount of antibody-complex formed 





less immunoreagents and in many cases could be more sensitive because more 
labelling molecules can be linked to the detection Ag or antibody for enhanced 
signal production and the interaction between the enzyme and food sample 
matrices could be avoided due to absence of the enzyme label during incubation 
(Morgan, 1989). While the direct detection method is essential when an accurate 
quantification is required for the assay, the indirect detection method is used in 
most solid-phase immunoassays. 
 
1.5.2.2 Indirect non-competitive ELISA 
This is the simple form of indirect antibody-captured ELISA which is a sensitive 
technique for quantifying molecules in solution. It is often used in the early stage 
of immunoassay development to detect primary Abs in antisera or screen 
hybridoma supernatants for searching desired Abs. The soluble antigen is 
adsorbed (coating) onto the surface of the microtitration wells and incubated. To 
prevent nonspecific binding, any vacant binding sites in the plate are sometimes 
blocked with the use of a protein such as bovine serum albumin (BSA) or 
gelatine. After blocking the diluted samples of antisera or hybridoma 
supernatants are then added to the wells and incubated to allow the Abs to bind 
specifically to the immobilized antigen. After washing the unbound molecules, 
those bound Abs can be detected by adding the secondary antibody. The 
secondary antibody is usually linked to an enzyme, and the addition of suitable 
substrate results in a colorimetric reaction. The colour can then be measured 
using a spectrophotometer. The resulting optical density (OD) is proportional to 
the amount of antigen present in the sample (Kemeny and Chantler, 1988; 






1.5.2.3 Indirect Competitive ELISA 
Competitive ELISA involves the use of two forms of the Ag, one is the sample 
Ag to be assayed and the other, a constant level of “tracer” or specific antigen 
immobilized on the microtitration plate well. Plates are coated with the specific 
Ag and these are then incubated with a mixture of Ab and the test sample. If 
there is no Ag in the test sample the antibody becomes fixed to the antigen-
sensitized surface. If there is Ag in the test solution, it binds with the Ab, which 
cannot then react with sensitized solid phase. The amount of Ab attached is then 
indicated by an enzyme-labelled Ab conjugate and enzyme substrate. The 
amount of inhibition of substrate degradation in the test sample (as compared 
with the reference system) is proportional to the amount of antigen in the test 
(Voller et al., 1978). Competitive ELISA, unlike two-site ELISA, permits both 
simultaneous and sequential incubation of sample and labelled antibody 
(Porstmann & Kiessig, 1992) and may be of greater specificity compared to the 
two-site ELISA (Makarananda et al., 1995). The direct ELISA and both indirect 
non-competitive and competitive ELISA are depicted in Figure 1-13. 
 
Figure 1-13: Different formats of enzyme-linked immunosorbent assay (ELISA). 






Generally, immunoassay techniques can be a cost effective detection and 
quantification method for trace contaminants or toxins in a wide variety of foods. 
Most modern immunoassays for environmental and food contaminants are 
based on the use of enzyme tracers to provide quantification signals 
(Meulenberg, 1997). This is because enzyme-based assays have appropriate 
sensitivity for most purposes and have been developed in a variety of 
configurations. The long shelf-lives and ease of distribution of enzyme-based 
immunoassays also make them suitable for field use. Thus, immunoassay is a 
very useful analytical technique that can be used for the development of specific 
and sensitive assays that would permit the determination of trace residues of 
contaminants such as mycotoxins or phytotoxins in small volume of samples 
which could be otherwise difficult to analyse by other more expensive analytical 
methods. Successful development of an immunoassay technique would however 
depend on the availability of Abs with appropriate affinities and specificities. 
 
1.5.3 Immunoassay application in food 
Immunoassays are now widely utilized in food analysis for determination of food 
contaminants and in the agrochemical industry for detection of chemical residues 
in plants, water and soil (Meulenberg, 1997; Ramesh et al., 2007; Sathe et al., 
2012). Different types of immunoassay techniques have been developed for the 
detection and quantification of hazardous compounds in food. Extensive 
research has been carried out on the development and use of various 
immunoassay techniques for monitoring occurrence and detection of mycotoxins 
(such as T-2, HT-2, deoxynivalenol, ochratoxin A and aflatoxin B1) in wheat, 





Liu et al., 2012; Li et al., 2016). ELISA is the most commonly used method (Li et 
al, 2009b). ELISA has also been used in monitoring residual insecticides and 
herbicides in several food commodities (Krikunova et al., 2002; Bo et al., 2008). 
Quan (2006) developed a sensitive enhanced chemiluminescene enzyme-linked 
immunosorbent assay (ECL-ELISA) for the detection of fumonisin B1 (FB1) in 
food and animal feeds. Pastor-Navarro et al. (2007) was able to develop an 
ELISA for detection of different tetracycline residues in honey. In another study, 
Chen et al., 2007 developed a sensitive ELISA method for monitoring neomycin 
(an aminoglycoside antibiotic) residue levels in milk and other biological 
matrices. Recently, electrochemical immunoassays have been developed for 
detection of zearalenone mycotoxin in foods and very useful because of their 
suitability for mass production, high sensitivity, large number of labels and 
nanotechnology applications (Hervás et al., 2009). Immunoassay has also been 
used for the determination of tracers of peanut protein contamination in complex 
food matrices (Morgan et al., 1986; Mills et al., 1997; Holzhauser and Veiths, 
1999). Despite numerous and elaborate studies done on detection and 
quantification of CGs in plant foods, surprisingly the use of immunoassay for its 
quantitative determination is still lacking, despite its inherent sensitivity, 






1.6 Aim of the project 
 
The aim of the study is to develop a rapid and sensitive enzyme-linked 
immunosorbent assay (ELISA) test for detection and quantification of linamarin, 
a cyanogenic glycoside in cassava and to determine its content in commercially 
available cassava-products in the UK. 
 
The whole thesis describes the experimental approach and results towards the 
following area: 
i) Linamarin (hapten) conjugation to a suitable carrier proteins and the 
production of the polyclonal antibody against linamarin. 
 
ii) Development of monoclonal antibody against linamarin. 
 
iii) Sample preparation to extract linamarin from plant tissues and food 
products and the development of an ELISA for the detection and 
quantification of linamarin in foods. 
 
 
The use of immunoassay and development of antibodies against linamarin for its 
direct determination and quantification in fresh cassava and processed products 
have not yet been reported although total cyanogenic contents in cassava have 
been extensively studied and investigated through various other methods as 
discussed previously in section 1.3.9. Successful conjugation of the immunogen 
followed by immunisation would provide good antibodies to be used in the ELISA 
for the detection and quantification of linamarin in foods. 
  
Chapter 2 : Materials and Methods 
 
2.1  Chemicals, Consumables and Solvents 
 
The following chemicals, consumables and solvents were obtained from: 
 
Sigma-Aldrich Chemical Co. Ltd, Poole, Dorset, UK 
• Naringin >=90%, from citrus fruit (N1376, 100 g) 
• Cyanuric chloride, 99% (C95501, 250g) 
• Acetone (31062, 2.5 L) 
• Methanol amd chromasolv (34898, 2.5 L) 
• Diethyl ether (296082, 1 L) 
• Amygdalin, from apricot kernels (A6005, 100 mg) 
• Sodium carbonate (S2127, 1 kg) 
• Sodium bicarbonate, ReagentPlusâ, ³99.5%, crystalline (S8875,1 kg) 
• Tweenâ 20 (P1379, 500 ml) 
• 3,3’, 5,5’ Tetramethylbenzidine (TMB) liquid substrate system for ELISA 
(T0440, 1 L) 
• 3,3’, 5,5’ Tetramethylbenzidine (TMB) liquid substrate, Supersensitive, for 
ELISA, ready to use solution (T4444, 100 ml) 
• Gelatin from cold water fish skin (G7765, 250 ml) 
• Gelatin from cold water fish skin, powder (G7041, 100 g) 
• Sodium phosphate dibasic, anhydrous, ³ 98.0% (71642, 1 kg) 
• Phosphoric acid >=85wt% solution in water (438081, 2.5 L) 





• Eppendorf® epT.I.P.S standard, capacity 20-300 µl (Z640107-1000EA) 
• Eppendorf® epT.I.P.S standard, capacity 50-1000 µl (Z640115-1000EA) 
 
Fisher Scientific Ltd., Loughborough, Leicestershire, UK 
• Disodium hydrogen orthophosphate dihydrate (S/4450/60,1 kg) 
• Potassium chloride, laboratory reagent grade (P/4240/53, 500 g) 
• Sodium chloride, for analysis, certified AR 99.5% (S/3161/53, 500 g) 
• Sulphuric acid, 95-97% (07208, 2.5 L) 
• Bovine serum albumin, free fatty acid (BP9704-100, 100 g) 
• Sodium hydroxide (S/4800/60,1 kg) 
• Hydrochloric acid, analytical reagent grade (~37%, H/1200/PB17, 2.5l) 
• Potassium carbonate anhydrous, analytical reagent grade (P/4120/53, 
500 g) 
• Sodium phosphate monobasic for analysis, 99% (Acros Organics, 7558-
80-7, 1 kg) 
• BioDesignDialysis TubingTM D304, 21.3 mm wet diameter – 3.57 ml/cm 
volume, 3500 MWCO (BID-050-020C, 20.5 m roll) 
• Eppendorf® epT.I.P.S standard 165 mm, 1-10 mL (10333682) 
• X1000 Microcentrifuge tube 2.0 ml, natural, snap cap (11558252) 
 
Scientific Laboratory Supplies Ltd., Nottingham, UK. 
• Whatman No. 1 150 mm filter paper circles (Fil2034) 






Calbiochem, Merck Chemicals Ltd., Nottingham, UK 
• Keyhole limpet hemocyanin (KLH), from Megathura crenulata, protein 
content 73% (374805, 250 mg) 
 
Eppendorf UK Ltd. 
• Eppendorf Researchâ Plus Pipette 0.5–1.0 μL 
• Eppendorf Researchâ Plus Pipette 1.0–20 μL 
• Eppendorf Researchâ Plus Pipette 10–100 μL 
• Eppendorf Researchâ Plus Pipette 10–200 μL 
• Eppendorf Researchâ Plus Pipette 100–1000 μL 
• Eppendorf Researchâ Plus Pipette 1000–10,000 μL 
 
Insight Biotechnology Ltd., Wembley, UK 
• Linamarin, (sc-203439, 50 mg) 
 
Invitrogen Life Technologies Ltd, Paisley, UK 
• Goat anti-rabbit IgG (H+L) secondary antibody, HRP conjugate, 1 mg (G-
21234). The species-specific enzyme-labelled secondary antibody was 
used as secondary antibody for the immunoassays using rabbit antisera. 
 
Morrisons Supermarket, Leeds, UK 






CovalAb UK Ltd., Cambridge, UK 
• Goat anti-mouse IgG (H+L) secondary antibody, HRP conjugate, 1 ml 
(LAB0252). 
• Goat anti-rabbit IgG (H+L) secondary antibody, HRP conjugate, 1 ml 
(LAB0273). 
 
Gilson Scientific Ltd., Bedfordshire, UK 
• Pipetman L Multichannel 20-300 µl 12 channel (FA10016) 
 
Greiner Bio-One Ltd., Gloucestershire, UK. 
• 96 Well ELISA plate, flat bottom, high bind (655061) 
• Pipette tip, to fit Gilson P200, yellow, 5000 per case (739295) 
• Eppendorf tube with attached cap, 1.5 ml, natural, 4000 per case 
(616201) 
• EASYseal plate sealer, transparent, 100 per case (676001) 
 
VWR International Ltd., Leicestershire, UK 
• Absolute ethanol, AnalaR NORMAPUR, ACS Reagent (20821.330, 2.5 L) 
• 2,4,6-Trinitrobenzene sulfonic acid, TNBS, 1% in methanol (BC86) 
• Potassium hydrogen orthophosphate (26923.298, 1 kg) 
• Parafilm sealing film, length-75 m, width-100 mm (291-1212) 
 









The general laboratory equipment used in this study are as follows: 
• Washing of polystyrene microplates was carried out using Tecan 
Hydroflex plate washer (Tecan Group Ltd., Männedorf, Switzerland). 
• A high resolution (0.001 Abs) photodetector Multiskan FC® plate reader 
(Thermo Scientific, Vantaa, Finland) and Tecan Spark 10M reader (Tecan 
Group Ltd., Männedorf, Switzerland) were used to determine the ELISA 
microplate well optical densities at 405nm. 
• Water (unless otherwise stated) was purified using a Millipore Direct-Q 5 
(Millipore, Watford, UK) which is a tap-fed purification system that purifies 
potable water to ultrapure (Type 1) water with resistivity of 18.2 MΩ cm 
(25°C) and a TOC value below 5 ppb at temperatures between 20 – 25oC. 
• Incubation of samples, substrate and antibody was carried out using a 
Sanyo incubator, model MIR-162 (Sanyo Electric Co. Ltd., Moriguchi, 
Japan). 
• Cassava samples were homogenised using a domestic blender, Tefal 
Mastermix BL800140, 850 watt (Tefal UK & Ireland, Berkshire, UK). 
• Centrifugation of extracts were performed using a refrigerated centrifuge, 
Thermo Scientific Heraeus Megafuge 16R (Life Technologies Ltd, 
Paisley, UK). 
• Solvent evaporation was performed using a rotary evaporator (Heidolph 





• The pH of solutions were measured with a Hanna HI2211 pH Meter 
(Hanna Instruments INC., Woonsocket, USA), calibrated with standard 
buffer solutions of pH 4, 7 or 10 each time before use.  
• Lyophilization of hapten-protein conjugates was carried out using a 
Labconco FreeZone 2.5L Freeze Dryer (Labconco, Kansas, MO, USA). 
• UV absorbance of samples were measured using a Jenway 6700 UV-Vis 
spectrophotometer (Bibby Scientific Ltd., Staffordshire, UK) with quartz 
cuvettes, 1 ml volume (Spectronic Analytical Instruments, Leeds, UK). 
• Mixing of solutions was carried out either by using IKA magnetic stirrer 
(IKA-Werke, Staufen, Germany) or by using an electric vortex mixer -
Fisherbrand Whirlimixer (Fisher Scientific Ltd., Leicestershire, UK). 
• Chemicals were weighed using an OHAUS Pioneer precision balance 
(OHAUS Europe GmBH, Switzerland) or AND precision balance (A&D 
Instruments, Oxfordshire, UK). 
• Dispensing of small volumes of reagents and solutions was carried out 
using Eppendorf Researchâ Plus pipettes ranging from 0.5-10,000 µl, 






2.3 Buffers, Solvents and Solutions 
2.3.1 Antigen coating buffer  
(0.05 M buffer solution of sodium carbonate bicarbonate, pH 9.6) 
Sodium carbonate (NaCO3, 2.65 g) and sodium hydrogen carbonate (NaHCO3, 
2.10 g) were each dissolved in water (500 ml) to obtain 0.05 M solutions. Sodium 
hydrogen carbonate (0.05M) was gradually added to sodium carbonate (0.05 M). 
50% Hydrochloric acid (HCl) or 4 M sodium hydroxide (NaOH) were used to 
adjust the pH to 9.4. The buffer was prepared fresh for daily use and any excess 
solution was discarded. 
 
2.3.2 Phosphate-buffered saline (PBS) 
Sodium chloride (NaCl,16.0 g), disodium hydrogen orthophosphate 
(Na2HPO4.12H2O, 3.56 g), potassium dihydrogen phosphate (KH2PO4, 0.4 g), 
potassium chloride (KCl, 0.4 g) were dissolved in water (1800 ml). The pH of the 
solution was adjusted to 7.4 using HCl (50%) or sodium hydroxide (4 M), as 
required. The solution was made up to 2L with water. The buffer can be stored 
at room temperature and was used within one week or kept at 4⁰C and used 
within 2 weeks. 
 
2.3.3 Phosphate-buffered saline plus Tween 20 (PBST) 
PBST buffer was prepared as 2.4.1 except that Tween 20 (1.0 ml, 0.05%) was 






2.3.4 Blocking buffers 
• Gelatine-PBST (1%, v/v). Gelatine (1.0 ml) was dissolved in PBST (99.0 
ml) as prepared in 2.4.3. This blocking buffer was prepared fresh for daily 
use and any excess solution was discarded. 
• Milk-PBST (1%, w/v). Skimmed-milk powder (1.0 g) was dissolved in 
PBST (100 ml) as prepared in 2.4.3. This blocking buffer was prepared 
fresh for daily use and any excess solution was discarded. 
• BSA-PBST (1%, w/v). BSA (1.0 g) was dissolved in PBST (100 ml) as 
prepared in 2.4.3. This blocking buffer was prepared fresh for daily use 
and any excess solution was discarded. 
• Soy-PBST (1%, w/v). Soy powder (1.0 g) was dissolved in PBST (100 ml) 
as prepared in 2.4.3. This blocking buffer was prepared fresh for daily use 
and any excess solution was discarded. 
 
2.3.5 Enzyme substrate  
3,3’, 5,5’ Tetramethylbenzidine (TMB) was used directly from stock solution as 
substrate for the horse radish peroxidase (HRP) attached to the secondary 
antibody. The TMB was kept in refrigerator at 4°C when not it use. 
 
2.3.6 TMB-HRP reaction stop solution (2 M sulphuric acid) 
Concentrated sulphuric acid (11.22 ml) was diluted in water (88.78 ml) with 






2.3.7 Rabbit primary antibody serial dilutions (Log 10 dilution) 
A series of primary antibody dilutions were prepared using the stock primary 
antibody obtained from the rabbit. Primary antibody (100 µl) was diluted with 
PBST (900 µl) in a 1.5ml eppendorf tube to give 1:10 dilution. An aliquot (100 µl) 
from the 1:10 dilution was diluted with PBST (900 µl) in another 1.5 ml eppendorf 
tube to make 1:100 dilution. These steps were repeated sequentially to get a 
series of dilutions up to 1:106 (v:v). 
 
2.3.8 Mouse/hybridoma primary antibody serial dilutions 
2 sets of primary antibody dilutions were prepared using the stock primary 
antibody obtained from the mice and hybridoma (Log 10 and 2-fold dilutions). 
Due to very small amount of antisera (150 µl, 1/5 dilution, v/v) being delivered by 
CovalAb UK Ltd., some adjustment need to be made when preparing the 
dilutions.  
 
2.3.8.1 Log 10 dilution 
Since the volume of mice antisera provided were small (~ 150 µl), and pre-diluted 
to 1:5 dilution, (15 µl) was diluted with PBST (1485 µl) in a 2.0 ml eppendorf tube 
to give an initial dilution of 1:500 dilution. An aliquot (500 µl) from the 1:500 
dilution was diluted with PBST (500 µl) in a 1.5 ml eppendorf tube to make a 
1:1,000 dilution. An aliquot (100 µl) from the 1:1,000 was diluted with PBST (900 
µl) to make a 1:10,000 dilution. The last steps were repeated sequentially to get 






2.3.8.2 2-fold dilution 
From the initial antiserum provided (1:5 dilution), (15 µl) was diluted with PBST 
(1485 µl) in a 1.5ml eppendorf tube to give 1:500 dilution. An aliquot (500 µl) 
from the 1:500 dilution was diluted with PBST (500 µl) into another 1.5 ml 
eppendorf tube to make the subsequent dilution. These steps were repeated 
sequentially to get a series of dilutions up to 1:64,000. 
 
2.3.9 Secondary antibody preparation (1/1,000, v/v) 
Secondary antibody (anti-rabbit IgG from goat with HRP, 10 µl) was diluted with 
PBST (990 µl) in a 15 ml conical tube to give a 1:1,000 dilution. If more than 10 
ml was required, 20 µl of secondary antibody was pipetted instead and diluted 
with PBST (980 µl), in a 20 ml conical tube.  
 
2.3.10 Antigen coating for microtitration plates (1µg/ml) 
Coating antigen (linamarin-CC-KLH, 1.0 mg) was dissolved in coating buffer (1 
L) to give a 1.0 µg/ml concentration. The solution was stirred for 1 hour and 
filtered using Whatman No. 1 filter paper to remove undissolved materials. The 
coating antigen solution was prepared fresh for daily use and any excess solution 
was discarded. Aliquots (300 µl) were pipetted into each well of the microtitration 
plate. The microtitration plate was then sealed using parafilm and incubated 
overnight at 4⁰C. The microtitration plate was washed 5-times with PBST the 
following day and dried for immediate use or stored in dry place and away from 






2.3.11 Standard antigen dilution 
Standard antigen (linamarin, 1.0 mg) was dissolved in PBST (1.0 ml) buffer in a 
1.5 ml eppendorf tube to make a 1.0 mg/ml dilution. An aliquot (100 µl) from the 
1.0 mg/ml solution was diluted with PBST (900 µl) in another 1.5 ml eppendorf 
tube to make a 1:10 dilution. This process were repeated sequentially to get a 
series of dilutions up to 1:106 (v:v). 
 
2.3.12 Buffer preparation for hapten-protein conjugation 
 
2.3.12.1 Potassium carbonate (5%, w/v) 
Potassium carbonate (50.0 g) was dissolved in water (1 L). 
 
2.3.12.2 Sodium carbonate/bicarbonate buffer, 0.05 M, pH 9.4 
The carbonate-bicarbonate buffer is prepared as described in 2.4.1. The buffer 
was prepared fresh for daily use and any excess solution was discarded. 
 
2.3.12.3 Sodium bicarbonate (4%, w/v), pH 9.4 
Sodium bicarbonate (4.0 g) was dissolved in water (100 ml). The pH was 
adjusted to 9.4 using 4 M sodium hydroxide. 
 
2.3.12.4 Phosphate buffer, 0.05 M, pH 5.5 
Sodium phosphate monobasic (NaH2PO4, 5.751 g) and sodium phosphate 
dibasic (Na2HPO4, 0.294g) were each dissolved in water (1 L). Both solutions 






2.3.12.5 Preparation of dialysis membrane 
Visking dialysis membrane was cut 15cm in length and soaked in water for 
approximately 1 hour and was used immediately.  
  




• For the first time, polyclonal antibodies against linamarin have been 
produced in rabbits. 
 
• Linamarin was successfully conjugated to BSA and KLH using the 
cyanuric chloride method, the former used as immunogen for 
immunization and the latter used as solid phase antigen. 
 
• Anti-linamarin antibody titre curves were obtained from both rabbits using 
an indirect non-competitive ELISA (incELISA). High antibody titre was 
obtained throughout all the test bleeds from both rabbits even at dilutions 
of 1 in 100,000. 
 
• The highest antibody titre and activity was obtained from Day-74 test 
bleed in R074 and Day-88 test bleed in R076.  Day-88 test bleed from 
R076 (R076D88) was selected and used in subsequent experiments in 
order to preserve identical conditions and consistency. 
 
• A standard curve was successfully developed using an indirect 
competitive ELISA (icELISA) after few optimization procedures. This is the 







PAbs are generated by injecting an immunogen into an animal and collecting the 
blood fraction containing the Abs after an appropriate time. In order to produce 
good antisera, the hapten-protein conjugate (immunogen) is often prepared in 
adjuvants. The immunological adjuvants non-specifically enhance or modify the 
immune response to co-administered antigens (Baldridge and Lacy, 2000), 
which vigorously affect antibody production compared to when antigen is 
administered alone. First developed by Jules Freund in the 1940s (Freund et al., 
1937, Freund, 1951), Freund’s adjuvant is designed to provide slow release and 
presentation of the immunogen to the immune system over an extended period 
of time providing a strong, persistent immune response of the animal (Green and 
Manson, 1998). The antigen-adjuvant emulsions optimized the immune stimulus 
by focusing a general immunostimulant and Ag in the same microenvironment 
where they can interact with antigen-presenting cells and lymphocytes 
simultaneously, hence providing a method of stimulating, by a short course of 
injections, the development of Abs of high titre (Baldridge and Lacy, 2000). The 
adjuvants are used as a water-in-oil emulsion, often prepared from non-
metabolizable oils (paraffin oil and mannide monooleate). During the 
emulsification process, the immunogen-containing water droplets become 
entrapped in the oil, forming particulates in a very viscous emulsion in which, 
upon administration into the host, acts as a depot of immunogen. The potency of 
this water-in-oil emulsion can be increased by incorporating immunostimulants.  
 
There are two types of Freund’s adjuvant used which are the complete Freund’s 





consists of the aqueous immunogen solution, mineral oil, an emulsifying agent, 
and heat-killed Mycobacterium tuberculosis, a very potent immunomodifier that 
attracts macrophages and other cells to the injection site which enhanced the 
host’s immune response. Meanwhile, IFA is identical to CFA except that the 
Mycobacterium tuberculosis is omitted (Baldridge and Lacy, 2000). However, the 
main disadvantage of Freund’s adjuvant is that it can cause granulomas, 
inflammation at the inoculation site and lesions. For this reason, the CFA is 
usually used only for the initial injections, and to minimize side-effects, IFA is 
used for the subsequent booster injections. 
 
Although large volumes of antiserum are produced from immunizing goats or 
sheep, polyclonal antisera raised in rabbits are often of high quality (Hancock 
and O’Reilly, 2005). Two female New Zealand rabbits were the animal of choice 
used in this study as they produce adequate amount of sera, have ready 
availability and are easy to maintain. In addition, the anti-rabbit IgG (detection 
antibody) are of a high quality and are readily and commercially available. The 
use of more than one individual animal is recommended, because the immune 
response could vary significantly between individual animals (Hancock and 
O’Reilly, 2005). Since the carrier is immunogenic, immunization with a hapten-
carrier conjugate elicits Abs to both carrier and hapten (Lewis, 2001).  
 
Injecting the immunogen into the animals allows the hapten-carrier molecule to 
interact with both T and B-cells. The carrier portion of the conjugate activates T-
cells, while Abs to both hapten and carrier are elicited by B-cells. The carrier 





complex class II or T-cell receptor epitopes and the haptens can then serve as 
B-cell determinants (Hancock and O’Reilly, 2005). B-lymphocytes which are 
present in mammalian spleen, marrow and gut-associated lymphoid tissue are 
responsible for the production of Abs to individual epitopes on a specific Ag 
(target molecule). The epitope is the specific site on the Ag and bound by single 
Ab. There are two types of epitopes; a linear epitope which consist of a 
continuous amino acids sequence, and a conformational epitope which consists 
of a non-continuous sequence of amino acid that can be folded or overlapping 
peptide chains on the surface of the target (Hsieh, 2010). The presentation of 
these epitopes to the cells of the immune system which occurs during the 
immunization process induces B-lymphocyte priming. The primed B-cells 
undergo clonal expansion and secrete antibody until the antigen has been 
destroyed or removed. The pool of antibody molecules produced by these cells 
is called polyclonal because it is derived from multiple clones of lymphocytes, 
each clone generating Abs with unique specificity to single epitopes (Burns, 
2005). PAbs are characterized based on their ability to distinguish between 
different antigens (specificity), their binding strength (avidity) and the optimal 






3.1.1 Aim of the chapter 
 
The aim of the work described in this chapter was to design and conjugate 
linamarin, a hapten to a suitable carrier proteins in order to generate a good 
immunogen to be used for the production of the polyclonal antibody against 
linamarin, and another conjugate to be used as the solid phase antigen. Selected 
pAb will be used to develop the ELISA for the detection and quantification of 
linamarin. 
 
This chapter describes the experimental approach and results towards the 
following areas: 
i) Design and synthesis of linamarin protein conjugates for antibody 
production and for use in an assay. 
 
ii) Immunization of rabbits in order to generate polyclonal antisera 
capable of recognizing linamarin. 
 
iii) The setting up, optimization and preliminary characterization of an 








3.2.1 Synthesis of hapten-protein conjugates 
 
Linamarin was conjugated to BSA and KLH using a cyanuric chloride conjugation 
method based on the successful attempt by Bolarinwa (2013) with amygdalin 
and suitability of the method as mentioned previously in section 1.4.3.3. The 
chemical reaction is depicted in Figure 3-2. The linamarin-BSA conjugate was 
used as immunogen for the production of anti-linamarin antiserum while the 
linamarin-KLH conjugate was used as a solid phase antigen. 
 
Figure 3-1: A schematic diagram showing the route for linamarin-CC (hapten) 
synthesis. Free linamarin standard was activated with cyanuric chloride by stirring a 





3.2.1.1 Linamarin-BSA Conjugate 
Linamarin was first activated with cyanuric chloride (CC) by dissolving CC (1.0 
mg) in acetone (1.0 ml). An aliquot of the solution (0.3 ml) was then transferred 
into a glass vial and the contents of the glass vial was allowed to evaporate under 
the fume hood. Linamarin (2.3 mg) was dissolved in 0.5 ml sodium carbonate-
bicarbonate buffer, pH 9.4 (5 μmol). Once the acetone had completely 
evaporated, the linamarin solution was added to the CC residue in the glass vial. 
The mixture was then stirred for 6 hours at room temperature (20 ± 2oC) to 
generate the activated hapten (linamarin-CC). For the immunogen carrier 
protein, BSA (6.6 mg) was dissolved in 0.05 M sodium carbonate-bicarbonate 
buffer (pH 9.4, 0.5 ml) to give a 0.1 μmol concentration. The BSA solution was 
then added to the activated hapten mixture and incubated overnight at 37oC. The 
protein:hapten mixture was then dialysed using 0.05 M phosphate buffer, (pH 
5.5), for 6 hours the following day. The protein:hapten mixture was transferred 
into a 50 ml conical tube and lyophilised using a freeze-dryer to obtain a white 
compound (the linamarin-CC-BSA conjugate). The conjugate was stored at -
20oC until required. The linamarin-CC-BSA conjugate was used as immunogen 
to generate anti-linamarin Abs in rabbits. 
 
3.2.1.2 Linamarin-KLH-conjugate 
Similar procedures as described in 2.5.1 were followed. Linamarin (2.3 mg) of 
and KLH (10 mg) were used instead for the conjugation in order to provide the 





3.2.2 Assessment of hapten-protein conjugates 
 
3.2.2.1 UV-spectrophotometric method 
The verification of hapten-protein conjugate and estimation of the number of 
moles of hapten conjugated to protein was estimated by UV spectrometry. 
Standard BSA, linamarin-CC-BSA or linamarin-CC-KLH conjugates (1.0 mg) 
were weighed in a 2.0 ml Eppendorf tube and dissolved in sodium carbonate-
bicarbonate buffer (pH 9.4, 1.0 ml) respectively. Each of the solutions was 
vortexed for 1 minute before being transferred into a quartz cuvette. Absorption 
spectrum analysis was done using wavelengths between 200-400 nm for each 
sample. The number of moles of hapten per mole of protein in the conjugate was 
determined using the maximum absorbance of amygdalin at 260 nm to calculate 
the molar extinction coefficient. The number of moles for conjugated hapten was 
calculated using Beer Lambert’s Law (A = εcl), where: 
 







3.2.2.2 Chemical method 
2,4,5-trinitrobenzene sulfonic acid assay (TNBS) was used to estimate the molar 
conjugation ratio of linamarin-BSA and linamarin-KLH conjugates. The method 
is based on the determination of freely available amino acid groups present in 
the carrier protein before and after hapten conjugation following its reaction with 
TNBS. Reaction of TNBS with primary amines generated trinitrophenyl, a highly 
chromogenic derivatives that can be readily measured spectrophotometricaly. 
Carrier protein (BSA or KLH, 2.0 mg) and both conjugates (linamarin-BSA and 
linamarin-KLH) were separately dissolved in sodium bicarbonate buffer (4%, w/v, 
pH 9.4, 2.0 ml). Aliquots of the above solutions (40, 80, 120, 160, 200 μl) were 
dispensed in triplicate into the wells of a microtitration plate to generate the 
standard curve. The volume in each well was made up to 200 μl using sodium 
bicarbonate buffer (4%, w/v, pH 9.4). TNBS (50μl, 0.1%, v/v) in sodium 
bicarbonate buffer (4%, w/v, pH 9.4) was added into each well and incubated for 
2 hours at 37oC for colour development. The absorbance reading for the whole 
microtitration plate was measured using the plate reader at 405 nm. The 
percentage substitution of amino acid in the carrier protein was used to estimate 
the conjugation ratio of hapten to carrier protein. 
 
% Substitution = OD of carrier protein – OD of hapten-protein conjugate x 100 
                 OD of carrier protein 
 






3.2.3 Production of polyclonal antibody against linamarin 
 
Anti-linamarin polyclonal antisera were raised in two rabbits by CovalAb UK Ltd., 
Cambridge, UK (CUK-1680). The immunization protocol employed was fairly 
standard and as follows. The immunogen (linamarin-CC-BSA) was used to 
immunize two female New Zealand White rabbits (weighing between 2 – 2.5 kg, 
coded 1529074 & 1529076) to generate pAbs. Blood was first collected from the 
ears of each rabbit for the pre-immune serum prior to the immunization process. 
The first injection, consisting of the immunogen (50 µg in 0.5 ml PBS) emulsified 
with Freund’s complete adjuvant (0.5 ml), was injected intradermally on multiple 
sites on the back of the rabbits. The rabbits were further boosted by injecting 
intradermally with the immunogen (50 µg) dissolved in Freund’s incomplete 
adjuvant (0.5 ml) three times at three-week intervals, with the final booster 
injection administered subcutaneously. Serum was taken via ear veins on days 
53 (test bleed 1, 4-5 ml) and 74 (test bleed 2, 4-5 ml), and from the heart on day 
88 (final bleed, 60-80 ml). The serum was separated from cells by centrifugation 
(3,000 rpm / 1,693 x g, 10 min at 4oC) and the polyclonal antibody (serum) was 
stored at -20oC until required. Table 3-1 shows a summary of the intradermal 










Pre-immune bleed (4-5ml) and starting immunisation with 1st intradermal 
injections of 0.5ml antigen + 0.5ml complete Freund/s adjuvant) 
21 
Second intradermal injections of 0.5ml antigen + 0.5ml incomplete Freund’s 
adjuvant 
42 
Third intradermal injections of 0.5ml antigen + 0.5ml incomplete Freund’s 
adjuvant 
53 First test bleed (4-5ml) 
63 
Fourth subcutaneous injections 0.5ml antigen + 0.5ml incomplete Freund’s 
adjuvant 
74 Second test bleed (12-15ml) 
88 Final bleed (60-80ml) 
 
 
3.2.4 Determination of anti-linamarin titre 
 
The activity of the pAbs obtained from the antisera was first investigated by 
constructing a titre curve. The primary antibody dilution was prepared as 
described in 2.3.7 and the microtitration plate was prepared as described in 
2.3.10. Serial dilutions of the antiserum (bleeds 53, 74 and 88-days along with 
the pre-immune bleed as control) were dispensed into coated microtitration plate 
wells (200 µl/well) in triplicate. The microtitration plate was sealed using parafilm 
and incubated overnight at 4oC. The microtitration plate was washed 5-times with 
PBST the following day and left to dry. Secondary antibody (goat anti-rabbit IgG 
coupled with horseradish peroxidase enzyme, prepared as described in 2.3.11, 
200 µl) was dispensed into each well and incubated for another 2 hours at 37oC. 
The microtitration plate was washed 5-times with PBST after the 2 hours 





each well and the plate left for 30 mins at room temperature to allow colour 
development. Noticeable changes in colour were observed. 2 M sulphuric acid 
(50 µl) was added into each well to stop the enzymic reaction. Finally the OD 
reading of each well was taken using a plate reader at 405 nm. 
 
3.2.5  Development of an ELISA standard curve for linamarin 
 
An icELISA was used to develop a linamarin standard curve. Linamarin-KLH 
conjugate was used as the solid phase antigen. The microtitration plate was 
prepared as described in 2.3.10. The blocking buffer of choice (prepared as 
described in 2.3.4, 300 µl) was dispensed into each well of the microtitration plate 
and incubated for 30 minutes at 37oC. Standard Ag (linamarin) serial dilutions 
were prepared as described in 2.3.11. Aliquots of each standard Ag dilution (100 
µl) was then dispensed into each well of the microtitration plate in triplicate along 
with anti-linamarin Ab (100 µl; v:v in PBST). The microtitration plate was sealed 
using parafilm and incubated for 2 hours at 37oC. The microtitration was washed 
5-times with PBST after the incubation and left to dry. The secondary Ab 
(prepared as described in 2.3.9, 200 µl per well) was dispensed into each well 
and incubated for another 2 hours at 37oC. The microtitration plate was washed 
5-times with PBST after the incubation and left to dry. TMB substrate (200 µl) 
was dispensed into each well and left for 30 mins at room temperature. 
Noticeable changes in colour were observed. Finally 2M sulphuric acid (50 µl) 
was added into each well to stop the reaction. The OD reading of each well was 
then recorded using a plate reader at 405 nm. Subsequently, the average optical 





linamarin standard (ranging from 1.0 mg/ml to 1.0 x 10-6 mg/ml) to form a 
calibration curve. A calibration curve was run with each plate to minimise 
variation from plate to plate and the equation of the line was used to calculate 
the amount of linamarin in the analysed samples. 
 
 
i) Colour development after 
substrate addition (TMB) 
 
ii) Colour development after addition 
of stop solution (2M H2SO4) 
 
iii) Plate washer and plate reader used throughout the study 
Figure 3-2: Images showing colour development in ELISA and current laboratory 
setup including the Tecan Hydroflex Plate Washer and Multiskan FC ® Plate 
Reader. i) Blue colour development  after addition of subtrate, ii) change of colour from 







3.3.1 Immunogen synthesis 
Cyanuric chloride (2,4,6-trichloro-1,3,5-triazine, CC) was used as a bridging 
molecule in the synthesis of immunogen (linamarin-CC-BSA). The molar ratio 
between hapten and protein (linamarin:BSA) used was based on a chemical 
optimization study performed between naringin and BSA (Bolarinwa, 2013). The 
optimum initial molar ratio of 50:1, hapten:protein, was chosen based in terms of 
resulting yields and practicality. A similar approach was used in the present study 
to conjugate linamarin to BSA. The final product ratio after the conjugation was 
estimated to be between 15:1 and 25:1, on assumption that the carrier protein 
completely reacted with hapten in the conjugate. The lyophilised linamarin-BSA 
conjugate is shown in Figure 3-3, which will be further assessed to confirm 
successful conjugation.  
 
 
Figure 3-3: Lyophilised linamarin-BSA conjugate. Freeze-dried for 36-48 hours and 







3.3.2 Assessment of the hapten-protein conjugates 
3.3.2.1 Spectrophotometric assessment 
Verification of conjugate synthesis and estimation of the number of moles of 
hapten conjugated per mole of protein was estimated by using UV-visible 
spectrometry. The results of UV absorption spectra of linamarin, BSA and 
linamarin-CC-BSA conjugate from the CC conjugation method are shown in 
Figure 3-4. The absorption spectra revealed a single peak of unconjugated BSA 
at 280nm and a significantly lower peak for the linamarin-BSA conjugate. An 
absorbance peak at 280nm for unconjugated linamarin was totally absent. 
 
 
Figure 3-4: UV absorption spectra of BSA, linamarin and linamarin-CC-BSA 
conjugate obtained from the cyanuric chloride method, showing the absorption 

























3.3.2.2 Chemical assessment 
A chemical method, utilizing the 2,4,6-trinitrobenzene sulfonate (TNBS) assay, 
was used to reinforce the verification of linamarin-BSA conjugate using the 
estimation of its percentage conjugation. The method is based on the sulphuric 
acid digestion of the protein with subsequent conversion of the nitrogen to 
ammonium sulphate. Reaction of TNBS with primary amines generated 
trinitrophenyl protein-sulphite complexes, highly chromogenic derivatives that 
can be readily measured spectrophotometrically. The standard curves obtained 
from this assay are shown in Figure 3-5. Both standard curves show excellent 
linearity (R2 values of 0.9955 for BSA and 0.9911 for linamarin-BSA conjugate). 
The standard curve of linamarin-BSA conjugate is clearly shifted much lower 
than the BSA standard curve.  
 
Figure 3-5: TNBS standard curves obtained with BSA and linamarin-CC-BSA 
conjugate obtained from the cyanuric chloride method, showing the reduction in  
free amino acids of BSA after conjugation to linamarin. Error bars represent the standard 
deviation of triplicate analyses. 
y = 0.0105x + 0.3366
R² = 0.9955




























3.3.3 Anti-linamarin antibody titre 
An incELISA was applied to investigate the activity of antisera generated against 
linamarin from both rabbits, coded 1529074 – R074 (rabbit 1) and 1529076 – 
R076 (rabbit 2), which were immunised with linamarin-CC-BSA. Each antiserum 
was prepared in a serial dilution, starting from highly concentrated (row A, 1/10, 
v/v) and gradually diluted (row B, 1/100, v/v – G, 1/107, v/v) in PBST buffer, 
together with blank samples (row H). This is to determine whether there are any 
anti-linamarin Abs present and if so, the lowest dilution of the antiserum that 
could bind to immobilised immunogen (linamarin-CC-KLH) with the pre-immune 
bleed as a control. Figure 3-6 shows the construction of a titre curve in a 
microtitration plate.  
 
Figure 3-6 Indirect non-competitive ELISA for polyclonal anti-linamarin antibody 
titre. The activities of the two test bleeds and the final bleed together with the pre- 






The blue colour in each of the wells indicates the primary Ab binding towards the 
immobilised linamarin-KLH conjugate, while the colourless reaction indicates 
zero binding. Darker colours indicate higher primary Ab binding to the linamarin-
KLH conjugate meanwhile lighter colours indicate lower binding. For rabbit 1 
(R074), the pre-immune serum shows some binding of the primary Ab towards 
the immobilised linamarin-KLH conjugate at 1/100 dilution. Test bleed 1 (Day 53 
bleed) and the final bleed (Day 88) both have antiserum activity at 1/10,000 
dilution. Test bleed 2 (Day 74) however, shows antiserum activity even at 
1/100,000 dilution. For rabbit 2 (R076), the pre-immune serum activity was quite 
similar to rabbit 1, although test bleed 1 (Day 53) and test bleed 2 (Day 74) 
indicated antiserum activity at more than 1/10,000 dilution. The final bleed (Day 
88) indicated antiserum activity at 1/100,000 dilution. 
 
The colour generated and displayed in Figure 3-6 was in concordance to the 
curves shown in both figures 3-7 and 3-8. Polyclonal antisera produced from both 
rabbit 1 (R074) and 2 (R076) generated high optical density values, indicating 
significantly high antibody binding towards linamarin-CC-KLH even at dilutions 
of more than 1:100,000 with no significant difference between any of the test 
bleeds (Figure 3-7 and Figure 3-8).  It can be clearly seen that in R074, the test 
bleed 2 (Day 74) shows the highest activity of all the bleeds meanwhile in R076, 






Figure 3-7: Titre curves of anti-linamarin antibody obtained from rabbit 1 (R074) 
immunized with linamarin – BSA conjugate (immunogen) from the cyanuric 
chloride method, showing the titre curves of 3 sera against solid phase antigen  
linamarin-KLH conjugate (1μg/ml) from the cyanuric chloride method, together with the 
pre-immune serum. Error bars represent standard deviation of triplicate analyses. 
 
 
Figure 3-8: Titre curves of anti-linamarin antibody obtained from rabbit 2 (R076) 
immunized with linamarin – BSA conjugate (immunogen) from the cyanuric 
chloride method, showing the titre curves of 3 sera against solid phase antigen  
linamarin-KLH conjugate (1μg/ml) from the cyanuric chloride method, together with the 

























































3.3.4 Development of an ELISA standard curve for linamarin 
 
The antisera obtained from rabbits immunised with linamarin-CC-KLH 
immunogen were used to establish the standard curves. The assay was based 
on an icELISA using free linamarin standard at concentrations ranging from 1 to 
100,000 ng/ml and linamarin-KLH conjugate for the immobilised phase. The 
procedure for the icELISA has been described previously in section 2.6.1. The 
curve was obtained by plotting the absorbance (405nm) on the y-axis and the 
logarithm of the concentration of standard linamarin on the x-axis as shown in 
Figure 3-9. The standard curve showed that as the concentration of free 
linamarin increased, the optical density decreased. 
 
 
Figure 3-9: icELISA standard curve of linamarin obtained from antibody generated 
from the cyanuric chloride conjugate. The primary antibody dilution was done at 4  
different dilutions, 1:5,000, 1:10,000, 1:15,000 and 1:20,000 and the solid phase antigen  
was linamarin-KLH. Overnight primary reaction incubation was at 4°C, secondary  
reaction was for 2 hours at 37°C and there was a 30min enzyme-substrate reaction time  




























3.3.5 Optimization of an indirect competitive ELISA (icELISA) for 
linamarin 
 
Ab dilution, incubation time, solid phase Ag concentration, and blocking buffers 
are factors that could be optimized to influence the sensitivity of the ELISA assay. 
However, it is imperative to determine which pool of antiserum to use and its 
optimum concentration to produce reliable and good standard curve. From the 
Ab titre results, test bleed 2 of R074 (R074D74) showed the highest affinity to 
linamarin in rabbit 1 meanwhile the final bleed of R076 (R076D88) from rabbit 2 
showed similar affinity to linamarin. Although there is no significant difference 
between test bleed 2 of R074 (R074D74) and final bleed of R076 (R076D88), 
R076D88 was chosen and used throughout the subsequent experiments in order 
to preserve identical condition.  
 
In order to achieve higher assay sensitivity with a better signal:noise ratio, a 
detection Ab (goat anti-rabbit IgG H+L HRP-conjugated) produced and supplied 
by CovalAb UK Ltd. was used for comparison with the detection antibody used 
previously from Invitrogen, Thermo Scientific. In addition, two different TMB 
substrates were investigated to improve the assay sensitivity. The TMB 
substrates used were TMB 1 (3,3',5,5'-tetramethylbenzidine liquid substrate 
system for ELISA, peroxidase substrate, Sigma Aldrich, UK) and TMB 2 
(3,3',5,5'-tetramethylbenzidine liquid substrate, Supersensitive, for ELISA, 
Sigma Aldrich, UK). Both were slightly different in term of cost with the former 
being more expensive per 100 ml solution. The results of the investigation are 
shown in Figure 3-10. From the results, TMB 1 provided better signal 





much. However, there was a huge leap in signal amplification between the two 
Abs used, suggesting that the detection Ab produced and supplied by CovalAb 
UK Ltd. had higher affinity towards the primary Ab compared to the one produced 
and supplied by Invitrogen, Thermo Scientific. Based on these results, TMB 1 
and detection Ab from CovalAb UK Ltd. were used in subsequent experiments. 
 
 
Figure 3-10: icELISA standard curve of linamarin obtained from antibody 
generated from the cyanuric chloride conjugate (R076D88), using two different 
detection antibodies and two different TMB substrates for signal generation. The  
antibody dilution was done at 1:15,000 and the solid phase antigen was linamarin-KLH.  
Overnight primary reaction incubation was at 4°C, secondary reaction was for 2 hours  
at 37°C and there was a 30min enzyme-substrate reaction time before stopping the 


























For the optimum primary Ab concentration determination, based on the results 
from Ab titre, several primary Ab dilutions were investigated as shown in Figure 
3-11. Other conditions were kept constant for the time being; a solid phase Ag 
concentration of 1.0 μg/ml was used throughout the assay development, 1% 
skimmed-milk (w/v) was used as blocking buffer, primary incubation time was 
done overnight at 4°C, secondary reaction incubation time was 2 hours at 37°C 
and 30 minutes enzyme-substrate reaction time allowed before the reaction was 
stopped and absorbance measured. 
 
 
Figure 3-11 icELISA standard curve of linamarin obtained from antibody 
generated from the cyanuric chloride conjugate, using 1% dried skimmed milk as 
blocking buffer. The primary antibody dilution was done at 4 different dilutions,  
1:15,000, 1:20,000, 1:25,000 and 1:30,000 and the solid phase antigen was linamarin- 
KLH. Overnight primary reaction incubation was at 4°C, secondary reaction was for 2  
hours at 37°C and there was a 30min enzyme-substrate reaction time before stopping 





























The icELISA was repeated several times using other dilutions up to 1/70,000 
(v/v) as shown in Figure 3-12.  
 
 
Figure 3-12: icELISA standard curve of linamarin obtained from antibody 
generated from the cyanuric chloride conjugate (R076D88), showing the binding 
of the antibody to the free linamarin standard. The antibody dilution was done at 8 
different dilutions, ranging from 1:20,000 to 1:70,000 and the and the solid phase 
antigen was linamarin-KLH. Overnight primary reaction incubation was at 4°C, 
secondary reaction was for 2 hours at 37°C and there was a 30min enzyme-substrate 
reaction time before stopping the reaction. Error bars represent standard deviation of 
triplicate analyses. 
 
The ELISA absorbance and sensitivity was greatly enhanced as shown in Figure 
3-12 where even at dilution of 1/70,000, the primary Abs were still able to 
recognize and bind with the unbound linamarin standard. The dilution of 1/50,000 






























The efficiency of different blocking agents used to block any non-specific reaction 
with the surface to improve the signal-to-noise ratio was investigated. The most 
common blocking buffers used in ELISA are BSA, gelatine from fish, non-fat 
(skimmed) milk and whole normal serum to name a few. BSA, dried skimmed 
milk and gelatine from fish were chosen as the blocking agents and were 
prepared as described in section 2.3.4. The standard curves indicating their 
blocking efficiency are shown in Figure 3-13. Apparently, BSA and gelatine seem 
to shift the curve to the right as compared to curve without any blocking (NB), 
meanwhile the use of dried skimmed milk powder shifted the curve to the left. 
 
 
Figure 3-13: icELISA standard curve of linamarin obtained from antibody 
generated from the cyanuric chloride conjugate (R076D88), with different blocking 
buffers. The antibody dilution was done at 1/50,000 and the and the solid phase antigen 
was linamarin-KLH. Overnight primary reaction incubation was at 4°C, secondary 
reaction was for 2 hours at 37°C and there was a 30min enzyme-substrate reaction time 
































Figure 3-14 shows the optimized icELISA standard curve for linamarin. The 
antibody dilution used was 1/50,000 and the solid phase antigen was linamarin-
KLH (1.0 µg/ml). Dried skimmed milk (1%, w/v) was used as blocking buffer and 
incubated overnight at 4°C. Anti-rabbit IgG from CovalAb UK Ltd. was used as 
detection Ab and TMB 1 from Sigma Aldrich, UK was used as substrate. 
Overnight primary reaction incubation was at 4°C, secondary reaction was for 2 
hours at 37°C and there was a 30 min enzyme-substrate reaction time before 
the reaction was stopped. 
 
 
Figure 3-14: Optimized icELISA standard curve of antibody generated from the 
linamarin-CC-BSA conjugate (R076D88). The antibody dilution used was 1/50,000 
and the solid phase antigen was linamarin-KLH. Each point represents the mean of 12 


























There are no previous reports of Ab production against linamarin. The only 
cyanogenic glycoside for which Ab has been developed was against amygdalin 
(Bolarinwa et al., 2014). The production of good Ab against low molecular weight 
compounds is rather difficult to achieve because of their inability to directly 
stimulate the immune system for Ab production. The important requirement is 
that the molecular structure of hapten should have a certain degree of complexity 
or rigidity, such as containing a benzene ring, heterocyclic group or branch 
structure and so on (Juan et al., 2010). Otherwise, it would be difficult to produce 
Ab against the hapten or even if the Ab is produced, the Ab titre would probably 
be very low. Some studies have shown that the rate of successful production of 
Ab for haptens containing benzene ring is 1/3, while for hapten without a benzene 
ring the success rate is 1/11 (Szurdoki et al., 1992). Perhaps due to the 
difficulties in choosing an appropriate conjugation technique to synthesise a 
suitable immunogen for immunization, to this day there are only three reports on 
immunoassay development for the analysis of CGs in plant foods. There are two 
reports on the qualitative analysis of amygdalin (Cho et al., 2006; Cho et al., 
2008), and one for the quantitative analysis of amygdalin as reported by 
Bolarinwa et al. (2014). The purpose of this study was to synthesize hapten-
protein conjugates for the production of polyclonal anti-linamarin antibody for the 
first time and to develop a competitive ELISA standard curve for linamarin. 
 
There are four important criteria that have been well defined by Goodrow et al. 
(1998), about the design of an ideal hapten derivative: i) the stereo structure, 





similar to those on the original hapten; ii) a spacer arm with several-carbon-chain 
length to couple with carrier is preferred, but the spacer arm should not induce 
the immunized animal to produce ‘arm antibodies’ or neodeterminants; iii) the 
presence of active group at the end of the spacer should not affect the electronic 
distribution of hapten molecule; and iv) after coupling with carrier, the basic 
molecular structure of the hapten should be retained. Hence, the most basic 
requirement of hapten design is to maintain the original molecular structure of 
the hapten and to exposed it on the surface of the carrier as much as possible, 
which in turn, will maximise the recognition of the hapten by the immune cells of 
the immunized animal, stimulating the animal to produce a specific immune 
response and generate high affinity and high specificity Abs against the hapten 
(Juan et al., 2010). Linamarin was conjugated to two carrier proteins (BSA and 
KLH) using the same conjugation method (cyanuric chloride, CC) to produce two 
different immunogens, the former was used as the immunogen for immunization 
and the latter was used as the coating Ag for the end-point assay. The CC 
conjugation method was chosen to conjugate linamarin to both BSA and KLH 
because of its simplicity and reactivity towards hydroxyl groups under mild 
conditions, which enabled coupling without affecting the structure of the target 
analyte (linamarin). In this technique, an alternative reactive group (i.e chloride 
group) was introduced into the linamarin structure prior to conjugation with the 
proteins. The idea was in line with earlier suggestions of an ideal hapten 
derivative that the coupling of alternative reactive groups away from antigenic 
determinants (characteristic structure and functional groups) of low molecular 
weight Ag prior to conjugation with carrier protein reduces the shielding effect 
and could increase the specificity of Abs produced against the Ag (Deshpande, 





CC to introduce dichlorotriazine by adding a solution of linamarin to dried CC 
residue in the activation process. Dried CC residue was used in the activation 
procedure in order to allow gradual solubilisation of the compound into the 
aqueous medium, preventing rapid breakdown and to avoid exposure of 
linamarin to the organic solvent (acetone) used to solubilise the CC. The first 
chlorine atom in the CC molecule reacted with hydroxyl groups of linamarin 
molecule to form stable linkages at low temperature and in alkaline pH to produce 
the conjugate (Abuknesha et al., 2005). The chemical reaction is clearly depicted 
in Figure 3-2. The optimum molar ratio of protein to hapten was based on the 
study of chemical optimization experiments done by Bolarinwa (2013) using 
naringin (a flavanone glycoside) and amygdalin which were 1:15 and 1:20. The 
protein to hapten ratio obtained in this study was in concordance with the 
recommended ratio to be used for good antibody production. According to 
Erlanger (1980), a good antibody titre can usually be obtained with a hapten to 
protein ratio of between 8 to 25. Kemp and Morgan (1986) reported that a 
conjugate with a high protein to hapten ratio may be good as an immunogen, 
while one with lower ratio maybe desirable as a coating antigen. A hapten density 
of 15 to 30 molecules per carrier protein was also reported to be good for the 
production of high antibody titres with moderate antibody affinities (Singh et al., 
2004). 
 
Linamarin-BSA and linamarin-KLH were tested for successful conjugation by 
both spectrophotometric and chemical methods Spectrophotometric results 
revealed that the unconjugated BSA and linamarin-BSA conjugate both had an 
absorbance peak at 280nm while the unconjugated linamarin had none. The 





the lack of chromophore in the structure that makes it impossible to absorb UV 
or visible lights and hence linamarin could not be detected by the UV scan at the 
selected wavelengths (200 – 400nm) or even at lower wavelengths. However, a 
reduced maximum peak of BSA in the linamarin-BSA conjugate suggested that 
a successful conjugation had occurred since the coupling of linamarin to BSA 
might have altered its maximum peak absorbance capacity, hence the reduction 
in the absorbance peak. The absence of an absorbance peak for linamarin 
means that the number of moles of conjugated hapten could not be calculated 
using the Beer-Lambert law. In order to reinforce the verification of a successful 
conjugation, a chemical assay method using TNBS assay was implemented.  
 
This assay with its many variations is based on the sulphuric acid digestion of 
the protein with subsequent conversion of the nitrogen to ammonium sulphate 
(Goodwin and Choi, 1970). The assay protocol used in this study was as 
modified by Kemp and Morgan (1986) and Bolarinwa (2014), based on the 
determination of free amino acid groups present in the carrier protein before and 
after hapten conjugation following its reaction with TNBS. There are 
approximately 59 amino groups from lysine residues of BSA and of these, 
approximately 30-35 are accessible for use in coupling to hapten according to 
Erlanger (1980) and Singh et al. (2004). The standard curves obtained from BSA 
and linamarin-CC-BSA conjugate from each of the proteins when subjected to 
analysis with TNBS were significantly different (Figure 3-5). The results indicated 
there was a reduction in the number of available amino groups in the linamarin-
BSA conjugate as compared to unconjugated BSA. The percentage substitution 
of linamarin calculated for linamarin-BSA from the cyanuric chloride conjugation 





calculated to be of 23:1, in concordance to other reports (Erlanger, 1980, Singh 
et al., 2004, Bolarinwa et al., 2014) suggesting a potentially good immunogen for 
antibody production. The CC method was initially devised for protein-protein 
conjugation and has only once before been used for hapten-protein conjugation. 
This is the first time linamarin was successfully conjugated to BSA using the CC 
method. 
 
The immunogen (linamarin-CC-BSA) was used to immunised two New Zealand 
female rabbits weighing between 2.0 ~ 2.5 kg. IcELISA was used to determine 
the titre of the antisera. The titre of an antisera refers to the amount of specific, 
functional Ab present in the serum. Functionally, titre is generally indicated by 
the amount a serum can be diluted and still give good signal in a particular assay. 
Thus, the titre depends on the assay used and it measures both the affinity and 
amount of an Ab directed against the Ag of interest. An Ab with high titre is 
valuable not only because it means the serum can be used in more experiments, 
but, more importantly, that the non-specific components present in any serum 
will be less of a problem since they can be diluted out.  
 
The colour generated by this indirect ELISA assay is due to the amount of 
secondary Ab (detection antibody – goat anti-rabbit IgG, H+L, HRP conjugated) 
bound to the primary Ab (rabbit anti-linamarin antibodies). The use of secondary 
Ab was very important at this stage to determine the presence of the desired 
primary Ab able to bind with linamarin-CC-KLH. This secondary Ab binds to the 
primary Ab because it recognizes the IgG Ab from a different species. HRP 





substrate (TMB), it generated a signal colour that could be measured using a 
microtitration plate reader. The intensity of the signal produced is directly 
proportional to the amount of Ag captured in the plate and bound by the detection 
reagents. The quality and intensity of signal production and its detection in 
developing a new ELISA assay are imperative to achieve optimum sensitivity, 
specificity, precision and batch-to-batch consistency.  
 
Polyclonal anti-linamarin titres were determined on microtitration plates coated 
with linamarin-CC-KLH conjugate. The pre-immune serum (serum taken just 
before the first immunization injection) for each rabbit shows slight but very 
minimal activity, which was expected due to non-specific binding of the sera 
towards the immobilised antigen and perhaps even towards the uncoated spaces 
on the wall of the microtitration wells. Both rabbits responded well to the 
immunogen challenge by producing Ab of a very high titre within 53 days (test 
bleed 1) of immunization showing antibody activity at a dilution of 1:10,000. 
Polyclonal antisera produced from both rabbit 1 (R074) and 2 (R076) indicated 
high Ab affinity towards immobilised linamarin-CC-KLH with no significant 
difference between any of the test bleeds as compared to the pre-immune serum. 
The antibody affinity of test bleed 2 (Day 74) of R074 and final bleed (Day 88) of 
R076 were exceptionally high as indicated by antibody activity detected even at 
dilution of 1/100,000, more so due to the fact that the antibody was derived from 
conjugated hapten. The final bleed from R076 (R076D88) was selected and used 







The R076D88 bleed was chosen from the Ab titre results and investigated for 
use in standard curve at four different dilutions (v/v) 1/5,000, 1/10,000, 1/15,000 
and 1:/20,000. The assay involves a competition between free standard 
linamarin with conjugated immobilised linamarin-KLH conjugate for binding to 
the Ab. In other words, the higher the amount of free linamarin present in the 
sample will reduce the number of primary Abs able to bind with the immobilised 
linamarin. Consequently, less enzyme-labelled secondary Ab binds to the 
primary Ab resulting in less enzyme activity and lower OD. The inverse 
relationship between the concentration of linamarin and the observed OD is 
clearly shown in Figure 3-8, which indicates that the anti-linamarin Abs were able 
to recognize and bind to the free linamarin, inhibiting the Abs from binding to the 
immobilised linamarin. The standard curves achieved indicated that even without 
subsequent optimization, the antibody was able to bind to free linamarin standard 
at a dilution of 1:20,000 with acceptable background noise.  
 
The standard curve as shown in Figure 3-8 however was generated using 
detection Ab (goat anti-rabbit IgG H+L, HRP-conjugated) produced and supplied 
by Invitrogen, Thermo Scientific. As secondary Abs are mainly used for the 
indirect detection of a target to which a specific primary Ab is first bound, and it 
requires more steps than using a detectable primary Ab, indirect detection of the 
target Ag has the advantage of increased sensitivity due to the signal 
amplification from multiple secondary Abs binding to a single primary Ab. 
Moreover, a given secondary Ab can be used with any primary Ab of the same 
type and host species, making it an infinitely more versatile reagent than 
individual labelled primary Abs. Secondary Abs with specificity for the primary 





the common labels, making these detection reagents useful commodities.  In 
order to achieve higher assay sensitivity with better signal:noise ratio, a detection 
Ab (goat anti-rabbit IgG H+L HRP-conjugated) produced and supplied by 
CovalAb UK Ltd. was used for comparison with the specific aims in mind. In 
addition, two different TMB substrates were investigated to determine one which 
produced better signal amplification. From the results, TMB 1 provided better 
signal amplification compared to TMB 2 although there was no significant 
difference between them. However, there was a huge leap in signal amplification 
between the two Abs used, suggesting that the detection Ab produced and 
supplied by CovalAb UK Ltd. has higher affinity towards the primary Ab 
compared to the one produced and supplied by Invitrogen, Thermo Scientific, 
which means that the assay sensitivity can be further enhanced quite 
significantly.  
 
In an ELISA, it is important to block the unoccupied sites on the surface of the 
well of the microtitration plate to reduce the amount of non-specific binding of 
proteins during subsequent steps in the assay. The blocking decreases the 
opportunity especially for signal-generating Abs to bind non-specifically to the 
well hence reducing background signal/noise. A variety of blocking proteins 
ranging from non-fat milk to highly purified proteins have been used to block any 
remaining ‘sticky’ spots on the well (Gibbs, 2001). The blocking buffer should 
improve the sensitivity of the assay by reducing the background interference and 
an optimal blocking buffer maximizes the signal-to-noise ratio, does not react 
with Abs and alter or obscure the epitopes of the immobilized protein. An 
individual blocking buffer will not be compatible with every system; therefore, 





for the highest signal-to-noise ratio in the assay due to each antibody-antigen 
pair having their own unique characteristics. The most common blocking buffers 
used in ELISA are BSA, gelatine from fish, non-fat (skimmed) milk and whole 
normal serum to name a few. Previous studies that worked on antibody 
development against hapten suggested that the use of 1% dried skimmed milk 
as blocking buffer was better compared to other buffers. The use of non-ionic 
detergent such as Tween 20 (0.05%, v/v) when used in conjunction with a protein 
blocker, provide added convenient and inexpensive blocking ability during wash 
steps by blocking areas on the surface that may become exposed due to 
protein/biomolecule desorption. In the current study, the use of dried skimmed 
milk (1%, w/v) was investigated and compared against other commonly used 
blocking agents, gelatine from fish (1%, w/v) and BSA (1%, w/v). From the results 
shown in Figure 3-12, the use of gelatine and BSA have actually increased the 
signal-to-noise ratio by shifting the standard curves to the right as compared to 
standard curve without any blocking. The use of 1% dried skimmed milk 
however, has shifted the curve to the left, which indicated an improved signal-to-
noise ratio and hence further enhanced the sensitivity of the assay.  
 
The present study demonstrated the use of CC conjugation procedure which 
involves activating the linamarin prior to conjugation to protein which enabled 
chloride bridging between the hydroxyl groups of linamarin and amine group of 
BSA could also be a useful alternative for other small molecular weight 
compounds which do not contain active groups such as -COOH, -NH2 or -OH or 
when the active groups on the hapten are very important to maintain the hapten 
immune characteristics and structural features to be used for coupling (Juan et 





from linamarin-BSA conjugate synthesized using the CC conjugation method 




A polyclonal anti-linamarin Ab was successfully raised against linamarin using a 
hapten linked to a carrier protein through a cyanuric chloride conjugation method. 
The linamarin antisera displayed an excellent Ab titre indicated by presence of 
binding activity even at 1:100,000 dilution. The Ab had desirable specificity 
towards linamarin as shown in the icELISA standard curve results which further 
optimized to improve the sensitivity of the assay. An Ab dilution of 1:50,000 was 
chosen for subsequent assay development and further characterization would 
be able to produce an ELISA with higher specificity and sensitivity. 
  
Chapter 4 : Production of Monoclonal Antibodies against 
Linamarin 
Summary 
• Production of monoclonal antibodies against linamarin was attempted. 
There have been no previous reports of this activity. 
 
• Seven female BALB/c mice were immunized into two separate 
procedures using linamarin-CC-KLH (4 mice) and linamarin-CC-BSA (3 
mice) to generate polyclonal antibodies against linamarin. 
 
 
• High antibody titre was obtained using non-competitive ELISA for all the 
test bleeds from both set of immunization. 
o Anti linamarin-KLH – 1/1000 ~ 1/100,000 
o Anti linamarin-BSA – 1/1000 ~ 1/70,000 
 
• Inhibition assay (competitive ELISA) against free linamarin could not be 
established: 
o for selected hybridoma supernatants from antisera produced by 
immunization using linamarin-CC-KLH conjugate. 









The previous non-existence of specific Abs, both pAbs or mAbs is not surprising, 
since linamarin is a very difficult hapten to raise specific Ab response against. 
The lack of functional groups on linamarin and low molecular weight (147.2) 
makes it a difficult target for the immune system to recognize and elicit an 
appropriate immune response. Abs can only be raised against derivatives 
including the hapten and a chemical entity resembling an immunogenic 
conjugate. With help from chemical modifications, the Ab binding site 
encompasses the hapten residue with the inclusion of the chemical linker and 
sometimes even amino acid residues on the carrier protein (Tuomola et al., 
2000). Chappey et al. (1994) reported that the influence of the spacer arm 
becomes crucial and high affinity against un-derivatized compounds are much 
more difficult to obtain when the molecular weight of the hapten is well below 
300 Da. Despite the limitations, polyclonal Abs against linamarin have been 
successfully developed and described in the chapter 3 using linamarin 
conjugated to BSA via a cyanuric chloride method, and since the Ab titre of the 
pAbs produced against linamarin was exceptionally high (working range of 
1:50,000 - 1:100,000, v/v), an attempt on mAbs production is highly probable. 
However, in immunoassays especially ELISA, both pAbs and mAbs have their 
advantages and disadvantages and the decision to use either of them depends 
on a number of factors, the most important of which are its intended use and 
whether the Ab is readily available from commercial suppliers or researchers 






MAbs are often considered superior to pAbs simply because of their exquisite 
specificity of binding, homogeneity and consistency. The monospecificity 
provided by mAbs is useful in evaluating changes in molecular conformation, 
protein-protein interactions, phosphorylation states and in identifying single 
members of protein families. It also allows for the potential of structural analysis 
(e.g, x-ray crystallography or gene sequencing) to be determined for the Ab on 
a molecular level. In the context of immunoassay, however, the monospecificity 
of mAbs is not always an advantage. For example, when the Ab is required to 
be bound to a solid support or be labelled and still retain activity, the loss through 
denaturation of a sensitive Ab species leaves many others in a polyclonal 
preparation; not so for a monoclonal (Peppard, 2000). Lipman et al. (2005) also 
reported that small changes in the structure of an epitope (e.g., as a 
consequence of genetic polymorphism, glycosylation and denaturation due to 
chemical modifications, coupling procedures) can markedly affect the function of 
mAb. Monoclonal preparations may also be less avid in binding than polyclonal, 
leading to lower performance in immunoassay (Stewart and Lew, 1985). In 
contrast, because pAbs are heterogenous and recognize a host of antigenic 
epitopes, the effect of change on a single or small number of epitopes is less 
likely to be significant. PAbs are also more stable over a broad pH and salt 
concentrations, whereas mAbs may be highly susceptible to small changes in 
both. That being said, successful assays are often set up with monoclonal, in 
competitive binding or by using their high specificity to ‘capture’ the antigen, 
followed by a second monoclonal or polyclonal Ab for detection purposes 
(Peppard, 2000). Mixtures of mAbs for either capture or detection can also be 
used effectively. Furthermore, these combinations of Abs and use of accurate 





of a group of closely related antigens (Glass et al., 2006), couples of cross-
reacting analytes (Mercader and Montoya, 2007), (Wittmann and Hock, 1991), 
or degradation products (Mercader et al., 2008). 
 
For the first time, pAbs have been successfully developed against linamarin. 
Although the pAbs were successfully generated within several months of 
initiating immunization, the same cannot be said for production of mAbs. One 
can reasonably expect a period of up to a year or longer in some cases, from 
immunization to generation of hybridomas, cloning and subsequent production 
of mAbs, often requiring considerable amount of expense and time. One major 
problem with pAbs is that the amount of Ab supply is limited to the size of the 
immunized animals, in this case the two New Zealand female rabbits. Once 
depleted, the next batch of pAbs generated from the same animal species would 
not be the same as the previous batch, leading to problems such as 
inconsistency and changes in avidity as they are harvested over time. In contrast 
to mAbs, once the desired hybridoma has been generated, mAbs can be 
generated as a constant and renewable resource, maintaining their consistency 
and homogeneity. To keep advancing the technique there is a need for new Abs 
and conjugates to novel analytes, because it is the availability for such 
immunoreagents that is the rate limiting step (Mercader et al., 2008). As far as 
linamarin is concerned, to our knowledge, no reports, whether using pAbs or 
mAbs, for analysis of linamarin in food have been published. The essential steps 








Figure 4-1: Essential steps in mAb production. A flowchart showing the main 
sequence of events in mAb production. 










4.1.1 Aim of the chapter 
In continuation of the cyanuric chloride conjugated hapten-protein (linamarin-
BSA conjugate) ability to elicit an immune response in rabbits that lead to 
production of an exceptionally good pAbs as described in chapter 3, the aim of 
the work described in this chapter was to use the same immunogen to immunise 
several BALB/c mice. The production of similarly good antisera could further be 
used to develop mAb against linamarin.  
 
This chapter describes the experimental approach and results towards the 
following area: 
i) Immunization of mice in order to generate polyclonal antisera capable of 
recognizing linamarin suitable for monoclonal antibody production. 
 
ii) Production attempt, for the first time, of mAbs against linamarin using 
linamarin-KLH conjugate and linamarin-BSA, both conjugated using the 
cyanuric chloride method. 
 
iii) Production of hybridoma cells through fusion, screening, cloning and 
culture of desired cells to produce mAbs. 
 







4.2 Methods: Monoclonal Antibody Production 
 
Immunization with linamarin-KLH conjugate 
KLH is well known as having higher immunogenicity compared to BSA mainly 
because of its sheer molecular weight and it has been used in various hapten-
protein conjugation works, producing good immune response and Abs against 
various haptens. A set of different BALB/c mice (4) were injected with the 
immunogen (linamarin-KLH) to assess the immune response and explore 
possibilities of obtaining good quality Abs as opposed to the linamarin-BSA 
conjugate. Table 4-1 shows a summary of the intradermally immunization 
protocol for the production of the anti-linamarin Ab in mice provided by CovalAb 
UK Ltd. 
 
Immunization with linamarin-BSA conjugate 
Since the immunization of 2 New Zealand rabbits using the linamarin-BSA 
conjugate to generate pAbs were successful as described in previous chapter, 
the same conjugate was used to generate pAbs in 4 BALB/c female mice 
(between 6-8 weeks old) for mAbs production. Linamarin-CC-BSA and linamarin-
CC-KLH conjugates were sent to CovalAb UK Ltd. for the immunization process, 
to be used as immunogen and a coating antigen respectively. Table 4-1 shows 
a summary of the intradermally immunization protocol for the production of the 







Table 4-1: Summary of the immunization protocol for the production of the 
anti-linamarin antibody in mice. 
Day Protocol 
0 Sampling of test serums (=30µl) and storage at -20°C 
0 to 14 
Multisite injections 
According to the protocol defined by Covalab 
Antigen and adjuvant (incomplete Freunds) 
24 Sampling of test serums (= 30µl) and storage at -20°C – ELISA test(1) 
27 
IP injection 
Antigen + Adjuvant (incomplete Freunds) 
38 Sampling of test serums (= 30µl) and storage at -20°C – ELISA test(1) 
48 
Subcutaneous injection 
Antigen + Adjuvant (incomplete Freunds) 
69 
Subcutaneous injection 
Antigen + Adjuvant (incomplete Freunds) 
80 Sampling of test serums (= 30µl) and storage at -20°C – ELISA test(1) 
97 
Subcutaneous injection 
Antigen + Adjuvant (incomplete Freunds) 
111 
Subcutaneous injection 
Antigen + Adjuvant (incomplete Freunds) 
122 Sampling of test sera (= 30µl) and storage at -20°C – ELISA test(1) 
151 Boost BALB/c R 
153 Fusion BALB/c R 
 
 
Determination of anti-linamarin titre (screening) 
Ab capture assays are often the easiest and most convenient of the screening 
methods. The non-competitive indirect ELISA similarly used for the 
determination of anti-linamarin titre in rabbits polyclonal antisera was 





and the microtitration plate was prepared as described in 2.4.10. Both sets of 
dilution (consisting of bleed 38, 80, 122, 153 or 255 days along with the pre-
immune bleed as control) were dispensed into coated microtitration plate wells 
(200 µl/well) in duplicate. The microtitration plate was sealed using parafilm and 
incubated overnight at 4oC. The microtitration plate was washed 5-times with 
PBST the following day and left to dry. Secondary Ab (goat anti-rabbit IgG 
coupled with HRP enzyme, prepared as described in 2.3.9, 200 µl) was 
dispensed into each well and incubated for another 2 hours at 37oC. The 
microtitration plate was washed 5-times with PBST after the 2 hours incubation 
and left to dry. TMB substrate (200 µl per well) was dispensed into each well and 
the plate left for 30 mins at room temperature to allow colour development. 
Noticeable changes in colour were observed. 2 M sulphuric acid (50 µl) was 
added into each well to stop the enzymic reaction. Finally the optical density 
reading of each well was taken using a plate reader at 405 nm. The mouse that 
produced the highest Ab titre consistency throughout the immunization period 
was selected for the fusion stage.   
 
Hybridisation and fusion 
During the fusion stage, the spleen from the selected mouse was removed and 
the antibody-producing B-lymphocytes were isolated from the spleen cells and 
were fused with murine myeloma cell line (SP20Ag/14). The splenocytes were 
distributed and fused with the myeloma cells inside 12, 96 well-microtitration 
plates, which were then cultured in HAT selective medium for 2 weeks. An ELISA 
test was performed on the hybridoma supernatants to screen for hybridomas 





performed by mixing the antibody-secreting cells with myeloma cells, centrifuged 
to generate good cell-to-cell contacts and fused with the aid of a fusing agent 
(polyethylene glycol, PEG). Three to five days before the fusion, the selected 
mouse was given a final boost on day 151 of the immunization. The boost was 
performed at least 3 weeks after the previous injection which allowed most of the 
circulating Abs to be cleared from the bloodstream by the mouse. The antibody-
producing B-lymphocytes were isolated from the spleen of selected mouse and 
fused with murine myeloma cell line (SP20Ag/14). This hybridisation procedure 
was done by CovalAb UK Ltd. using their own protocol. Details of the 
hybridization and cell culture are shown in Table 4-2. 
Table 4-2: Fusion and hybridisation details of mouse R. 
Mouse BALB/c R 
Date of the last boost 01/11/2016 
Number of spleen cells extracted 42 x 106 
Seeding date 03/11/2016 
Distribution 11 plates 
Number of seeded wells 992 
Density 0.2 x 106 
Volume of culture medium per well 250µl 
Culture medium RPMI 1640*, 20% SVF*, HAT*, HCS* 
*Royal Parkwell Memorial Institute (RPMI) 1640 growth media 
*Stromal Vascular Fraction (SVF) 
*Hypoxanthine Aminopterine Thymidine (HAT) 





Culture and propagation 
After the fusion process, the hybridomas were distributed inside 11, 96 well-
microtitration plates, which were then cultured in culture medium containing 
Royal Parkwell Memorial Institute (RPMI) 1640, 20% Stromal Vascular Fraction 
(SVF), Hypoxanthine Aminopterine Thymidine (HAT) and Hybridoma Cloning 
Supplement (HCS) for 2 weeks as described in Table 4-1. An ELISA test was 
performed on the hybridomas supernatants to screen for those secreting the 
desired Ab binding activity. Selected hybridomas was transferred into 24-wells 
plate and ELISA test was repeated 7-10 days after the transfer. Hybridomas (10 
cell lines) were selected for freezing and this was done in 25cm3 flasks where 3 
vials (1 vial; 5-6 x 106 cells) are cryo-stored per hybridoma prior to the cloning 
stage. Partial Ab isotyping (IgG and IgM) were done at this stage as well.  
 
Cloning and cryopreservation 
Cloning of the selected hybridomas was done on a 96-well plate using the limiting 
dilution procedure. After 10-15 days, culture supernatants in each well were 
screened using ELISAs to determine positive wells. The 8 best cell lines were 
selected and transferred to a 24-well plate for another 7-10 days culture and 
were tested again with ELISA to select the best 3 clones. The selected clones 
were transferred to 25 cm3 flasks for another 2 weeks of culture. Full isotyping of 
clones and determination of the Ig subclass (IgM, IgG1, IgG2a, IgG2b, IgG3 and 
light chains) was completed throughout the culture period. 3 vials (1 vial; 5-6 x 
106 cells), each containing one clone per hybridoma was cryo-frozen and stored 







4.3.1 Immunization with linamarin-KLH conjugate 
Initially, the immunization of the mice was supposed to be carried out using 
linamarin-BSA conjugate (the same conjugate used for immunization of rabbits 
in Chapter 3) as agreed before the start of the project, but towards the end of the 
immunization period, CovalAb UK Ltd. informed that they had immunized the 
mice using linamarin-KLH instead which was supposed to be the solid phase 
antigen. After deliberate discussion with the scientific director of CovalAb, we 
have agreed to carry on with the project, based on the main aim of generating 
mAbs, in which, if successful, would produce clone of cells that secrete highly 
specific Abs against linamarin, regardless of the carrier used during the 
immunization period. 
 
Four female BALB/c mice were injected with immunogen (linamarin-CC-KLH) for 
the immunization to take place. The immunoreactivity of the antisera collected 
from day 0 (pre-immune bleed), day 38, day 80 and day 122 generated from all 
mice, coded 1902V, 1902B, 1902R, 1902N (V, B, R and N) was evaluated using 
a non-competitive indirect ELISA against fixed amount (1.0 µg/ml) of solid phase 
antigen (linamarin-CC-BSA). Two sets of dilutions were used to test the antisera 
(2-fold and log 10 dilutions). This is to determine the lowest dilution of the 
antisera that could bind to the immobilized antigen above the background 
determined by the pre-immune bleed as a control. The antisera samples were 
arranged in the microtitration plate as shown is Figure 4-2 and Figure 4-3. 





able to bind with the immobilised antigen based on their dilutions. The darker the 
colour, the higher amount of antibody-antigen complexes. 
 
a) Pre-immune antisera test  
 
b) Negative control test on BSA 
Figure 4-2: Non-competitive indirect ELISA for polyclonal anti-linamarin antibody titre 
derived from mice. The activities of the a) pre-immune bleed (Day 0) for all mice (V, B, R, and 
N) and b) negative control test (on BSA). The results represent triplicate determinations for a), 
duplicate determinations for b). 
 




Figure 4-3: Non-competitive indirect ELISA for polyclonal anti-linamarin antibody titre 
derived from mice. The activities of all bleeds (Day 38, Day 80 and Day 122) for all 4 mice (V, 
B, R, and N). Each section represents triplicate determinations for each mouse down the 





The assessment of the immunoreactivity is based on the range of the optical 
density where; i) Titre < 0.20: no immunoreactivity, ii) 0.20 < titre < 0.80: low 
immunoreactivity, iii) 0.80 < titre < 3.20: good immunoreactivity and iv) Titre > 
3.20: excellent immunoreactivity. From colorimetric observation, all test bleeds 
from the mice indicated positive reaction with the immobilised antigen compared 
to the background determined by the pre-immune bleed. The ELISA test using 
the 2-fold dilutions did not show much different in terms of colour intensity 
between the bleeds and dilutions. However, for the log10 dilutions, the shades 
of blue can be seen gradually turning from darker to lighter shade going down 
the Ab concentration. The optical density values were used to construct the Ab 
titre curves as shown in Figure 4-4 to 4-7 and were concurrent with the 
colorimetric observations. Remarkably, all four mice responded really well to the 
immunization in which the antisera that they produced were closely similar and 
able to recognize immobilised linamarin even at dilutions beyond 1/100,000. 2 
booster injections were administered in between each test bleed resulting in the 
titre values to increase dramatically between the pre-immune bleed and the 1st 
test bleed (day 38). The subsequent booster injections seemed unable to 
improve the immunoreactivity of the antisera that much as shown in the 2nd test 
bleed (day 80) and the 3rd test bleed (day 120) results. Interestingly, similar 
results were exhibited by all four mice; i) all mice sera displayed high levels of 
pAbs with good immunoreactivity; the titre values were between 0.50 – 1.80 at 
1/100,000 dilution, ii) the 1st test bleed (day 38) has the highest immunoreactivity. 
From the test, Mouse R antisera exhibited good consistency throughout the 
bleeds and hence were chosen for the fusion stage as described in section 4.2. 
Mouse V, B and N were scheduled for another booster injection to investigate 






Figure 4-4: Titre curves of anti-linamarin antibody obtained from BALB/c mouse 
V immunized with linamarin – KLH conjugate (immunogen) from the cyanuric 
chloride method, each showing the titre curves for three different bleeds (Day 38, Day 
88 and D122) along with the pre-immune bleed. Error bars indicate the standard 
deviations of triplicate analyses. 
 
 
Figure 4-5 Titre curves of anti-linamarin antibody obtained from BALB/c mouse B 
immunized with linamarin – KLH conjugate (immunogen) from the cyanuric 
chloride method, each showing the titre curves for three different bleeds (Day 38, Day 
88 and D122) along with the pre-immune bleed. Error bars indicate the standard 
















































Figure 4-6 Titre curves of anti-linamarin antibody obtained from BALB/c mouse R 
immunized with linamarin – KLH conjugate (immunogen) from the cyanuric 
chloride method, each showing the titre curves for three different bleeds (Day 38, Day 
88 and D122) along with the pre-immune bleed. Error bars indicate the standard 
deviations of triplicate analyses. 
 
 
Figure 4-7: Titre curves of anti-linamarin antibody obtained from BALB/c mouse 
N immunized with linamarin – KLH conjugate (immunogen) from the cyanuric 
chloride method, each showing the titre curves for three different bleeds (Day 38, Day 
88 and D122) along with the pre-immune bleed. Error bars indicate the standard 















































Following the hybridisation step and post culture period of two weeks, screening 
was performed on surviving clusters of hybridoma cells to determine those that 
were producing Abs against the antigen. The assessment of the 
immunoreactivity was based on the range of the OD where, 0.30 < OD < 0.50: 
low immunoreactivity; 1.00 > OD > 0.50: good immunoreactivity and OD > 1.00: 
very good immunoreactivity. There were 37 positive clusters of hybridoma cells 
identified from the screening as shown in Table 4-3. Clusters 1A3, 1G5, 1D9, 
4D1, 4B2, 5B9, 6H6, 6G11, 6B12, 7A3 and 11H4 showed promising 
immunoreactivities with OD well over 2.000.  
Table 4-3: Screening results for hybridomas culture supernatants by CovalAb UK 
Ltd.  
 
Hybridomas On antigen Hybridomas On antigen 
1F2 1.895 6A1 1.932 
1A3 2.537 5B11 1.015 
1G5 2.732 6H6 2.554 
1B9 0.435 6H8 0.415 
1D9 2.551 6F9 0.625 
1D10 0.426 6H9 0.350 
2G8 0.328 6G11 2.690 
2H12 0.458 6H11 0.377 
3B7 1.378 6B12 2.531 
3E12 0.821 7G2 0.379 
4D1 2.537 7A3 2.569 
4A2 1.357 7F8 0.330 
4B2 2.590 8D6 0.831 
4G8 1.155 9H8 0.502 
5G5 1.159 9H12 0.916 
5D8 1.315 10F1 0.316 
5B9 2.488 10D3 0.497 
5C10 1.451 11H4 2.605 
2C7 1.631     
*Results from CovalAb UK Ltd. 
Screening method: ELISA, Solid phase antigen: Linamarin-CC-BSA, Supernatant dilution: ½ 





All 37 positive hybridomas were transferred into 24-well plates and grown for 
another 7-10 days to confirm the stability and secretion properties. The results 
are shown in Table 4-4.  
Table 4-4: Hybridoma culture supernatants after 7-10 days growth. Negative 
control on BSA was also performed. 
 
Hybridomas On antigen On BSA Hybridomas On antigen On BSA 
1F2 1.701 0.118 6A1 0.850 0.107 
1A3 1.999 0.277 5B11 0.121 0.102 
1G5 2.013 0.223 6H6 2.046 0.142 
1B9 0.097 0.054 6H8 0.199 0.104 
1D9 2.100 0.068 6F9 0.612 0.433 
1D10 0.153 0.083 6H9 0.069 0.070 
2G8 0.127 0.108 6G11 2.167 0.098 
2H12 0.140 0.121 6H11 0.152 0.176 
3B7 0.154 0.051 6B12 2.110 0.097 
3E12 0.120 0.057 7G2 0.119 0.091 
4D1 1.998 0.098 7A3 2.119 0.093 
4A2 0.244 0.163 7F8 0.509 0.305 
4B2 2.337 0.193 8D6 0.172 0.900 
4G8 1.613 0.199 9H8 0.203 0.211 
5G5 0.302 0.082 9H12 0.999 0.797 
5D8 1.298 0.238 10F1 0.127 0.800 
5B9 2.029 0.240 10D3 0.598 0.301 
5C10 0.476 0.359 11H4 1.244 0.097 
2C7 0.442 0.164       
*Results from CovalAb UK Ltd. 
Screening method: ELISA, Solid phase antigen: Linamarin-CC-BSA, Supernatant dilution: ½ 
indicates OD value over 1.00. 
 
The immunoreactivity of the Abs produced by all the hybridomas decreased as 
compared to the first screening results in Table 4-3. Most of the Abs produced 







Table 4-5: Isotype of the antibodies produced by the culture supernatants from 
CovalAb. Only hybridomas that produced IgG Ab isotype were selected for further 
screening. 
 
Hybridomas Isotype Hybridomas Isotype 
1F2 IgG 6A1 IgG 
1A3 IgG 5B11 - 
1G5 IgG 6H6 IgG 
1B9 - 6H8 - 
1D9 IgG 6F9 IgM 
1D10 - 6H9 - 
2G8 - 6G11 IgG 
2H12 - 6H11 - 
3B7 - 6B12 IgG 
3E12 - 7G2 - 
4D1 IgG 7A3 IgG 
4A2 - 7F8 IgM 
4B2 IgG 8D6 - 
4G8 IgM 9H8 - 
5G5 - 9H12 IgM 
5D8 IgM 10F1 - 
5B9 IgG 10D3 IgM 
5C10 - 11H4 IgG 
2C7 -     
*Results from CovalAb UK Ltd. 
 indicates IgG isotype only. 
 
Out of the 37 hybridomas, only 13 were selected based on their 
immunoreactivity, stability of the Ab secretions and isotype they produced (Table 





7A3 and 11H4 were selected for further testing. CovalAb UK Ltd. sent out the 






Figure 4-8: Antisera from culture supernatants of 13 selected hybridomas with 
IgG isotype sent by CovalAb Ltd. All antisera came pre-diluted in PBS (1:5). 
 
Direct non-competitive ELISA was again used to determine the titre of the 
antiserum from each culture supernatant. Dilutions made were 1/5, 1/10, 1/16, 
1/32, 1/64, 1/100, 1/1,000 and 1/10,000 and arranged as shown in Figure 4.9. 
The OD readings were listed in Table 4-5. Most of the culture supernatants 
showed gradual decreased in colour intensity and OD readings as the dilution 
ratio increased. All cultures have shown good immunoreactivity towards the solid 
phase antigen (OD: >1.00) except for culture 11H4 which OD values indicated 
poor recognition and binding properties. Major differences in immunoreactivity 





significant change in colour intensity and OD readings. Culture 1D9, 4B2 and 
6B12 still possessed good immunoreactivity at 1/10,000 (OD values >1.00) 
whereas others have already showed poor immunoreactivity and some to non-







Figure 4-9: Non-competitive indirect ELISA for polyclonal anti-linamarin antibody titre derived from 13 selected hybridomas 
culture supernatants. Each section represents duplicate determinations. 
 
Table 4-6: OD readings of the indirect non-competitive ELISA test in Figure 4-9 
 
 1A3 1D9 1F2 1G5 4B2 4D1 5B9 6A1 6B12 6G11 6H6 7A3 11H4 
1/5 2.81 3.49 1.74 2.50 3.72 3.49 3.35 1.45 3.42 3.51 3.08 2.86 0.56 
1/10 2.68 3.46 1.12 2.24 3.54 2.44 3.28 0.83 3.44 3.15 2.65 2.70 0.23 
1/16 2.66 3.58 1.06 2.43 3.72 2.77 3.27 0.59 3.29 3.16 2.70 2.80 0.21 
1/32 2.36 3.53 0.73 1.98 3.65 1.72 3.35 0.47 3.24 2.69 2.55 2.67 0.16 
1/64 1.67 3.51 0.60 2.00 3.75 1.24 3.24 0.34 3.18 2.34 1.95 2.73 0.12 
1/100 1.64 3.36 0.37 1.25 3.53 0.82 3.20 0.30 2.97 1.81 1.50 2.25 0.09 
1/1k 0.32 3.04 0.15 0.77 3.33 0.16 2.53 0.13 2.77 1.05 0.39 1.72 0.07 






Figure 4-10: Indirect competitive ELISA for monoclonal anti-linamarin antibody titre derived from 12 selected hybridomas culture 
































































Hybridoma 11H4 was discarded due to very poor immunoreactivity (Figure 4-9 
and Table 4-6). Twelve of the remaining culture supernatants were subjected to 
indirect competitive ELISA to investigate the ability of the Abs to bind with the 
standard linamarin (unbound linamarin). The results are shown in Figure 4-10. 
The competition between the unbound linamarin standard and immobilised 
antigen for binding with the Abs were poor. Thus, the inhibition of the Ab by 
unbound standard was not promising as most of the Abs tend to bind to the 
immobilised antigen rather than the unbound linamarin standard. However, 
some of the Abs in culture supernatants (1A3, 5B9, 6H6, 6A1 and 7A3) still 
demonstrated slight inhibition of the Abs binding to immobilised antigen between 
unbound linamarin concentration of 0.1 to 1.0 µg/100µl (Figure 4-10). This 
indicated that there might be a slightest chance to get a clone that would be able 
to secrete mAb, specific and has binding properties towards the standard 
linamarin after cloning by limiting dilution step.  





Negative control  
(BSA, 5μg/ml) 
Hybridoma FSN CovalAb FSN CovalAb 
1A3 2.814 2.787 0.050 0.081 
1D9 3.489 2.872 0.056 0.100 
1G5 2.499 2.719 0.050 0.081 
4B2 3.722 2.743 0.058 0.147 
4D1 3.487 2.639 0.059 0.081 
5B9 3.349 2.953 0.078 0.075 
6B12 3.424 2.686 0.063 0.098 
6G11 3.506 3.189 0.064 0.141 
6H6 3.080 2.818 0.059 0.097 
7A3 2.858 2.728 0.057 0.153 





OD readings from dilution 1/5 were used to compare the results from CovalAb 
and ten culture supernatants that displayed excellent immunoreactivity towards 
the solid phase antigen were selected for cloning (Table 4-7). The cloning was 
performed as described in section 4.2 by CovalAb UK Ltd. Following a 10-15 
days of culture after the limiting dilution procedure, two of the hybridomas (1A3 
and 4D1) were discarded due to instability and loss of ELISA activity. Eight 
remaining hybridomas were transferred to a 24-well plate for another 7-10 days 
culture and were tested again with ELISA to select the best three clones. The 
cultures were frozen accordingly at different steps of the protocol (Table 4-7). 
Inhibition assay (icELISA) was performed to investigate the ability of the mAbs 
to bind with the unbound linamarin standard. The test came out negative as the 
three selected clones (5B9, 6H6 and 7A3) were not able to show inhibition and 
binding property towards the unbound linamarin even after limiting dilutions. All 
the tests were done by CovalAb UK Ltd. However, the three other mice (V, B 
and N) were still subjected to further boost of immunogen injections just before 
the fusion stage of lymphocytes gathered from mouse R. The bleeds were taken 
from the mice on day 255 and were tested for their immunoreactivity and 
compared with mouse R bleed that was taken on day 153. Results are shown in 
Figure 4-11. No significant difference between the day 255 bleeds of mice V, B 
and N after prolong exposure to the immunogen as compared to mouse R bleed 
on day 153. Hence, from the reported results together with the negative inhibition 
assay that we did, and after lengthy discussion with CovalAb UK Ltd. we 
concluded that we were not able to generate mAb against linamarin using 
lymphocytes from mouse R and immunogen (linamarin-CC-KLH) and therefore 
had to put the project to halt. We initiated a new project, this time using linamarin-





Table 4-8: Number of vials frozen at different steps of protocol. Only positive 
hybridomas were frozen.  
 






6.5 x 10^6 23/01/2017 1 
6.9 x 10^6 27/01/2017 1 
9.9 x 10^6 31/01/2017 1 
6H6 
3.5 x 10^6 23/01/2017 1 
3.6 x 10^6 27/01/2017 1 
5.3 x 10^6 31/01/2017 1 
5B9 
4.1 x 10^6 23/01/2017 1 
6.4 x 10^6 27/01/2017 1 
6B12 
7.5 x 10^6 27/01/2017 1 
5.5 x 10^6 31/01/2017 1 
3.5 x 10^6 06/02/2017 1 
1G5 
5.8 x 10^6 27/01/2017 1 
4.2 x 10^6 31/01/2017 2 
1D9 
7.8 x 10^6 06/02/2017 1 
5.1 x 10^6 10/02/2017 2 
4B2 
4.8 x 10^6 06/02/2017 1 
4.9 x 10^6 10/02/2017 2 
6G11 
6.3 x 10^6 06/02/2017 1 
4.2 x 10^6 10/02/2017 2 







Figure 4-11: Non-competitive indirect ELISA for polyclonal anti-linamarin 
antibody titre derived from mice after prolong exposure to immunogen. The 
activities of all bleeds from mice V, B and N that went through booster injections and 
bleed taken on day 255 compared to mouse R bleed taken on day 153. Each section 



























4.3.2 Immunization with linamarin-BSA conjugate 
As we were unable to generate monoclonal antibody against linamarin using 
linamarin-CC-KLH as the immunogen, we decided to use the immunogen that 
had successfully generated excellent pAbs against linamarin in rabbit as 
described in Chapter 3, linamarin-CC-BSA. Four female BALB/c mice were 
injected with immunogen (linamarin-BSA) for the immunization to take place. 
However, one of the BALB/c mice (mouse N) died during the early stages of the 
immunization hence only bleeds from 3 surviving mice were gathered. The 
immunoreactivity of the antisera collected from day 0 (pre-immune bleed), day 
38, day 88 and day 130 generated from all mice, coded MP-00050V, MP-00050B 
and MP-00050R (V, B & R) was evaluated by a non-competitive indirect ELISA 
using linamarin-KLH as the solid phase antigen. The titre curves of all the test 
bleeds from the mice are shown in Figure 4-12 to 4-14. The assessment of the 
immunoreactivity was similarly conducted as described in section 4.3.1 ( i) Titre 
< 0.20: no immunoreactivity, ii) 0.20 < titre < 0.80: low immunoreactivity, iii) 0.80 
< titre < 3.20: good immunoreactivity and iv) Titre > 3.20: excellent 
immunoreactivity). As expected, all mice responded well to the immunization in 
which the antisera that they produced exhibited high levels of pAbs showing 
good immunoreactivity towards bound linamarin even at dilutions beyond 
1:30,000. 2 booster injections were administered in between each test bleed and 
as a result, the titre values increased significantly between i) the pre-immune 
bleed and the 1st test bleed (day 38), ii) the 1st test bleed (day 38) and the 2nd 
test bleed (day 88). However, the titre values between the 2nd test bleed (day 38) 








Figure 4-12: Titre curves of anti-linamarin antibody obtained from BALB/c mouse 
V immunized with linamarin-CC-BSA conjugate (immunogen), each showing the 
titre curves for three different bleeds (Day 38, Day 88 and D130) along with the pre-
immune bleed. Error bars indicate the standard deviations of triplicate analyses. 
 
 
Figure 4-13: Titre curves of anti-linamarin antibody obtained from BALB/c mouse 
B immunized with linamarin-CC-BSA conjugate (immunogen), each showing the 
titre curves for three different bleeds (Day 38, Day 88 and D130) along with the pre-


















































Figure 4-14: Titre curves of anti-linamarin antibody obtained from BALB/c mouse 
R immunized with linamarin-CC-BSA conjugate (immunogen), each showing the 
titre curves for three different bleeds (Day 38, Day 88 and D130) along with the pre-
immune bleed. Error bars indicate the standard deviations of triplicate analyses. 
 
 
Figure 4-15: Day 130 antibody titres comparison between mouse V, B and R. Error 














































The Ab titre tests were performed using 2 sets of dilutions (2-fold dilution and 
log10 dilution). Figure 4-15 shows the Ab titre results for the day-130 test bleed 
of all mice using log10 dilution and the OD readings of 2-fold dilution test are 
shown in Table 4-8. Mouse B and Mouse R exhibited similarly close Ab titre with 
the latter being slightly better as the Ab concentration became more diluted. 
However, the Ab titres for all the mice this time around were not as good as the 
previous immunisation using linamarin-CC-KLH as the immunogen. In previous 
antisera titres, the immunoreactivity was still present at 1/100,000 dilution for all 
mice but in current titres, immunoreactivity was poor beyond 1/70,000 dilution 
and nearly absent passed the 1/100,000 mark. 
Table 4-9: Day 130 antibody titres comparison between mouse V, B and R using 
2-fold dilutions.  
 D130 (Absorbance values at 405nm) 
1/dilution V B R 
2000 3.25 3.61 3.58 
4000 3.14 3.29 3.37 
8000 2.26 2.51 2.77 
16000 1.20 1.66 1.90 
32000 0.64 0.99 1.17 
64000 0.34 0.51 0.60 
128000 0.19 0.28 0.31 
Blank 0.05 0.08 0.06 
 Linamarin-CC-KLH 1μg/ml 
 
Based on the Ab titre results, both mouse B and R were selected for the indirect 
competitive ELISA test in order to check their binding ability towards unbound 
linamarin standard (Figure 4-16 and 4-17). Two bleeds from day 88 and day 130 
were used although bleed from day 130 has the highest titre compared to other 
bleeds. Unfortunately, the results showed that the Ab did not bind with the 
unbound linamarin, therefore no significant inhibition occur even at higher 





88 bleed (1/5,000 and 1/10,000), meanwhile for day 130 bleed, 1/ 2,000 and 
1/5,000 were used. For day 130 test, the Ab concentration used was higher 
because in day 88 test, 1/10,000 dilution resulted in very poor OD readings.  
 
 
Figure 4-16: Indirect competitive ELISA results for day 88 test bleeds from Mouse 
B and R. Error bars indicate standard deviation of triplicate analyses. 
 
 
Figure 4-17: Indirect competitive ELISA results for day 130 test bleeds from Mouse 

















































The results in this section were quite similar to those obtained in previous 
section, where, both immunogens were able to elicit immune response in mice 
and produced Abs with excellent antiserum titre, showing immunoreactivity even 
at Ab dilution of 1:100,000 (linamarin-CC-KLH) and 1:70,000 (linamarin-CC-
BSA), however they both failed to produce antihapten antibodies as indicated by 







The successful development of pAb of high immunoreactivity against linamarin 
previously discussed in Chapter 3 prompted the idea of synthesizing monoclonal 
antibody using the same immunogen (hapten-conjugate) synthesised using 
cyanuric chloride method. MAb production against linamarin has never been 
attempted yet at the time this study was conducted. The availability of mAbs 
would open up huge possibilities in all areas of Ab use because reagents could 
be created with specificity to a single domain (epitope) on the target substance. 
Additionally, Abs could be generated to compounds that had previously been 
regarded as impossible when using conventional serum production which 
explains the lack of literature on the matter, the CGs, currently being the main 
focus of this study. In previous chapter, the discussions were mainly focusing on 
the success of the conjugation method using cyanuric chloride bridging method 
producing an immunogen capable of eliciting the rabbit’s immune response and 
eventually synthesised pAb that has high antibody titre and very low limit of 
detection and quantification towards linamarin. In this chapter however, the 
attempts made to produce mAb against linamarin were not giving the anticipated 
results whereby although both linamarin-CC-KLH and linamarin-CC-BSA 
conjugates were both able to elicit good immune response in mice, for some 
reason they both failed to recognize free linamarin. Despite the negative results, 
plenty of findings from both attempts could be used to improve the understanding 
on ways hapten and large immunogenic proteins interact with each other in terms 
of their hydrophobicity and hydrophilic properties, epitope orientations and 
electronic configurations on different carrier proteins, variable levels of immune 





These factors underlined the basis of designing optimum yet efficient conjugation 
method that will eventually lead to secretion of desired Abs with high specificity 
towards the free hapten instead of the hapten derivatives. This will be the main 
discussion in this section and perhaps it will provide the basis of mAb production 
against linamarin, covering most of the important aspects at the same time 
addressing problems and challenges for the betterment and future work.  
 
It is well known that generation of specific and sensitive Abs against small 
molecules is greatly dependent upon characteristics of the hapten-protein 
conjugates (Rajesh et al., 2013). Ideally, conjugation should yield 100% 
conjugate of well-defined chemical structure, possess stable linkage and 
practical yet simple (Fasciglione et al., 1996). However these criteria are 
extremely hard to achieve and most of the conjugation procedures have large 
differences in terms of their conjugation efficiencies. The coupling of hapten to 
protein conjugate with optimal epitopes density without altering the basic 
molecular structure of the former is the most critical step required for the 
generation of good immunogen. Another important factor to be aware of is the 
introduction of new immunodominant epitopes (called neodeterminants) that are 
usually introduced by the most coupling agents which significantly reduces the 
specificity of humoral immune response (Fasciglione et al., 1996). Therefore, 
conjugation methods should be considered on the basis of that the carrier and 
coupling agents with low immunoreactivity should be selected to reduce the 
immune response against neodeterminants and at the same time able to 






In present study, BSA and KLH were both used as carrier proteins, the former 
being the carrier of choice to be used as immunogen initially and the latter as 
solid phase antigen to the hapten, linamarin. This was decided based on the high 
immune response obtained in rabbit, exhibiting excellent antiserum titre and 
working dilution of more than 1:100,000 (see Chapter 3). However, CovalAb UK 
Ltd. was somehow adamant in using linamarin-KLH conjugate although the initial 
request was to use linamarin-BSA conjugate. This mixed up was only brought to 
attention after the fusion procedure and since it was almost halfway through the 
mAbs development process and with extra assurances provided by the technical 
director from CovalAb UK Ltd. on their past experiences and successes in 
dealing with mAbs induced by hapten-KLH conjugates, the project was allowed 
to run. Similar to previous work in pAbs development, the immunisation 
responses and subsequent screenings were monitored with a non-competitive 
assay using homologous hapten labels, commonly done using hapten-
conjugates having different carriers from that of the immunogen. The pre-fusion 
antiserum titre of the mice were excellent (1:100,000), as good as the rabbit’s 
antiserum titre. Screening of the hybridoma supernatants revealed that most of 
the antiserum produced by the hybridomas failed to show significant binding to 
the free linamarin although some displayed slight inhibition at the highest 
linamarin concentration (Figure 4-10). While the use of carrier heterogeneity 
ensures that irrelevant carrier-specific antibodies are not measured, it still 
detects hapten-specific antibodies that include carrier protein structures in their 
epitopes which explains this type of behaviour. In the current work, the use of 
cyanuric chloride as the coupling agent (crosslinker, bridging molecule) between 
hydroxyl group in the glycoside and amino group in carrier protein was supposed 





mice was directed largely towards the bridging molecules producing antibodies 
specific for the linamarin-derivatives, and not for the free hapten, underlining the 
fact that the bridge effect is emphasised with small haptens (Chappey et al., 
1994), although this was not the case with Abs produced by the rabbits. Despite 
the results, the slight inhibition by the free linamarin was enough to warrant 
continuation towards the cloning stage and perhaps after the limiting dilution and 
successful cloning, some of the hybridoma clones would have been able to 
produce mAb specific to the free linamarin. Final tests by CovalAb UK Ltd. on 
the supernatants of the best three selected hybridoma clones were negative. 
Perhaps, the immune response in mice was also largely directed against either 
the neodeterminants (the e-lysine aminic bond) or those regions of the haptens 
involved in the coupling reaction. Due to the small size of the hapten, the bridging 
molecule will always recognised to some degree as well. In addition, most of the 
bridging molecules including spacer arms contained functional groups that were 
found to be important antigenic determinants (Tuomola et al., 2000). It is possible 
that the hapten, when linked to the carrier by a short linker group, was masked 
by or lost within the protein tertiary structure (Paxton et al., 1976). It was 
concluded that linamarin-CC-KLH conjugate was unable to generate mAbs 
specific to free linamarin perhaps due to factors mentioned and this approach 
was not pursued any further and prompted another attempt of mAb production; 
this time using the linamarin-CC-BSA conjugate.  
 
The immunisation with linamarin-CC-BSA conjugate was expected to produce 
good immune response in mice, similarly as good as their rabbit counterparts or 





the case. The antiserum titre was slightly lower than those obtained from 
previous attempt (1:70,000), which is expected due to smaller molecular size of 
BSA as compared to KLH, though still considered an excellent titre nonetheless. 
As there was a high risk of choosing mAb with a high affinity for the hapten 
derivative but low affinity for the free hapten, a competitive assay step was 
included in the screening at an early stage (pre-fusion stage) on top of the non-
competitive assay. The competitive assay result was not as expected as very 
little inhibition by the unbound linamarin occur and it seemed like the Abs had 
higher avidity towards the solid phase antigen. For some reason, the 
immunisation with linamarin-CC-BSA failed to produce antihapten antibodies in 
mice, as opposed to rabbit’s immune response towards the same immunogen 
described in Chapter 3. Since the Abs from the immunization using linamarin-
CC-BSA had also failed to establish a good inhibition assay and binding property 
towards free linamarin, due to budget and time constraint, this project was 
terminated at the end of the immunization stage. 
 
Dealing with interspecies immunization, various immunogenic carriers have 
been successfully used; among them, BSA was the most widely assayed for 
many reasons. BSA is inexpensive and readily. In addition, this protein proved 
to be heterologous enough to provoke adequate mice immune response in most 
cases (Naar et al., 1999) but not necessarily to haptens. Most of monoclonal 
antibodies approved for clinical application are of mouse origin. However, the 
mouse system is limited by a small spleen and mice used are usually inbred, 
thus offering less diversity of its immune responses. In contrast, as the original 
and still reliable model system to produce antibodies for laboratory use, the rabbit 





specificity. The rabbit immune system on the other hand generates antibody 
diversity and optimizes affinity by mechanisms different from those mice and 
other rodents (Zhang et al., 2017). Rabbits belong to the order Lagomorpha, 
which is evolutionary distinct from the order Rodentia, to which, for examples, 
mice and rats belong. Rabbit antibodies are able to recognize epitopes on 
antigens that are not immunogenic in rodents (Rief et al., 1998), increasing the 
total number of targetable epitopes and facilitating the generation antibodies to 
enhance the immunoreactivity (Yu et al., 2015). It has been observed that rabbits 
elicit strong immune response against small molecules and haptens, which is 
uncommon in rodents (Feng et al., 2011). Furthermore, rabbits use different 
mechanisms to genetically generate and diversify their primary and secondary 
antibody repertoires compared to mice, effectively creating a complementary set 
of binders (Weber et al., 2017). As of most strategies to generate mAb are based 
in the recovery of B cells from the spleen, bone marrow or blood, they are present 
in higher quantities in rabbits than in mice due to their overall larger body size 
(average body weight of a 3-month old laboratory rabbit is 2.5 kg compared to 
25 g for a 6-week old laboratory mouse). That’s 50 times more splenocytes 
containing B cells that could be recovered from rabbits as opposed to mice (Feng 
et al., 2011).  
 
However, the main challenge of using rabbit antiserum to generate mAb is the 
absence of stable rabbit myeloma lines to generate viable hybridomas (Raybould 
and Takahashi, 1988). Raybould and Takahashi generated the first stable rabbit-
mouse stable hetero-hybridoma by polyethylene glycol mediated fusion of rabbit 
spleen B cells with the mouse myeloma cell line SP2/0-Ag14. However, after 





mAb secretion by the hetero-hybridoma. The first rabbit homo-hybridoma was 
developed in 1995 in the laboratory of Katherine Knight (Spieker et al., 1995) 
and their findings subsequently led to the discovery of the first stable rabbit 
plasmacytoma cell line, 240E-1 which could be used as an efficient fusion 
partner to generate rabbit homo-hybridomas. However, the stability of the 
obtained homo-hybridomas was still a major concern and IgG secretion 
decreased over time. For this reason Zhu and Pytela (2009) attempted to further 
improve the initial 240E-1 cell line by iterative subcloning to screen clones with 
higher fusion efficiency, yielding hybridomas with higher genetic stability and 
more stable rabbit IgG secretion. The obtained fusion cell line of 240E-W and its 
successors 240E-W2 and 240-W3, which are characterised by higher fusion 
efficiency and the absence of endogenous rabbit heavy- and light-chain 
secretion (US Patent 7,429,487) are part of the proprietary RabMab platform of 
Epitomic, Inc (now Abcam, Inc.) and available commercially. The availability of 
stable rabbit fusion cell line provides an alternative to mAb generation through 
the murine cell line and perhaps this approach is something that could be 
considered in order to generate mAb against linamarin or a very small hapten. 
 
Several authors have outlined the importance of the physicochemical 
interactions between haptens, carrier proteins and bridging molecules when 
designing hapten-conjugate to ascertain success in mAb production (Fasciglione 
et al. 1996; Harrison et al., 1991; Goodrow et al., 1995). 
i) Carrier choice is critical in obtaining a high immune response 





ii) Hydrophobic haptens, modifying the tertiary structure of carrier 
proteins, are hidden in the core of the proteins thus avoiding or limiting 
any productive interaction with the immune system. 
iii) Specific carriers should be used to obtain high specific immune 
response against hydrophobic haptens. 
iv) Synthesis of a number of hapten derivatives with different bridge 
structures and attachment sites is generally recommended to explore 
maximum number of possibilities for obtaining good quality antibodies 
as well as for further assay improvement. 
v) One should resist the temptation to use the existing functional groups 
of the hapten for the conjugation reaction when working with smaller 
molecules because the smaller it gets, the more important is the 
retention of the group’s identity. 
 
4.5 Conclusion 
In general, the results of this study underline the importance of hapten design in 
the development of antibodies against compounds with simple structures and 
very low molecular weights. The hapten structure developed in this study 
successfully highlighted the choice of host animal for immunisation is something 
that should be considered especially when mAb generation is concerned. MAb 
should, however, be seen as complementary to those derived from animal serum 
because each has its place in immunochemistry. The unique specificity, defined 
affinity, and avidity of the mAb are very desirable when looking at cell surface 
markers or single epitopes on a viral protein. In contrast, the broad specificity of 





of a virus or in techniques such as immunoaffinity purification. MAbs may perform 




Chapter 5 : Sample Preparation and Determination of 
Linamarin in Cassava and Food Products 
 
Summary 
• The indirect competitive ELISA for linamarin developed in chapter 3 
was optimised and a sensitive standard curve was constructed using 
four parameter logistic regression analysis to achieve limit of detection 
(LoD) for linamarin of 1.5 ng/ml and working range of 0.215 µg/ml and 
24.5 µg/ml. 
 
• The cross-reactivity of the Ab with other structurally-related CGs was 
low amygdalin (4.80%), prunasin (6.48%) and mandelonitrile (6.40%). 
 
• No apparent matrix effects were seen with the ELISA when linamarin 
standards were dissolved in assay buffer or cassava extract and 
analysed.  
 
• The linamarin content of fresh cassava and processed products was 
successfully detected and quantified with the ELISA. The level of 
linamarin (HCN- mg/kg, fresh or dry weight basis) equivalent were 
ranging from as low as 0.003 to 43.08 mg/kg. The results obtained 






• Summary of cyanogen levels is shown in table below. 
1. Acute lethal dose of cyanide 0.5 – 3.5 mg/kg body 
weight 
2. Regulatory safe limit of total cyanide in food 
(WHO, FSANZ) 
10 mg/kg  
3. Regulatory safe limit of total cyanide in food 
(Ministry of Industry and Trade of Indonesia) 
40 mg/kg 
4. Highest concentration of linamarin found in a 
product (cassava root) 
43.08 mg/kg fw 
5. Lowest concentration of linamarin found in a 
product (tapioca flour)  







5.1 Introduction  
One direct method that have not been studied as much in terms of CGs detection 
and quantification is the immunoassay. The inherent characteristics of 
immunoassay in terms of rapidity, reliability, high sensitivity and specificity make 
it an excellent analytical technique in the food and agrochemical industry. 
Immunoassays are now widely utilized in food analysis for determination of food 
contaminants, mycotoxins, pesticide residues, detection and quantification of 
proteins, enzymes, vitamins and other naturally occurring substances (Schneider 
& Hammock, 1992; Goodrow & Hammock, 1998; Spinks, 2000; Burkin & 
Galvidis, 2010; Ackermann et al., 2011, Lei et al., 2011). Despite its success, 
until now, there are only three reports on immunoassay development for the 
qualitative analysis of CGs in plant foods, amygdalin (Cho et al., 2006; Cho et 
al., 2008) and one for its quantitative analysis as reported by Bolarinwa et al., 
(2014). This trend can be rationalised by the unavailability of suitable Abs to 
perform the immunoassay, largely due to the difficulty in designing and producing 
a stable hapten-conjugate (immunogen). Enzyme-linked immunosorbent assay 
(ELISA) would fulfil this entire requirement in addition to its high throughput and 
ease of use. The successful production of pAbs in chapter 3 would allow the 
ELISA to be optimised and characterized for the detection and quantification of 
linamarin in food samples.  
 
Direct and indirect analysis of CGs in general and linamarin in particular have 
been discussed in section 1.3.9. From the literature, there have been few studies 
conducted utilising the acid hydrolysis of the CGs and indirect semiquantitative 





Bradbury et al. (1999) for total cyanide content analysis in fresh cassava and 
food products. Cardoso et al. (1998) conducted the first field trial of the picrate 
paper kit on cassava flour in Mozambique followed by Ernesto et al. (1999) where 
they analysed the cyanogen content in the roots and also the thiocyanate content 
in human urine. Djazuli and Bradbury (1999) conducted cyanogen content 
analysis of cassava roots and flour in Indonesia using both acid hydrolysis and 
picrate kit method. These indirect methods measured the total amount of HCN 
in samples that require samples to be processed Cyanogen content of cassava 
root of 179 cultivars grown in Indonesia were investigated and they found out 
only 40% of 179 cultivars grown in Indonesia is safe for consumption using the 
safe regulatory limit of 40 mg/kg body weight is used (set by Ministry of Industry 
and Trade of Indonesia). Adindu et al. (2003) investigated the cyanogen contents 
in ready-to-eat food products from cassava such as gari (20~30 mg/kg fresh 
weight), fufu (10~30 mg/kg fresh weight) and tapioca (10~20 mg/kg fresh weight) 
and found out the mean total cyanogen contents were all higher than 10 mg/kg 
fresh weight). Burns et al. (2012) conducted the analysis in Australia and found 
an alarming level of total cyanide concentration (262 mg/kg dry weight) in one of 
the cassava chips product. It will only take about 40-270 g (approximately a 
packet of crisps) of these crisps to reach the lethal dose for 20 kg child according 
to the 10 mg/kg body weight regulatory limit introduced by FSANZ in 2009. In 
New Zealand, Cressey et al. (2013) conducted analysis on all plant-based foods 
that contain CGs and they detected total hydrocyanic acid in all samples of 
cassava root (whole or grated) but not in any further processed products (flour, 
tapioca). Yeoh and Sun (2001) introduced an enzyme-dipstick technique based 
on the picrate method, and assessed 35-cassava based foods available in 





equivalent/kg. In the UK, studies on cyanogen contents (amygdalin) in food (fruit 
kernels ie apricot, cherry, peach, apple, apple juice, almonds) were conducted 
by Bolarinwa et al. (2014) using immunoassay and HPLC and traces of 
cyanogens were detected but unlikely to pose health problems to consumers. 
There is no report on cyanogen contents of fresh cassava and food products 
available in the UK market at the moment. UK only imported about 2,500 tonnes 
cassava and cassava products per year according to FAO, mainly to cater niche 
population of Black British people of African and Carribean descent and British 
Asian communities which consume cassava occasionally as part of special 
dishes or delicacies. These group of ethnicities would be the most at risk of 
getting intoxicated if certain imported batches of fresh cassava were of the bitter 
variant and the cassava products, post processing, still contain high traces of 
cyanogens. All cassava products that were bought in this study have no warning 
regarding possible risk of cyanogen traces and let alone handling and 
preparatory instructions. The availability of such data would be helpful in 
assessing the need for better monitoring, labelling and public awareness of the 
potential health issue this residual cyanogens in foods could pose, not only in 
those containing linamarin in particular but all plant-based foods containing CGs. 
 
One of the challenges in using ELISA for detection of analyte in tissue sample is 
the sample preparation. Sample preparation for fresh cassava products requires 
careful planning due to the presence of the endogenous linamarase enzyme, 
which could be released due to mechanical damage to the tissue caused by 
processing or preparation prompting rapid degradation of linamarin to HCN. 
Sample preparation is also important to reduce the matrix effect in an ELISA. 





studied previously. For example, extraction of linamarin using ethanol or 
methanol with the inactivation of endogenous linamarase enzyme by boiling or 
enzyme precipitation was investigated by Zitnak et al. (1977). The use of 
orthophosphoric acid during diced (1cm cubes) cassava parenchymal tissue (30-
100g) homogenization was reported by Cooke (1978). The use of boiling 80% 
ethanol together with solvent:sample ratio of 10 to 1 v/w treated with blender for 
2 mins,  filtered and concentrated seems pretty much straight forward and simple 
(Brimer et al., 1983). King and Bradbury (1995) investigated the use of methanol 
during extraction for preparative HPLC and a mixture of hydrochloric acid (HCl) 
and methanol during extraction for analytical HPLC. Saka et al. (1978) and Linley 
et al. (2004) homogenized and extracted the linamarin using orthophosphoric 
acid. Sornyotha et al. (2007) investigated the use of different acids (HCl, H2SO4, 
H3PO4 or CH3COOH), using a modified version of the method of Cooke (1978). 
Tivana et al. (2014) reported the use of phosphoric acid and water for extraction 
of linamarin in fresh and processed cassava products. Most of the extraction 
methods mentioned were necessary to i) inactivate the endogenous linamarase 
enzyme, ii) maintain the acidic pH of 4~6 to prevent dissociation of cyanohydrins 
to acetone cyanohydrin and HCN, iii) use the extract for total cyanogens 
assessment (free cyanide HCN/CN-, acetone cyanohydrin and the glucosides, 
linamarin and lotaustralin). Considering the exhaustiveness of methods to extract 
and analyse cyanogens content in cassava from the literature, it was really 
surprising that ELISA was not one of them. Hence, methodology for sample 
preparation to extract linamarin from plant tissue to be assessed using ELISA 






5.1.1 Aim of the chapter 
 
The main aim of this chapter is to use the pAbs developed described previously 
in chapter 3 to detect and quantify the amount of residual linamarin present in 
fresh cassava and food products available in the UK. In order to do so, the most 
optimal way of sample preparation from food sample is imperative and this has 
been compared to various extraction and purification methods for cyanide 
quantification in various food products that have been developed and improvised 
throughout the years.  
 
This chapter describes the experimental approach and results towards the 
following area: 
i) Optimisation of the indirect competitive ELISA for the determination of 
linamarin in fresh and processed cassava products.  
 
ii) Optimal sample preparation for linamarin assessment using ELISA. 
 
iii) Determination of linamarin in fresh and processed cassava products 







5.2.1 Linamarin extraction from fresh cassava and food products 
 
5.2.1.1 Extraction of linamarin using ethanol 
The ethanol extraction method was adapted and modified from Brimer et al. 
(1983), Ruengpravut and Chulavatnol (1999) and Bolarinwa et al. (2014). Diced 
(1 cm x 1 cm) raw frozen cassava root (20 g) were immediately homogenized 
with chilled ethanol (kept in -20°C freezer overnight, 80 ml) for 15 s at low speed, 
followed by 1 min (2 times) at highest speed in a food processing blender. The 
homogenate was filtered through Whatman No. 1 filter paper into a small sized 
beaker (250 ml), placed in bucket of ice to maintain low working temperature and 
any residues remaining in the blender jar were rinsed off using more chilled 
ethanol (20 ml). The filtrate was then transferred into two (50 ml) conical tubes 
and placed in the ice bucket while waiting for other extraction to be completed. 
The filtrates were then centrifuged at 5,000 rpm / 4,696 x g rcf for 20 min at 4oC. 
The supernatants were then transferred with care into a new conical tube 
avoiding agitation of the pellet. Ethanol was completely evaporated from the 
supernatants using a rotary evaporator (40 minutes, 80 mbar, 50°C, 75 rpm). 
Once the solvent has completely evaporated, linamarin was dissolved in water 
(100 ml). The sample was then transferred into smaller tubes for storage in -20°C 







5.2.1.2 Extraction of commercially available cassava products 
Cassava products are not readily available in supermarkets or chain stores within 
the UK such as Morrisons, Tesco, Asda, Sainsbury or Aldi to name a few. 
However it could be purchased from local groceries stores specialized in 
international foods to serve certain ethnic or cultural backgrounds. Fresh and 
processed food samples used in this study were purchased from local 
supermarkets in Leeds, UK as mentioned previously and online during the period 
of June 2017 to December 2018 as listed in Table 5-1.  A total of 5 local 
supermarkets (Morrisons, Asda, Tesco, Sainsbury, Iceland) and 2 local groceries 
shops (Continental and Sing Kee) were visited. Of those, only the 2 local 
groceries (Continental and Sing Kee) sold cassava products. Only 1 online 
retailer (Tropical Sun Foods) was found to deliver cassava products directly to 
consumers. All available cassava products from these three retailers were 
purchased. Items were mostly bought only once to have a snap-shot picture 
(overview) of the presence of linamarin in products sold in Leeds. All the fresh 
cassava parts and wet products were stored at -20°C prior to extraction and 
analysis.
  
Table 5-1: Commercially available raw cassava and processed cassava products in the UK market. These products were bought 
from Sing Kee Chinese Supermarket, Leeds, UK and CC Continental Supermarket, Leeds, UK. 
 
No Product Product description Place of purchase Brand / Origin Weight (g) 
1. 
 
Fresh cassava root 
Continental Supermarket, 
Brudenell Grove, Leeds, UK 








Brudenell Grove, Leeds, UK 
Ades, Cameroon 500 
3. 
 
Cassava chunks (frozen) 
Continental Supermarket, 















Cassava dough (fermented) 
Continental Supermarket, 




Pure tapioca flour 
Sing Kee Supermarket, Cross 
Stamford Street, Leeds, UK 
UP, Thailand 455 
7. 
 
Black tapioca pearls 
Sing Kee Supermarket, Cross 
Stamford Street, Leeds, UK 







Green tapioca pearls 
Sing Kee Supermarket, Cross 
Stamford Street, Leeds, UK 
AAAAA, Thailand 250 
9. 
 
White tapioca pearls 
Sing Kee Supermarket, Cross 
Stamford Street, Leeds, UK 











Cassava chips (barbeque) 







Cassava chips (lightly 
salted) 































5.2.2 Optimization of the indirect competitive ELISA (icELISA) 
method 
Ab dilution, incubation time, coating Ag concentration, and blocking buffers are 
factors that could be optimized to influence the sensitivity of the assay. 
Evaluation of the optimisation process was based on the IC50 value and the 
coefficient of the linear equation (R2). From previous studies with amygdalin, an 
overnight incubation at 4°C of the primary Ab and Ag standard gave the lowest 
IC50 and higher R2 values reflecting a higher sensitivity assay (Bolarinwa et al., 
2014). Lower IC50 values indicate better ELISA sensitivity. The same incubation 
time and temperature were implemented for subsequent assays. Coating Ag 
concentration of 1.0 μg/ml was used throughout the assay development. 
Previous studies that worked on Ab development against hapten suggested that 
the use of 1% dried skimmed milk as blocking buffer was better compared to 
other buffers. However, for this investigation, these studies were repeated using 
1% BSA, 1% gelatine, 1% skimmed-milk and 1% soy as the blocking buffers. 
The use of a non-ionic detergent such as Tween 20 (0.05%, v/v), when used in 
conjunction with a protein blocker, provides added convenient and inexpensive 
blocking ability during wash steps by blocking areas on the surface that may 
become exposed due to protein/biomolecule desorption. 
 
5.2.2.1 Cross-reaction determination 
Cross-reaction determinations were carried out by incubating a range of 
concentrations of closely related CGs with the polyclonal anti-linamarin Ab 
(1:50,000 dilution) and comparing the response with that of linamarin. The cross 





mandelonitrile and amygdalin was determined by icELISA. Cross-reactions of 
the pAb were determined using: 
 
%Cross-reactivity (CR) = (IC50 of linamarin/IC50 of analogue) x 100 
 
5.2.2.2 Determination of matrix effect 
Non-specific interactions between Ab and the microtitration plate, proteins and 
other components in the sample, often known as matrix effects, can result in 
erroneous readings. The effect that other substances in the sample might have 
on the ability to detect the specific target material, are most commonly observed 
when using plasma and serum samples. Matrix components can affect the 
binding of antibody to protein or alter the signal-to-noise ratio hence it is 
important to investigate this effect prior to conducting assay on unknown 
samples. The determination of matrix effects was conducted by plotting normal 
standard curves (standards dissolved in assay buffer and standards dissolved in 
cassava extracts). The cassava extracts (containing non-detectable linamarin) 
were diluted in assay buffer (1:5 – 1:100, v:v, PBST) and used for the preparation 
of linamarin standard. 
 
5.2.2.3 Determination of linamarin in food products 
The extracted samples analysed by ELISA were diluted in assay buffer (1:10, 
v/v). Standard curves were performed with every analysis. Every ELISA plate 
had triplicate of negative control (secondary antibody control i.e primary antibody 
+ analyte + no secondary antibody), triplicate of positive control (primary 





blank (no primary antibody + buffer (minus the analyte) + no secondary 
antibody). Unknown concentrations were determined by using the equation from 
the four parameter logistic regression (4PL) curve. The similar pre-treated 
samples were also tested using MColortestTM Cyanide Test Kit from Merck for 







5.3.1 Linamarin extraction from fresh cassava and food products 
Three key areas were addressed prior to linamarin extraction from fresh cassava 
products: i) pre-processing storage condition, ii) suitability of the sample to be 
processed and iii) condition of the processing area. Fresh cassava tuber that had 
been bought fresh from the grocery shop was wrapped in a film and kept under 
separate storage conditions i) -86°C, ii) -20°C and iii) 4°C for a period of two 
weeks. The cassava tuber stored at -86°C had become rock solid and it was 
quite impossible to cut using a knife. The tuber had to be cut using a metal saw 
instead and the cross section of the tuber can be seen in Figure 5-1. The time 
taken to dice the sample into (1 cm x 1 cm) size was well over 5 mins and giving 
the sample ample time to thaw. 
 
   
   
Figure 5-1: Fresh cassava tuber stored at -86°C. The tuber is frozen solid and difficult 
to cut normally using knife. Metal saw had to be used instead. 
 
The cassava tuber stored in -20°C however, was much softer than the one stored 





the metal saw easily sliced through the tuber. The time taken to dice this sample 
into (1 cm x 1 cm) size took about 2 mins. 
 
   
Figure 5-2: Fresh cassava tuber stored in -20°C freezer.  
 
The cassava tuber stored in 4°C refrigerator was not doing so well compared to 
the other two storage conditions (Figure 4-3). Although the tuber could be cut 
and dice easily but black spots were spotted within the root parenchyma 
indicating signs of PPD due to presence of hydroxycoumarins release due to 
stress conditions. 
 
   
Figure 5-3: Fresh cassava tuber stored at 4°C refrigerator. 
 
The processing area was initially to be conducted in a cold room in order to 
minimise enzyme activation but due to some technical difficulties, the processing 






Extraction of the fresh cassava samples were conducted using chilled ethanol 
stored in -20°C. After homogenization, sample filtration was done as depicted in 
Figure 5-4. All filtrates were collected and stored temporarily in a bucket of ice to 
maintain low working temperature in order to minimise linamarin degradation by 
the linamarase enzyme. 
 
Figure 5-4: Extraction setup for linamarin from fresh cassava tuber and leaves. A 
bucket of ice was used to maintain low working temperature. 
 
Homogenates residue and supernatants from ethanol extraction are shown in 
Figure 5-5 and 5-6. Cassava cortex residue which contain only the root 
parenchyma appeared to be whitish, peel residue was brownish due to the colour 
of the peel and cassava leaves was greenish due to the presence of chlorophyll. 
   
a. Cassava cortex b. Cassava peel c. Cassava leaves 
Figure 5-5: Sample homogenates residue left after filtration. a) cassava cortex, b) 






Leaves, tuber, tuber and peel, peel 
Figure 5-6: Supernatants collected after centrifugation. From left a) cassava leaves, 
b) cassava tuber, c) cassava tuber and peel and d) cassava peel homogenised in chilled 
ethanol. 
 
Ethanol from the filtrates were removed using the rotary evaporator and resulted 
in dried residue that can be seen adhered to the glass surface of the flask (Figure 
5-7). The residue was dissolved in water (100ml). The sample was then 
transferred into smaller tubes for storage in -20°C until required. The same 
procedure was used for sample preparation on processed cassava products both 
in wet and dry forms.  
   
a. Cassava cortex b. Cassava peel c. Cassava leaves 
Figure 5-7: Sample filtrates after ethanol had been completely evaporated. Dried 






5.3.2 ELISA optimisation 
Most of the ELISA optimisation have been carried out in chapter 3. The optimised 
conditions include: i) primary Ab dilution (1 in 50,000 dilution), ii) secondary Ab 
manufacturer (CovalAb UK Ltd.), iii) type of TMB substrate (TMB1, refer section 
3.3.5) and iv) blocking buffers (dried skimmed-milk) were chosen for subsequent 
icELISA assessment. Other conditions such as i) incubation time of antigen 
coating buffer (overnight at 4°C), primary Ab (overnight at 4°C for non-
competitive ELISA, 2 hours at 37°C for competitive ELISA) and secondary 
antibody (2 hours at 37°C), ii) substrate incubation (30 mins) and iii) 
concentration of coating antigen (1.0 µg/ml) were based on work done by 
Bolarinwa and Al-Maghrabi (personal communication) where both have 
assessed and evaluated the conditions and suggested accordingly. All the 
conditions investigated for optimization were used to generate an icELISA 
standard curve against linamarin using polyclonal anti-linamarin Ab produced 
from CC conjugate at dilution of 1:50,000 (v/v). Mean values from 12 different 
standard curves were used to construct a standard curve using four parameter 
logistic analysis (4PL) provided by AAT Bioquest (2019) (Figure 5-8) where the 
value of the curve parameters is shown in the form of 4PL equation as follows: 
 
Where y is the absorbance obtained (nm), x is the concentration of the linamarin 
(log unit), (top) and (bottom) are the maximum and minimum responses (nm), 
respectively, Log EC50 is the value that produces a 50% signal response and 






Figure 5-8: Optimised standard curve for the indirect competitive ELISA for 
determination of linamarin. The equation of the line is for concentrations which are 
higher than 1.5 ng/ml. Error bars indicate the standard deviations of 12 different curves. 
 
The optimized icELISA standard curve obtained was characterised based on 
IC50, limit of detection (LoD) and working range of the assay. The 50% inhibition 
(IC50) of the standard curve was estimated to be 2,100 ng/ml (2.1 µg/ml) The 
LoD represent the lowest amount of analyte in a sample which can be detected 
but not necessarily quantitated as an exact value. The LoD was calculated based 
on the value of three times the standard deviation of the blank value or the lowest 
concentration of linamarin utilized. The limit of quantification (LoQ) was 
calculated based on the value of ten times the standard deviation of the blank 
value. These values were then interpolated from the sigmoidal dose-response 





calculated including the confidence interval. The LoD, was estimated to be 1.5 
ng/ml (0.0015 µg/ml) and the working concentration range of the assay, which 
was defined as the concentration that corresponds to 20% inhibition (IC20) and 
80% inhibition (IC80) was determined to be 215 ng/ml (0.215 µg/ml) and 24,500 





5.3.3 Cross-reaction of the polyclonal anti-linamarin antibody 
The reactivity of the obtained antiserum towards other structurally related 
cyanogenic glycosides to linamarin was investigated to determine the specificity 
of the antibody. Figure 5-9 shows the icELISA results of linamarin and the other 
analogues. Table 5-2 shows the data for linamarin and the analogues including 
their chemical structures with the IC50 values and percentage of cross-reactivity 
(CR) against linamarin.  
 
Figure 5-9: Competitive ELISA standard curve of linamarin obtained from 
antibody generated from the cyanuric chloride conjugate, using 1% dried 
skimmed milk as blocking buffer. 
†The antibody dilution was 1:50,000 and the solid phase antigen was linamarin-KLH 
(1μg/ml) from the cyanuric chloride method with milk blocking, overnight primary 
reaction incubation at 4°C, secondary reaction for 2 hours at 37°C and 30 min enzyme-

















Table 5-2: Cross-reaction data for linamarin and three other structurally 
related cyanogenic glycosides. 
 


















IC50 = Concentration of the analyte required for 50% inhibition of antibody binding to 
the coating antigen. 
 
 
From the results, it can be seen that the antiserum (R076D88) had poor CR with 
all of the three cyanogenic glycosides tested as the percentage of CR is well 
below 10%. There is close similarities of CR values between amygdalin, prunasin 






5.3.4 Matrix effect 
Cassava flour extract containing undetectable levels of linamarin was diluted in 
assay buffer (1:5, 1:10 and 1:15, v/v) and was then used for preparation of 
linamarin standard. As can be seen from Figure 5-10, the linamarin standard 
dissolved in the cassava flour extract was superimposed with linamarin standard 
dissolved in assay buffer, which indicates the absence of matrix effect in the 
ELISA assay. Dilution factor of 5 prior to ELISA is adequate to give similar results 
to standard assay buffer and dilution factor of 10 and 15.  
 
Figure 5-10: ELISA standard curve obtained by preparing linamarin in assay 
buffer and cassava flour extract diluted in assay buffer, i) Std – standard dissolved 
in assay buffer, ii) 1:5 – standard dissolved in cassava flour extract at 1:5 dilution, v/v, 
iii) 1:10 - standard dissolved in cassava flour extract at 1:10 dilution, v/v, iv) standard 
dissolved in cassava flour extract at 1:15 dilution, v/v.  Error bars indicate the standard 


























The linearity (R2 = 0.9719) of the ELISA assay response with tapioca flour 
extract also confirms the absence of matrix effect in the assay (Figure 5-11). 
 
 
Figure 5-11: Linearity of the ELISA assay response with cassava flour extract. 






























5.3.5 Determination of linamarin in food products 
The results obtained from the analysis of a variety of food products using the optimised ELISA method are shown in Table 5-3. As a 
comparison, a cyanide test kit that measures the amount of free cyanide ions in the sample were also performed. 
Table 5-3: Analysis of linamarin on fresh cassava and processed products (mg/kg fresh weight) 
No Sample ELISA MColortestTM Cyanide Test from 
Merck  
 Fresh cassava parts 
Linamarin (mg/kg) 
fresh weight (wet product) 
dry weight (for dry product) 
 Free cyanide ions (mg/l CN-) 
1. 
 
Fresh cassava root (stored in -
20 oC) 












Cassava cortex (stored in -
86oC) 












 Processed cassava products    
5. 
 















Pure tapioca flour 0.003 ± 0.001 <0.1 - 
9. 
 
Black tapioca pearls 0.036 ± 0.020 <0.1 - 
10. 
 
Green tapioca pearls 












Cassava flour 0.033 ± 0.014 <0.1 - 
13. 
 
Cassava chips (barbeque) 























Gari yellow 0.282 ± 0.10 
 
0 
Each value is expressed as mean ± standard deviation (n = 6 determinants). 




From the results, the amount of linamarin detected in the cassava cortex (stored 
in -20°C) is the highest followed by cassava leaves, cassava cortex (stored in -
86°C) and cassava peel. For the processed cassava products, the frozen 
cassava chunks and pieces still contain residual linamarin and for the rest of the 
dried products, the amount detected were well below 1.0 mg/kg dry weight. The 
results obtained from the cyanide test kit were negative for all the dried products 







Successful determination of biologically active compounds from plant material is 
largely dependent on the type of solvent used in the extraction procedure. 
Properties of a good solvent in plant extraction includes, low toxicity, ease of 
evaporation at low heat, promotion of rapid physiological absorption of the 
extract, preservative action, inability to cause the extract to complex or 
dissociate. The factors affecting the choice of solvent are quantity of target 
analytes to be extracted, rate of extraction, diversity of different compounds 
extracted, diversity of inhibitory compounds extracted, ease of subsequent 
handling of the extracts, toxicity of the solvent in the bioassay process and 
potential health hazard of the extractants, not to mention what is attended with 
the extract (Eloff, 1998). It is also important to take into account of the fact that 
the end product of the sample preparation will contain traces of residual solvent, 
hence the solvent should be non-toxic and should not interfere with the bioassay. 
 
Linamarin is a hydrophilic compound and therefore suitable to be extracted using 
a non-polar solvent. Acetone, ethanol and methanol are all excellent solvents 
widely used for extraction of many hydrophilic and lipophilic components from 
plants especially tannins, phenolic compounds and other antioxidant compounds 
(Tiwari et al., 2011). Apart from that they are also more efficient in cell walls and 
seeds degradation which have non-polar character and facilitate the release of 
more compounds from cells and more importantly is the inactivation of the 
endogenous linamarase enzyme preventing the degradation of linamarin 
compound. Additionally, ethanol was found easier to penetrate the cellular 





2010). Polarity of ethanol can be easily manipulated by adding water v/v (10% 
water to 90% ethanol) to improve its extractant capability on certain compounds 
such as flavonoids. Methanol on the other hand is much more polar than ethanol 
but due to its cytotoxic nature, it is unsuitable for extraction in certain kind of 
studies as it may lead to incorrect readings and results (Cowan, 1999). With all 
the above in mind, supported by the findings of Brimer et al. (1983), Ruengpravut 
and Chulavatnol (1999) and Bolarinwa et al. (2014), chilled ethanol was opted 
as the solvent to extract linamarin from the cassava and food products. The 
amount of solvent to sample ratio used in this study was in agreement with 
previous reports that suggested ideal solvent to weight ratio of 10:1 (v/w) (Das 
et al., 2010). 
 
In terms of recovery, analytical recovery refers to the amount of a target analysed 
relative to the ‘true’ amount present, usually expressed as a percentage. It is 
often difficult to recover 100% of a target analyte, particularly for a solid sample. 
Firstly, of course, there are losses during extraction; no process will be 100% 
efficient. Secondly, in real samples, low molecular weight analytes are often 
intimately embedded in the matrix. Thus, such analytes may be bound to 
insoluble structures or entrapped in networks of, for example, plant cell wall 
material. The usual way of calculating recovery is to ‘spike’ the sample with a 
known amount of the analyte dissolved in a volatile solvent. The solvent is 
allowed to evaporate, and the sample extracted and analysed. The amount of 






Of course, such experiments can never provide the recovery of the unknown, 
real analyte present, for the reasons described above. ‘Spiking’ will always give 
an over-estimate of true recovery, often a considerable over-estimate and 
therefore false re-assurance. Consistency of recovery (backed by assay 
validation) is a far more important measure. In the present example, the assay 
has been validated and consistency has been shown in several ways, but in 
particular by the data provided by the superimposability and linearity studies (see 
Figures 5-10 and 5-11).  
 
Based on the biological nature of cyanogenic glycosides, recovery is unlikely to 
be a problem due to its solubility and lack of binding to matrix (since plants use 
glycosides as the means of solubilising and transporting materials around the 
organism. The biggest problem is that as soon as the plant material (solid, of 
course) is prepared for extraction by cutting, chopping, homogenising, etc, then 
the target analyte will start to degrade by enzymic action. This is, of course, why 
there has been a lack of quantitative methods of analysis for cyanogenic 
glycosides in the literature especially for linamarin (see section 1.3.9). 
Consequently, considerable efforts have been made in the present study to 
investigate sample extraction methods in order to maximise recovery and 
minimise losses. The results (see Figures 5-2 and 5-4) show that the optimal 
extraction procedure is as follows. 
(i) Freeze the sample at -20⁰C.  
(ii) As soon as practically possible, homogenise the sample at 0⁰C and 





(iii) Any work prior to evaporation of the extractant requires working within 
the ice container to maintain low surrounding temperature. 
 
Improvement of the ELISA method in this study was based on investigating the 
effect of varying some factors that were not usual in immunoassay optimisation 
(choice of substrate and detection antibody) to improve the signal to noise ratio 
(chapter 3). The results obtained from this study showed that the best assay 
sensitivity was observed with these sets of conditions: i) solid phase antigen 
concentration, 1.0 µg/ml; ii) blocking buffer, 1% dried skimmed milk-PBST; iii) 
detection antibody manufacturer and dilution, CovalAb UK Ltd. and 1:1,000; iv) 
incubation time of antigen coating, overnight at 4°C; v) incubation time of primary 
reaction, overnight at 4°C; vi) incubation time of secondary reaction, 2 hours at 
37°C; vii) substrate reaction time, 30 mins. The standard curve for linamarin 
detection and quantification in cassava products was constructed using four 
parameter logistic (4PL) regression analysis software to provide more accurate 
assessment of the assay. This is true for any bioassays that depends on dose 
response or receptor-ligand binding assays that often follow a sigmoidal, or “s” 
shaped curve. This type of curve is particularly useful for characterizing ELISA 
because the results tend to be linear across a specific concentration magnitudes 
and beyond this linear range, the response quickly plateau and approach the 
minimum and maximum, one of the reason linear regression model is not 
preferable when dealing with this type of assay.  
 
As this is the first time a pAb had been successfully generated against linamarin, 





the use of antibodies and ELISA for detection and quantification of cyanogenic 
glycosides are also limited. The first study on successful production of pAbs to 
cyanogenic glycosides was reported by Cho et al. (2006) on amygdalin, raised 
against hapten-conjugate made using succinic anhydride to amygdalin in 
pyridine solution. Subsequent work by the same author and co-workers 
produced a recombinant antibody for the same analyte. Bolarinwa et al. (2014) 
reported a much simpler conjugation method utilising cyanuric chloride as the 
bridging molecule between the hapten and protein carrier and was able to 
produce highly sensitive working ELISA. Therefore, results from these three 
reports were used for comparison with the results from this study specifically on 
the limit of detection (LoD) and limit of quantification (LoQ). LoD is the lowest 
analyte concentration likely to be reliably distinguished from the blank and at 
which detection is feasible. LoQ is the lowest concetration at which the analyte 
can not only be reliably detected but at which some predefined goals for bias and 
imprecision are met. In other words, LoD values should be higher than the blank 
and LoQ values maybe equivalent to the LoD or it could be at a much higher 
concentration. These values are important for tests used to discriminate between 
the presence or absence of an analyte and to reliably measure low levels of 
analyte. LoD however is not to be confused with the assay sensitivity which is 
represented by the slope of the calibration curve. Cho et al. (2006) reported a 
detection limit of 0.1 µl/ml for the amygdalin ELISA method that employed pAb 
and detection limit of 0.5 ng/ml obtained from recombinant antibody. The LOD 
from this study (1.5 ng/ml) was more sensitive than the pAb amygdalin assay 
(0.1 µl/ml) (Cho et al., 2006) and not far off as compared to the recombinant Ab 
amygdalin assay (0.5 ng/ml) (Cho et al., 2008). Bolarinwa et al. (2014) reported 





ng/ml, with working concentration range between 10 ng/ml (IC20) and 10,000 
ng/ml (IC80), after further optimization and characterization. The anti-amygdalin 
antibody was generated from the amygdalin conjugated to BSA using the 
cyanuric chloride method, similarly used in this study to conjugate linamarin to 
BSA. Both the detection limit (1.5 ng/ml) and IC50 value (2,100 ng/ml) of the 
competitive ELISA standard curve for linamarin developed in this study was 
slightly higher than the LoD determined in the competitive ELISA standard curve 
for amygdalin developed by Bolarinwa et al., 2014. The Ab dilution used in this 
study (1:50,000) however is much higher compared to the anti-amygdalin study 
(1:30,000). Comparison between these findings are shown in Table 5-4. 
 













Linamarin 0.0015 0.215 2.10 24.5 1:50,000 
Amygdalin 0.0002 0.01 0.05 10.0 1:30,000 
 
IC50 = concentration of the analyte required for 50% inhibition of the antibody binding 
to the coating antigen. (IC20 = 20% inhibition, IC80 = 80% inhibition) 
LOD = Limit of detection is concentration that corresponded to the optical density of zero 
binding (i.e direct binding of the antibody to the solid phase antigen) reduced by 3 times 
the standard deviation of the mean zero binding. 
 
The lower LoD reported for the anti-amygdalin Ab was perhaps due to the 
presence of benzene ring in the amygdalin structure and its higher molecular 
weight (457.431) compared to linamarin (247.247), enabling it to elicit a better 
immune response and to generate pAb with higher affinity and specificity. The 
finding corresponds to the report of Szurdoki et al. (1992), which showed that the 





while for hapten without benzene ring the success rate is 1/11. In general, 
polyclonal antisera are complex mixtures of a considerable number of clonal 
products, and as a result they are capable of binding to multiple antigenic 
determinants (Diano et al., 1998). The above examples suggest that different 
hapten-conjugated proteins (immunogens), with different reactive groups, 
modified at different sites with different steric structure exposed with the 
introduction of spacer arm leading to different Abs in titre, affinity and specificity 
as reported by Kim et al. (2003). Nonetheless, both results from Bolarinwa et al. 
(2014) and presented in this study further strengthened the suitability and 
efficiency of cyanuric chloride to be used as bridging compound for conjugation 
involving cyanogenic glycosides or other very small hapten. 
 
The cross-reactions of the antibody for a group of similar compounds were 
investigated to determine the specificity of the antibody. The results obtained 
(Figure 5-9) showed that the antibody was specific for linamarin, with cross 
reactions of 4.80% for amygdalin, 6.48% for prunasin and 6.40% for 
mandelonitrile respectively. The result indicates that although these compounds 
share close structural similarity to linamarin, the antibody exhibited direct 
recognition to part of the hapten distal from the bridge attachment to the protein 
carrier. The distal site recognition was part of specific antibody characteristic 
described by Szurdoki et al., (1995). Cross reactivity may be attributed to 
absence of specific antibody binding to the structural feature common to the 
hapten of interest and related compounds, whether they are of close proximity 






The matrix effect in the ELISA assay was investigated by comparing the 
linamarin standard prepared in cassava flour extract to those prepared in normal 
assay buffer. The results obtained showed that the standard curves obtained 
were quite similar without any significant difference between all of them. The 
absence of non-specific interference was also confirmed with the linearity of the 
ELISA assay response when tapioca flour extract was analysed (Figure 5-10). 
 
Application of the ELISA assay to determination of linamarin and processed food 
products followed the matrix effect validation procedure. The results obtained 
from the determination of linamarin and food products using the optimised ELISA 
showed an acceptable results when compared to previous findings. Study by 
FSANZ suggested that there is sufficient enzymatic capacity in the microflora of 
the coecum to completely hydrolyze large amounts of linamarin as no unchanged 
linamarin was excreted in the faeces following oral ingestion. As total HCN levels 
are more readily determined than linamarin levels, the linamarin ARfD was 
converted to an ARfD for total HCN measured in cassava, for analytical 
convenience. One mole of linamarin can release one mole of hydrocyanic acid if 
hydrolysis is complete and on this basis linamarin ARfD equates to an ARfD for 
HCN in cassava of 0.08 mg/kg body weight, the ARfD for hydrocyanic acid 
provided a margin of exposure of seven which, given the steep dose-response 
curve for HCN toxicity, was considered to be appropriate. Linamarin content is 
expected to be high in the root parenchyma but that is not always the case as it 
can varies due to changes in the environment. The linamarin levels (HCN- mg/kg 
equivalent) detected in the fresh cassava parts (root cortex, 43.08, peel, 13.17 
and leaves, 30.78 mg/kg fresh weight, Class 2, Costa Rica) bought in the UK 





linamarin content in cassava is usually measured as a whole tuber, the linamarin 
content of unprocessed whole root (root + peel) is 56.25 mg/kg, more or less 
similar to value reported by Burns et al. (2012). The commercially processed 
cassava (chunks and diced, Daily Delight, India), were subjected to minimal 
processing (peeling, washing, cut into chunks or diced into smaller pieces, 
packing and freezing). These processing methods have indeed reduced the 
amount of linamarin considerably (chunks, 14.51, diced, 9.22 mg/kg) as 
compared to the unprocessed root. Most of the linamarin, having good solubility 
in water perhaps had been leached out from the chunks and diced cassava, 
notably in higher amount from the diced variant due to increase in total surface 
area over volume. Cassava dough contains 2.03 mg/kg amount of linamarin. 
This was expected due to the amount of processing involved in preparing the 
cassava dough and the fermentation process that might occur during storage. 
The rest of the highly processed products (cassava and tapioca flour) contains 
almost undetectable amount of linamarin, same goes to all of the tapioca pearl 
and gari variants. Apparently both cassava crisps (lightly salted and BBQ 
flavoured) have linamarin residual of less than 1.0 mg/kg dry weight. As the 
commercial picrate kit method used by Bradbury to measure total cyanogens in 
food samples was not available to be purchased, another test kit was purchased 
and used to measure the amount of cyanide ions present in the samples for 
comparison purposes. This method however lacks the enzymatic break down of 
linamarin to HCN/CN- and uses the König reaction instead for colorimetric 
determination of cyanogens in the sample. Since most of the linamarase 
enzymes have been inactivated and discarded during the extraction of linamarin, 
there should be very little or zero amount of cyanide ions present in the samples 





HCN/CN- in wet samples were expected due to the waiting time between 
chopping and homogenization in the extraction steps as linamarase enzyme 
might have not yet been fully inactivated and removed, provided there are still 
residual linamarin left in the product, HCN/CN-  liberation can still occur albeit at 
lower rate therefore giving positive readings. No HCN/CN- were detected in all of 
the dried samples whereby all of the enzymes have been inactivated and leached 
out during the processing. The test kit was not the best kit to validate the results 
of the ELISA as it measures the amount of HCN/CN- in sample meanwhile the 
latter measures the amount of the linamarin. Furthermore, the amount of 
HCN/CN-  detected in fresh leaves sample might have been falsely represented 
by the colorimetric indicator. This was due to the fact that the leaves extract was 
the only sample that had slightly greenish colour prior to the test and it caused 
the colour formation to be much darker than it probably should (Figure 5-5). This 
comparison however, able to highlight some of the limitation of semi-quantitative 
measurement using colorimetric method as opposed to the direct quantification 
of the CGs using ELISA. 
 
In order to fully understand the results, it is imperative to note that the toxic effect 
of cyanide on human depends on body size, health status, the dose of cyanide 
ingested and the time duration over which it is ingested. Table 5-5 shows the 
amount of each product required to be consumed in order to reach the lethal 
doses according to different body weights based on the acute lethal dose of 
hydrogen cyanide for human which is 0.5-3.5 mg/kg body weight based on the 
results in Table 5-3. These calculations, however, do not take into account the 







Table 5-5: Minimum lethal doses of cyanide and amount of products 





Product consumption to reach the lethal amount (kg) based on 
body weight 
Body weight (kg)  10 20 40 60 80 100 
Lethal range of 
cyanide (mg/kg) 0.5-3.5 5 - 35 10 - 70 21 - 140 30 - 210 40 - 280 50 - 350 
Product         
Cassava roots 43.08 0.1 - 0.8 0.2 - 1.6 0.5 - 3.2 0.7 - 4.9 0.9 - 6.5 1.2 - 8.1 
Cassava peel 13.17 0.4 - 2.7 0.8 - 5.3 1.5 - 10.6 2.3 - 15.9 3.0 - 21.3 
3.8 - 
26.6 
Cassava leaves 37.08 0.1 - 1.9 0.3 - 1.9 0.5 - 3.8 0.8 - 5.7 1.1 - 7.6 1.3 - 9.4 
Frozen cassava 




(diced) 9.22 0.5 - 3.8 1.1 - 7.6 
2.2 - 
15.2 3.3 - 22.8 4.3 - 30.4 5.4 - 38 
Cassava dough 2.03 2.5 - 17.2 
4.9 - 







Cassava flour 0.033 - - - - - - 
Tapioca flour 0.003 - - - - - - 
Black tapioca pearl 0.036 - - - - - - 
Green tapioca pearl 0.008 - - - - - - 
White tapioca pearl 0.023 - - - - - - 
Gari 0.425 - - - - - - 
Ijebu gari 0.282 - - - - - - 
Yellow gari 0.270 - - - - - - 
Cassava crisps 
(lightly salted) 
0.449 - - - - - - 
Cassava crisps 
(BBQ) 
0.455 - - - - - - 
*Products containing less than 1.0 mg/kg cyanogen were not calculated as they are negligible. 
 
A teenager weighing 60 kg could eat 0.9 kg of cassava root before reaching the 
lethal limit but a child of 20 kg would only need to eat as little as 0.2 kg of the 





only sampled once and may not be representative of the linamarin content of 
foods available in the UK. Another limitation was that some of the foods (e.g 
fresh cassava roots or products) were not cooked. Various methods are 
employed in different parts of the world where cassava is consumed. These 
methods consist of different combinations of peeling, chopping, grating, slicing, 
soaking, drying, frying, boiling and fermenting. In Africa, where cassava flour is 
a major food product, wetting is an effective method of removing cyanide 
(Bradbury, 2006; Cumbana et al., 2007). Frozen or fresh roots that are usually 
boiled, baked or fried before consumption, can reduce the concentration of total 
cyanide in these products by 10-75% (Nambisan and Sundaresan, 1985; 
Montagnac et al., 2009b), but may not reduce the concentration below the safe 
limit. Based on the results presented here, it is strongly advisable that the 
maximum 10 mg/kg safe level of cyanogens in food products to be monitored to 







The developed ELISA method was considerably sensitive with LoD of 1.5 ng/ml 
and IC50 of 2.1 µg/ml. Cross-reactivity of the antibody with other related 
cyanogenic glycosides was low (4.80-6.40%). The antibody was therefore highly 
specific for linamarin. No matrix interference was found in the ELISA. The 
amount of residual linamarin retained in fresh unprocessed cassava root and 
leaves as well as those frozen ready-to-use products are the biggest concern 
according to the results of this study as the levels had exceeded the regulatory 
limit of cyanide allowed in food set by WHO, FSANZ (10 mg/kg). Based on these 
limited results, the acute public health implications will vary according to the level 
of total cyanogens in the specific cassava products and the amount of the 
product consumed by the consumer in the UK. Committee of Toxicity UK 
reported that there are limited data on chronic intake of cyanogenic glycosides 
available in the UK to make it a concern. Perhaps, with further survey and 
assessment using larger samples would give a clearer view of current cyanide 
occurrence in cassava based products to help authority set the ARfD, regulatory 
and maximum limit allowed in all the cyanogenic food plants available in the UK. 
Consumption of such cyanide-containing products, therefore, poses a health 








Chapter 6 : General Discussion, Future Work and Conclusions 
 
6.1 General Discussion 
Linamarin is one of the major cyanogenic glycoside, being present in the 
cassava, staple food to some 800 million people worldwide. The cassava are 
largely consumed raw or processed into wide varieties of products either for 
personal or commercial purposed. Consumption of improperly processed food 
products could result in serious health problems for consumers due to exposure 
to cyanide derived from linamarin. Children, more commonly then adults, are 
usually the victim of cyanide poisoning because of their low bodyweight. Multiple 
cases of cyanide poisoning in schools from consumption of small quantities of 
poorly cooked cassava from ‘bitter’ cultivars have been reported (section 1.3.6). 
Unintentional poisoning can also occurs in adults due to consumption of 
improperly processed food products (Akintowa & Tunwashe, 1992; Suchard et 
al., 1998; Sanchez-Verlaan et al., 2011). This is because most of the processing 
methods employed for cassava processing in industry or by the individuals do 
not necessarily involve complete removal of linamarin, thus resulting in the 
presence of residual linamarin in the final product. Therefore, the need for a 
sensitive detection method for monitoring linamarin in processed foods becomes 
important. There are exhaustive list of published information on the detection of 
linamarin using standard analytical method (which involved the use of laborious, 
expensive and highly specialised equipment). Furthermore, most reports as 
reviewed in section 1.3.9 measure total hydrogen cyanide-generation potential, 





food products has not been investigated and there is apparently no report on the 
use of immunochemical methods for linamarin detection. This present study 
therefore covers most of the experimental works performed in order to raise good 
pAb against linamarin and to establish a sensitive immunoassay capable of 
detecting and quantifying linamarin in cassava food products within the UK, data 
that is also have not been previously investigated and reported. 
 
Since conventional methods for direct linamarin detection involved the use of 
expensive equipment, there is need for a rapid, simple, more sensitive and cost-
effective method that can be applied away from the laboratory. An enzyme-linked 
immunosorbent assay (ELISA) method would fulfil these requirements. An 
ELISA method can provide visual results which are useful for field work as a form 
of qualitative analysis in addition to its quantitative analysis. The three published 
studies on the detection of amygdalin using an ELISA method were based on 
the quantitative and qualitative analysis of amygdalin in raw foods (Cho et al., 
2006 & 2008, Bolarinwa et al., 2014). In the present study, pAb was produced 
against linamarin and the generated antibody was characterized and used to 
quantify the amount of linamarin in raw and processed food products. 
Establishing an ELISA technique for linamarin detection is not an easy task. The 
use of pAb and perhaps the ability of generating mAb against the analyte of 
interest has always been the long-term goal in immunochemical research. The 
rabbit’s pAb produced in this study was highly immunoreactive and sensitive 
towards linamarin therefore enables a very sensitive and specific ELISA 
technique to be developed after several optimisation studies. This has prompted 
the mAb production against linamarin using the common animal host, mouse. 





(linamarin-CC-KLH and linamarin-CC-BSA), both antisera, although has high 
titre, failed to bind with free linamarin in the inhibition assay. The results of this 
study underline the importance of hapten design in the development of 
antibodies against compounds with simple structures and very low molecular 
weights. Although the increased understanding of antibody–antigen interaction 
resulting in a more rational design of haptens, there is still a practical difficulty in 
predicting which chemical structure is required for the production of specific and 
sensitive antibodies against a particular analyte. The inability of mouse immune 
system to produce specific antibody against free linamarin successfully 
highlighted the choice of animal host for immunisation is something that should 
be considered carefully especially when mAb generation is concerned.  
 
The results of this study also showed that specific antibody can be produced 
against non-chromophore, low molecular weight cyanogenic glycosides such as 
linamarin. The developed ELISA was more sensitive than the polyclonal ELISA 
reported by Cho et al. (2006) and was not that far off from those reported by 
Bolarinwa et al. (2014). The ELISA described in the present study has been 
internally validated in a number of ways, looking at sensitivity (Table 5-4, Figure 
5-8), specificity (Figure 5-9), robustness (section 5.3.2), superimposability 
(Figure 5-10), linearity (Figure 5-11) and by ‘sense checking’ results from 
investigations into extraction and with the results from analysis of samples 
(section 5.3.6). However, correlating quantitative analysis of linamarin has 
proved extremely difficult. There is little published information on the detection of 
linamarin in food samples, even HPLC has not been utilised as might have been 
expected, this is because of the difficulties of working with glycosides in 





compound, does not have a characteristic uv spectrum, which makes it even 
more difficult when it comes to detection. However, in the work of Bolarinwa et 
al. (2013), determination of amygdalin in food product using the optimised ELISA 
assay for amygdalin showed an excellent correlation with that obtained with the 
HPLC method with R2 value of 0.983. As described in section 1.3.9, methods for 
estimation of linamarin have been described and most reports were based on 
colorimetric detection of derivatives formed after reaction with hydrogen cyanide 
released upon hydrolysis of the analyte, measuring the total cyanide-generating 
potential instead of individual compound. There are kits available commercially 
based on this principle but only the kit measuring the free cyanide ions present 
in a sample was available at the time of study. The picrate paper method kit used 
extensively and mainly by Bradbury was not available to be purchased from any 
of the scientific suppliers to make better comparison and correlation with the 
ELISA described in present work. Since there are currently no reported studies 
on linamarin quantification in food samples using ELISA therefore comparison 
was made with previous studies on cyanogenic potential of cassava products 
using picrate paper methods as depicted in Table 6-1. The reported 
measurement of total cyanide potential is understandably higher since it 
represents the total of cyanogenic potential in the sample consisting of HCN/CN-  
liberated by the linamarin, acetonecyanohydrin and free cyanide ions meanwhile 
ELISA only measures the amount of linamarin present in the sample. Different 
cultivars and origin of the cassava might also contributed to the differences in 
HCN amount in each respective studies. The results of the quantitative analysis 
of linamarin in foods using the ELISA in this study exhibited close similarities to 
the result from previous studies indicating that the ELISA method could be a 


















icELISA Cassava tuber, 
peeled (Costa 
Rica) 
 43.08 - 
Picrate paper Cassava tuber 
(TMS 50395, 
TMS63397) 
41, 47  Bradbury et al. 
(1999) 
Picrate paper Cassava tuber 
(Indonesia) 







46  Yeoh and Sun 
(2001) 
Picrate paper Cassava tuber, 
peeled (Vietnam) 











Nevertheless, the free cyanide ion test kit was purchased and used to further 
validate the assay. The results from the kit showed negative results for dried 
cassava products but for most wet products (Table 5-3), there were slight change 
of colour indicating the presence of cyanide ions within the samples. Although it 
did not measure the amount of linamarin in the samples, the kit however, able to 
point out the small presence of free cyanide ions in wet cassava samples 
potentially liberated during the extraction process, despite all the steps taken to 
minimise the hydrolysis of linamarin by the endogenous linamarase enzyme. 
Whilst correlation is often, rightly or wrongly, seen as the ultimate procedure in 
assay validation, in reality the ultimate procedure in validation should be inter-
laboratory trials where a limited number of laboratories all analyse the same 
samples using the same method of analysis. Such studies are expensive and 





there is significant commercial interest, or where there are significant regulatory 
factors involved. Thus if it was decided that there should be a regulatory level 
governing the maximum amount of cyanogen glycoside present if human food 
in, say, the EU, then there would have to be an internationally-accepted method 
of analysis in place to support the regulations. 
 
Finally, the amount of residual linamarin retained in fresh unprocessed cassava 
root and leaves as well as those frozen ready-to-use products are the biggest 
concern according to the results of this study as the levels had exceeded the 
safe limit of cyanide intake set by WHO, FSANZ (10 mg/kg). The estimated lethal 
dose would be around 0.5 ~ 3.5 mg/kg body weight. The UK Committee of 
Toxicity has set a total daily intake (TDI) of cyanide at 20 μg/kg body weight but 
none on the regulatory safe limit. This method could also be used to assess the 
effect of residual linamarin on chronic low dose dietary intake. The set limits 
however do not take into account the general health and nutritional status of the 
consumer, which may alter the effective lethal limit. Current labelling on cassava 
products imported into the UK are lacking hazardous warning related to presence 
of CGs in the product and not to mention any preparation or cooking instructions 
hence, the poor awareness of the public on this matter since cassava is not the 
main source of diet in the UK. These findings suggest that appropriate warning 
label and preparation instructions are necessary for any cassava products 







6.2 Suggestion for future work 
Based on the findings of this study, further works could be carried out in the 
future as follows: 
i) Since this was the first time the cyanuric chloride conjugation method 
was used for immunogen production, studies on the use of this method 
for the synthesis of hapten-protein conjugate for antibody production 
against other CGs or other very small hapten could be investigated. 
 
ii) The unsuccessful attempts made in producing mAb against linamarin 
in this study warrants another look into the alternative of using rabbit’s 
generated monoclonal antibodies as opposed to mouse. The hapten-
conjugate synthesis also could differ from batch to batch hence 
conjugates of multiple batches are advisable so that only those with 
optimum hapten-protein ratio is selected for immunization. 
 
iii) The developed ELISA should be used for linamarin detection and 
quantification in fresh cassava and food products available in other 
countries that consume cassava as staple and in considerable amount 
compared to countries in this part of the world. 
 
iv) HPLC analysis or other standard direct quantification methods will 
need to be performed concurrently in order to validate and compare 






v) Further investigation of the development of a more rapid ELISA test in 
form of a lateral assay (dipstick test) for linamarin and other CGs would 
provide a rapid and easy point of care testing (POCT) method of 
analysis of CGs within the industry or on the field. Other use of the pAb 
or successfully generated mAb would be the incorporation onto self-
assemble layers of graphene and gold nanoparticle on screen-printed 
electrode for highly sensitive analyte detection using a portable 
potentiometric or voltammetric device that could provide exact 







The objectives of the present research which were, to generate antibodies 
against linamarin and use it to develop a highly sensitive enzyme-linked 
immunosorbent assay (ELISA) for the determination of linamarin content in 
varieties of fresh and processed cassava products available in the UK were all 
achieved. The unsuccessful attempts in producing monoclonal antibodies 
against linamarin have given valuable insights of the complexity involved when 
it comes to planning and producing new hapten-conjugate to raise the antibody 
against. This study also revealed a wide range of cyanide concentration in 
commercially available cassava based products in UK. As the negative impacts 
of excess cyanide consumption are well known, it is clear that careful regulation 
of the importation of cassava products may be necessary to monitor and control 
the amount of total cyanogen in both fresh and some of the ready-to-eat 
products. The use of immunoassays in determination of CGs in foods requires 
more research and therefore a reliable and sensitive ELISA method 
demonstrated in this study would be very important for the development of other 
immunoassay methods that was deemed impossible for very small haptens and 
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y = 0.015x + 0.5162 
R² = 0.998 
y = 0.0086x + 0.4852 

































Linear (BSA Standard) 
Linear (Linamarin-cc-
BSA conjugate) 
TNBS standard curves obtained with BSA and linamarin-BSA conjugate from the cyanuric 
chloride method, showing the reduction in free amino  acids of BSA 
after conjugation to linamarin 
UV absorption spectra of BSA (carrier protein), linamarin (hapten) and linamarin-cc-BSA 
(conjugate) from the cyanuric chloride method  
Immunization to raise the polyclonal antibodies 
¾ Application of optimised ELISA method to quantify linamarin  
amount in fresh and cassava products. 
Linamarin-cyanuric chloride-BSA conjugation steps 
Hapten-protein conjugate assessment (spectrophotometric analysis) 







The aim of this study is to develop a specific, 
sensitive immunoassay for determination of 
linamarin in cassava and cassava products. 
How we designed the immunogen? 
How we assessed the conjugate? 
How did it occur chemically? 
How we raised the antibody? 
What are we going to do with it? 
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Lower conjugate peak 
and reduction in free 
amino acids in BSA from 
TNBS assay compared to 
standard BSA indicated 
that conjugation had 
occurred!! 
Hapten = Linamarin 
Carrier molecule =  
Bovine serum albumin (BSA) 
Immunoassay, using antibody 
specificity can be used in rapid, 
simple and cost effective 
methods of analysis to detect 
linamarin in food. 
Cyanogenic glycosides release hydrogen cyanide 
(HCN) under certain conditions leading to toxic 
effects: 
¾ Cyanide poisoning, tropical ataxic neuropathy, 
konzo  upper motor neurone disease, goitre, 
in extreme cases, death. 
Cassava (Manihot esculenta Crantz) 
also known as tapioca, manioc 
Immunization plan 
Characterization of the immunoassay (ELISA) method to determine linamarin  
in food samples: 
 
¾ Optimisation of the indirect competitive ELISA 
¾ Cross-reactivity study 
¾ Determination of matrix effect 
 
And finally: 
9 The amount of linamarin retained in fresh and processed cassava are not 
negligible based on previous studies. 
 
9 The availability of an appropriate antibody could lead to the development of a 
simple dip-stick procedure that could be used away from specialised  
resources. 
Take home message 7 
Hydrogen cyanide  inhibits 
cellular respiration 
 Linamarin is of low molecular weight (<1000 daltons)  it can t elicit immune  
     response to produce antibody unless it is conjugated to a bigger protein. 
 
 
 
243 
 
